Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",A1BG,Alpha-1B-glycoprotein,17637,50,0.36 [0.08-1.54],0.167079005341016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AAMDC,Mth938 domain-containing protein,17158,52,1.38 [0.84-2.27],0.2085214960682977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,20108,81,0.79 [0.55-1.13],0.1985123174545823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,17001,51,2.99 [1.78-5.04],3.677504771461037e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABHD14B,Protein ABHD14B,19966,80,1.06 [0.75-1.50],0.7350200759063245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,20108,81,1.74 [1.35-2.24],2.3117274987220907e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABO,Histo-blood group ABO system transferase,17611,51,0.96 [0.79-1.15],0.6335577775388753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,17001,51,1.53 [1.02-2.27],0.0377544154250654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19761,80,1.37 [1.10-1.71],0.0043610155217675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",17281,52,0.99 [0.66-1.48],0.9644143396723576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",17610,52,1.10 [0.82-1.47],0.5373490271333712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACAN,Aggrecan core protein,20011,82,4.15 [2.07-8.33],6.033749825031265e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACE,Angiotensin-converting enzyme,17611,51,5.06 [2.61-9.82],1.624887075003598e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,19823,80,1.54 [1.14-2.06],0.0042514257903517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACHE,Acetylcholinesterase,17227,49,2.57 [1.34-4.94],0.0045842117282732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,17522,52,1.36 [1.07-1.73],0.0113448493956655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,20208,82,0.92 [0.63-1.36],0.6770539885652125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,17083,52,0.82 [0.44-1.53],0.5364866282974237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,20316,83,2.86 [1.91-4.28],3.225856014022607e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,20337,81,1.76 [1.27-2.44],0.0006590002031311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACRBP,Acrosin-binding protein,17526,51,1.48 [0.85-2.58],0.1662107380059032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACRV1,Acrosomal protein SP-10,17083,52,1.64 [1.38-1.95],1.7634668569197183e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,17001,51,1.18 [0.59-2.36],0.6440278285351881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",19823,80,3.02 [2.44-3.75],7.941750014897081e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTN2,Alpha-actinin-2,17001,51,2.03 [1.49-2.78],8.234625919255458e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTN4,Alpha-actinin-4,19834,81,1.42 [0.89-2.26],0.1430458477429261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,19986,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACY1,Aminoacylase-1,20208,82,1.20 [0.89-1.62],0.2330706645254076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17001,51,1.67 [1.12-2.49],0.0111385135725081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACYP1,Acylphosphatase-1,17159,49,1.15 [0.76-1.75],0.5120617690028676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA,Adenosine deaminase,20408,82,2.56 [1.68-3.91],1.2614403479477647e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA2,Adenosine deaminase 2,20127,82,7.85 [5.60-11.02],8.761903092432266e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17083,52,6.83 [4.47-10.44],6.204515802733334e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,19823,80,0.99 [0.52-1.89],0.9794796793502728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,20021,81,8.09 [5.02-13.03],8.710390534758626e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,20408,82,8.85 [4.55-17.20],1.2576312239039665e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,20329,81,3.11 [1.94-4.98],2.4095072564610803e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17522,52,6.99 [4.11-11.89],6.835474841885307e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17083,52,2.43 [1.51-3.91],0.0002585251020232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,20456,83,0.65 [0.29-1.42],0.2783361377108788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,20108,81,2.59 [1.67-4.02],2.112687107477372e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,19823,80,2.04 [1.57-2.64],8.106157175320743e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17083,52,2.54 [1.46-4.41],0.0009613370987272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,20289,81,2.01 [1.28-3.15],0.0024181783498117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,17614,50,3.66 [2.03-6.60],1.6205050509222447e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,17158,52,0.46 [0.16-1.37],0.1620759378062902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,17610,52,1.67 [0.88-3.17],0.1131034890576223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,19761,80,0.67 [0.31-1.44],0.3016207943402709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADD1,Alpha-adducin,17227,49,1.24 [0.84-1.83],0.2708260310170957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,19986,81,9.21 [5.48-15.49],5.3243923803399455e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,17227,49,4.20 [2.38-7.41],7.618515244744512e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,17522,52,2.00 [1.36-2.96],0.0004961004195166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,20290,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,20375,83,5.53 [3.73-8.21],1.7569428415807418e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,17610,52,1.56 [0.62-3.94],0.3470413528427548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,20108,81,2.21 [1.90-2.56],3.751012802593033e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,20208,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,17030,52,0.77 [0.49-1.23],0.2797628823293137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,17227,49,0.94 [0.65-1.36],0.7429649083521168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,19823,80,0.95 [0.75-1.21],0.679836551148854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADIPOQ,Adiponectin,17637,50,0.67 [0.47-0.95],0.0266030757548598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADM,Pro-adrenomedullin,20371,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,17001,51,0.93 [0.61-1.41],0.732497367530639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFAP1,Actin filament-associated protein 1,17227,49,1.02 [0.73-1.43],0.9189609543854868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFM,Afamin,17637,50,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFP,Alpha-fetoprotein,19951,81,0.28 [0.20-0.39],1.0135051834595461e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,17030,52,1.08 [0.79-1.49],0.6345059190081935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,20166,79,2.26 [1.48-3.43],0.0001427189750471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,19585,75,1.95 [1.65-2.32],1.1116587516856135e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR3,Anterior gradient protein 3,19719,80,1.77 [1.35-2.32],3.630170333189847e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRN,Agrin,20290,80,6.77 [4.87-9.42],6.012766619052881e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRP,Agouti-related protein,20408,82,2.26 [1.64-3.12],7.281486883018014e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGT,Angiotensinogen,17611,51,0.82 [0.26-2.56],0.7344785100921105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGXT,Serine--pyruvate aminotransferase,20208,82,1.22 [0.96-1.56],0.1036209705301625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHCY,Adenosylhomocysteinase,20208,82,1.32 [0.99-1.75],0.0545520953669747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,17158,52,2.65 [1.51-4.64],0.0006595159510249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK2,Protein AHNAK2,17158,52,4.48 [2.68-7.48],1.0840062017966242e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,17526,51,1.03 [0.68-1.55],0.8913650958291848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,17611,51,1.31 [0.49-3.53],0.5879501966589477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,20183,80,0.87 [0.69-1.08],0.2024682293952495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",17117,51,1.02 [0.73-1.42],0.8975881333467064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AIF1,Allograft inflammatory factor 1,19761,80,1.39 [0.96-2.00],0.0789324347403983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,17158,52,1.49 [1.08-2.04],0.0149080657615123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",20077,81,1.33 [1.11-1.59],0.0017917893964444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,20208,82,0.74 [0.54-1.01],0.0580045827604956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",17573,52,1.30 [1.01-1.69],0.0453915918966551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKAP12,A-kinase anchor protein 12,17227,49,2.10 [0.88-5.04],0.0947282224510506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,19761,80,1.13 [0.86-1.48],0.3696383017672476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,17117,51,1.45 [1.05-1.99],0.0222812458814177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,19823,80,1.43 [1.11-1.86],0.0064431663307024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,17083,52,1.41 [1.02-1.95],0.0379389363100882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,19753,77,1.25 [0.91-1.71],0.1616617655801001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,17572,52,1.16 [0.93-1.43],0.1869317837950294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,19679,79,1.15 [0.81-1.65],0.4326519857300749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALCAM,CD166 antigen,20456,83,5.28 [2.29-12.15],9.10363187263198e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,20222,80,0.81 [0.56-1.18],0.2754858925630669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",17526,51,1.28 [0.88-1.86],0.1954614039296868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",20117,80,1.31 [1.06-1.62],0.0124091165778137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",17572,52,1.08 [0.63-1.88],0.7701651189687773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALMS1,Alstrom syndrome protein 1,17281,52,0.95 [0.52-1.72],0.8559963072425189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,17083,52,1.25 [1.01-1.54],0.041564854906034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALPP,"Alkaline phosphatase, placental type",20108,81,0.95 [0.79-1.14],0.5657854340026158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMBN,Ameloblastin,19834,81,0.94 [0.47-1.90],0.8717810925445338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMBP,Protein AMBP,20335,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,17614,50,0.75 [0.26-2.16],0.5918871868038728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,19753,77,1.23 [0.93-1.64],0.1506849293799733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMIGO1,Amphoterin-induced protein 1,17117,51,0.67 [0.34-1.34],0.2580009109883199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,20108,81,3.69 [1.63-8.35],0.0017099660968627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMN,Protein amnionless,19834,81,1.28 [0.85-1.92],0.2300036075009478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMOT,Angiomotin,17227,49,0.61 [0.30-1.22],0.1620672357029026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMOTL2,Angiomotin-like protein 2,17453,50,1.53 [0.98-2.40],0.0619894323319311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMPD3,AMP deaminase 3,17573,52,0.77 [0.53-1.12],0.1661451530003738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,16475,49,0.37 [0.20-0.68],0.0013814427190267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY2A,Pancreatic alpha-amylase,19402,77,0.58 [0.38-0.89],0.0134973274428971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY2B,Alpha-amylase 2B,18821,76,0.60 [0.39-0.92],0.0205814569744324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANG,Angiogenin,20192,82,4.12 [2.70-6.30],6.000740994103471e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPT1,Angiopoietin-1,20113,80,0.90 [0.71-1.14],0.3800809284274923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPT2,Angiopoietin-2,20371,81,4.70 [3.20-6.92],3.778028323852466e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,19930,81,4.01 [2.08-7.71],3.196212663466613e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,20224,80,1.43 [0.89-2.31],0.1422624725475205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,20250,82,0.47 [0.29-0.77],0.0029441444783973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,20254,80,8.70 [5.62-13.45],2.3150470376447813e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,20371,81,3.53 [2.32-5.38],3.6361934115948565e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANK2,Ankyrin-2,17001,51,0.90 [0.60-1.35],0.6083988032073504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,17083,52,1.31 [0.94-1.81],0.106476791454633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,16965,52,0.87 [0.53-1.44],0.5991387857522179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,19761,80,0.76 [0.51-1.13],0.1682344535219133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,17158,52,0.73 [0.32-1.66],0.45652211937514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANPEP,Aminopeptidase N,20306,82,2.73 [1.53-4.87],0.0006784696920281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA1,Annexin A1,17127,49,1.69 [1.07-2.66],0.0233250243623054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA10,Annexin A10,19753,77,1.41 [1.15-1.72],0.0008040910293666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA11,Annexin A11,20130,80,1.16 [0.85-1.59],0.3559100860381738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA2,Annexin A2,16883,52,1.25 [0.89-1.75],0.1991938097858823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA3,Annexin A3,20329,81,1.13 [0.85-1.50],0.3888049147011722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA4,Annexin A4,20123,81,1.02 [0.77-1.35],0.8828037593798894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA5,Annexin A5,19689,77,3.86 [2.50-5.97],1.2529137049247723e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],19834,81,1.39 [1.12-1.72],0.0023111786091945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AOC3,Membrane primary amine oxidase,20332,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,17526,51,1.50 [1.11-2.01],0.0076371207978654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AP2B1,AP-2 complex subunit beta,17117,51,0.99 [0.55-1.77],0.9657452132898594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AP3B1,AP-3 complex subunit beta-1,17522,52,1.51 [1.08-2.10],0.0150944769172696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,17573,52,1.29 [0.76-2.19],0.3408007941856079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,20108,81,1.71 [1.23-2.38],0.0013236752611586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APCS,Serum amyloid P-component,17468,50,0.38 [0.20-0.73],0.0035207173501846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,20296,81,0.90 [0.64-1.27],0.5531128193125302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APLP1,Amyloid-like protein 1,20208,82,0.79 [0.54-1.17],0.2389757073018728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA1,Apolipoprotein A-I,17637,50,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA2,Apolipoprotein A-II,17611,51,1.91 [1.17-3.12],0.0094199405858054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA4,Apolipoprotein A-IV,17637,50,3.69 [2.66-5.12],6.529359752269451e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOB,Apolipoprotein B-100,17611,51,0.92 [0.28-3.01],0.8910787843881867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOBR,Apolipoprotein B receptor,17158,52,1.09 [0.58-2.05],0.7978439671719229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOC1,Apolipoprotein C-I,17607,50,0.11 [0.06-0.21],2.0937405382279955e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOD,Apolipoprotein D,16888,46,0.23 [0.09-0.57],0.0015783586404175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOE,Apolipoprotein E,17637,50,0.31 [0.18-0.54],3.117112231812636e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOF,Apolipoprotein F,17611,51,1.16 [0.48-2.80],0.7447938162807064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOH,Beta-2-glycoprotein 1,20222,80,1.91 [1.21-3.03],0.005689865161637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOL1,Apolipoprotein L1,17611,51,0.32 [0.20-0.51],1.715373903984435e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOM,Apolipoprotein M,20287,82,0.10 [0.06-0.18],7.387367161549059e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APP,Amyloid-beta precursor protein,20199,79,1.09 [0.81-1.46],0.5788983987032168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APPL2,DCC-interacting protein 13-beta,17227,49,0.99 [0.77-1.27],0.920993870415968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APRT,Adenine phosphoribosyltransferase,19973,81,1.74 [1.11-2.71],0.0151664445742818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,17281,52,0.84 [0.55-1.30],0.4355021073726373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AREG,Amphiregulin,20108,81,3.74 [2.84-4.92],5.681818158574623e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARF6,ADP-ribosylation factor 6,17522,52,1.21 [0.93-1.56],0.1531793038384012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARFIP1,Arfaptin-1,17572,52,1.16 [0.79-1.70],0.4618430388880364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARG1,Arginase-1,20075,80,0.49 [0.34-0.72],0.0002511140987187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARG2,"Arginase-2, mitochondrial",17526,51,1.27 [0.77-2.10],0.351264582353484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,19761,80,0.96 [0.61-1.49],0.8446905067076189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,19761,80,1.26 [0.93-1.71],0.1319159133229046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,17281,52,1.25 [0.67-2.35],0.4850103489321933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,17227,49,1.15 [0.82-1.61],0.4045536413660306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,16965,52,1.29 [0.99-1.67],0.0598236124651701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,17573,52,1.33 [0.98-1.79],0.0687990787240306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,17572,52,1.46 [1.12-1.92],0.0053518107539472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,20157,80,1.17 [0.96-1.42],0.1203749899693476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,17030,52,1.40 [1.05-1.88],0.0227313217984259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,17030,52,1.02 [0.53-1.99],0.9475481946935974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,19753,77,0.83 [0.49-1.42],0.4980949221163319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,17001,51,0.90 [0.60-1.34],0.5891708368263434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,17001,51,1.10 [0.56-2.14],0.7881561558812021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,17030,52,0.76 [0.45-1.31],0.3248083709499175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,19834,81,1.29 [0.77-2.16],0.3385783347482476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,17001,51,0.97 [0.58-1.63],0.9180609765708754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARSA,Arylsulfatase A,20222,80,0.98 [0.65-1.50],0.9359863889570396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARSB,Arylsulfatase B,20108,81,1.22 [0.86-1.74],0.2572688360114308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,20332,82,6.97 [4.61-10.53],3.1392098102810894e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,17030,52,1.02 [0.66-1.55],0.9422602544773944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARTN,Artemin,19834,81,0.79 [0.47-1.34],0.390057742281207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASAH1,Acid ceramidase,17423,50,1.38 [0.86-2.24],0.1855525721869523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASAH2,Neutral ceramidase,20021,81,0.82 [0.59-1.14],0.2323669919038573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,20021,81,8.13 [5.10-12.95],1.2775569021740941e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,17611,51,7.55 [3.62-15.76],7.161644703731408e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASPN,Asporin,17610,52,1.84 [0.99-3.42],0.0528147992020997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,17572,52,1.39 [0.93-2.06],0.1046603668033911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,17158,52,0.98 [0.75-1.29],0.9102254980885242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASS1,Argininosuccinate synthase,17001,51,1.06 [0.75-1.48],0.7428802364170062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,19753,77,1.09 [0.83-1.42],0.5464478778303736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,16965,52,1.71 [0.92-3.16],0.0879904271091952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATG16L1,Autophagy-related protein 16-1,17522,52,1.30 [0.95-1.78],0.1027979233905855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATG4A,Cysteine protease ATG4A,19761,80,0.74 [0.52-1.05],0.0936256404403258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATOX1,Copper transport protein ATOX1,20289,81,1.74 [1.28-2.37],0.0003775780613235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,17001,51,1.07 [0.64-1.80],0.7850573072625007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,17001,51,0.98 [0.42-2.26],0.95465717994186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,17001,51,1.27 [0.71-2.29],0.4213137213167518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP1B4,Protein ATP1B4,16965,52,0.77 [0.38-1.55],0.4658796994027647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,17001,51,0.74 [0.42-1.32],0.3136270556529741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",17001,51,0.62 [0.31-1.24],0.1774161165920932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",20290,80,1.09 [0.91-1.31],0.3301687463146698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",19753,77,0.91 [0.54-1.53],0.7339328944769572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP6AP2,Renin receptor,19761,80,1.72 [1.23-2.41],0.0016572746452639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,20108,81,0.61 [0.26-1.42],0.2508715720823388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,19720,76,0.99 [0.72-1.35],0.9382127500207552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,17158,52,1.36 [0.95-1.94],0.0904485659408141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,17001,51,1.09 [0.84-1.41],0.527411235073598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,17522,52,4.13 [2.90-5.89],4.7087958505833684e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATRN,"Attractin, Isoform 2",17637,50,0.50 [0.10-2.45],0.3939963257876112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATXN10,Ataxin-10,19753,77,1.10 [0.83-1.47],0.5118427521826094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATXN2,Ataxin-2,17030,52,0.95 [0.73-1.22],0.6794774838402461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATXN2L,Ataxin-2-like protein,17572,52,1.07 [0.61-1.88],0.8018252867612508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATXN3,Ataxin-3,17573,52,1.11 [0.73-1.71],0.6169752071518484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AXIN1,Axin-1,20157,80,1.20 [0.97-1.48],0.0980202215928472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,20332,82,7.49 [4.20-13.36],8.982107308564246e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AZI2,5-azacytidine-induced protein 2,17572,52,1.20 [0.75-1.92],0.4476274857013483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AZU1,Azurocidin,19581,82,1.02 [0.80-1.32],0.8525034322063205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B2M,Beta-2-microglobulin,17637,50,2.29 [1.68-3.14],2.24125457192374e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,17001,51,0.58 [0.14-2.34],0.4423565532638062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17158,52,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",20290,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",20222,80,2.23 [1.01-4.93],0.0481041043066035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,17083,52,0.69 [0.25-1.95],0.4869057107560509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BACH1,Transcription regulator protein BACH1,20157,80,1.20 [0.91-1.58],0.1914993513107578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,19986,81,2.09 [1.27-3.44],0.0038461562147735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,17083,52,1.52 [0.95-2.44],0.0842491150081143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAG6,Large proline-rich protein BAG6,19823,80,1.30 [0.74-2.28],0.3568493040120998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19761,80,1.54 [1.19-1.99],0.0010333022140624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,19761,80,6.34 [4.31-9.32],6.591074525898645e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,20157,80,1.16 [0.95-1.41],0.1373515040542612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAP18,Chromatin complexes subunit BAP18,17573,52,1.42 [1.07-1.89],0.0147550795846609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,17117,51,1.20 [0.93-1.54],0.1661014529408397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAX,Apoptosis regulator BAX,19724,77,1.22 [0.97-1.53],0.0932295285390374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAM,Basal cell adhesion molecule,20222,80,3.93 [2.21-7.00],3.2934188841762603e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAN,Brevican core protein,20021,81,0.36 [0.21-0.63],0.0002903680682869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",17610,52,2.17 [1.06-4.43],0.0335882724265595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",17030,52,0.58 [0.30-1.13],0.1105261113255094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCHE,Cholinesterase,17288,51,0.59 [0.27-1.30],0.1904241012317494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2,Apoptosis regulator Bcl-2,17522,52,1.41 [1.02-1.97],0.0388022095754647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L1,Bcl-2-like protein 1,17573,52,1.18 [0.89-1.55],0.2453027550105965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",20157,80,4.75 [2.70-8.34],6.128520482674171e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,17083,52,1.75 [1.28-2.39],0.0004329032018463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,16965,52,1.14 [0.79-1.66],0.487618270119996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,17526,51,1.01 [0.55-1.85],0.9821977332628882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCR,Breakpoint cluster region protein,20157,80,1.20 [0.97-1.50],0.100407245504008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BDNF,Brain-derived neurotrophic factor,17614,50,0.96 [0.70-1.32],0.8130700666066559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BECN1,Beclin-1,17158,52,1.38 [0.90-2.11],0.1444644963522019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BEX3,Protein BEX3,16965,52,1.18 [0.73-1.89],0.5026947451375302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BGLAP,Osteocalcin,17614,50,0.94 [0.71-1.25],0.6687581849637465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BGN,Biglycan,19719,80,0.98 [0.83-1.16],0.8211785638796285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,17030,52,0.97 [0.67-1.42],0.8828630193210629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,17001,51,0.79 [0.28-2.25],0.6559065875556442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BID,BH3-interacting domain death agonist,20157,80,0.92 [0.68-1.26],0.6135080956245635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BIN2,Bridging integrator 2,20222,80,1.13 [0.91-1.40],0.2863155532499244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,19761,80,1.36 [1.01-1.85],0.0459015834163169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BLMH,Bleomycin hydrolase,20456,83,0.99 [0.54-1.81],0.9646457528809717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BLNK,B-cell linker protein,17083,52,0.98 [0.49-1.95],0.9593707439236436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,17030,52,0.79 [0.52-1.22],0.2917431981557852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,17573,52,1.02 [0.52-1.98],0.9591396272589944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BLVRB,Flavin reductase,20222,80,0.70 [0.51-0.97],0.0296187069830579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMP10,Bone morphogenetic protein 10,17227,49,2.50 [0.95-6.52],0.0621915010482577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMP4,Bone morphogenetic protein 4,19986,81,1.98 [1.39-2.83],0.0001601562614597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMP6,Bone morphogenetic protein 6,19797,80,1.48 [0.92-2.39],0.1059724573554772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,17227,49,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,17610,52,1.22 [0.57-2.61],0.6125516729850977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17083,52,2.25 [1.39-3.64],0.0009642765981128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BOC,Brother of CDO,19823,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BOLA1,BolA-like protein 1,17030,52,1.68 [1.18-2.41],0.0043845435518336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,17158,52,1.12 [0.68-1.85],0.6615078823066185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BPIFA2,BPI fold-containing family A member 2,16552,49,0.82 [0.64-1.05],0.1168730476773061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BPIFB1,BPI fold-containing family B member 1,20157,82,0.67 [0.51-0.89],0.0060296065967259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BPIFB2,BPI fold-containing family B member 2,17569,52,0.69 [0.47-1.02],0.059822122793487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRAP,BRCA1-associated protein,17371,51,1.15 [0.89-1.49],0.2865241080445723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRD1,Bromodomain-containing protein 1,17281,52,0.75 [0.29-1.94],0.5468926466522891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRD2,Bromodomain-containing protein 2,17030,52,1.44 [0.79-2.63],0.233095384391195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRD3,Bromodomain-containing protein 3,17001,51,1.16 [0.71-1.88],0.5536242763501015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRDT,Bromodomain testis-specific protein,17001,51,0.89 [0.43-1.83],0.7485943443040126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRK1,Protein BRICK1,19753,77,2.19 [1.49-3.22],6.196683389351392e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,17030,52,1.23 [0.82-1.85],0.3097500899608298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,17572,52,1.31 [0.69-2.49],0.4061083273606697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BSG,Basigin,20379,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BSND,Barttin,16965,52,1.05 [0.49-2.25],0.894566240658117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,20368,81,1.23 [0.74-2.03],0.4187299004972901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BST2,Bone marrow stromal antigen 2,20368,81,1.51 [1.14-2.00],0.004048936095062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTC,Probetacellulin,19761,80,1.16 [0.90-1.50],0.2562991516964241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTD,Biotinidase,17637,50,1.08 [0.29-4.04],0.9141801383449653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTLA,B- and T-lymphocyte attenuator,16965,52,1.06 [0.80-1.41],0.6827901747829963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,17488,51,1.53 [1.05-2.24],0.0285373801755991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,20290,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,20157,80,2.89 [2.13-3.91],7.239858621710431e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTNL10,Butyrophilin-like protein 10,16965,52,1.11 [0.62-1.98],0.7216128105779862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C19orf12,Protein C19orf12,19753,77,0.99 [0.73-1.34],0.9345039514285566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,17001,51,1.54 [0.77-3.08],0.2269061608069189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,20314,82,8.28 [4.24-16.17],6.056501677028583e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",17572,52,1.10 [0.78-1.55],0.5879078126750584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QL2,Complement C1q-like protein 2,17083,52,0.58 [0.32-1.06],0.0786528116997102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,20332,82,2.76 [1.95-3.92],1.2353297367215848e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,17227,49,3.25 [1.64-6.45],0.0007663145592902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,17572,52,2.09 [1.26-3.47],0.0043473793307558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,17194,49,2.23 [1.17-4.24],0.0148450451487179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1R,Complement C1r subcomponent,17637,50,0.31 [0.05-1.76],0.1853027252434829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1RL,Complement C1r subcomponent-like protein,17603,50,6.40 [1.78-23.06],0.0045059836327074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1S,Complement C1s subcomponent,17637,50,0.78 [0.21-2.87],0.7047399342810567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C2,Complement C2,20287,82,8.42 [3.15-22.51],2.177577573877401e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,19720,76,1.27 [0.84-1.92],0.2478940353883405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C2orf69,UPF0565 protein C2orf69,17117,51,1.21 [0.85-1.72],0.2947634707621237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C3,Complement C3,16719,47,0.66 [0.31-1.41],0.2836284695411321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C4BPB,C4b-binding protein beta chain,20289,81,0.90 [0.57-1.42],0.6551568452697027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C5,Complement C5,17637,50,0.75 [0.11-4.89],0.7611274379503752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C7,Complement component C7,17198,49,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C7orf50,Uncharacterized protein C7orf50,17573,52,0.62 [0.14-2.67],0.5233276742346409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C8B,Complement component C8 beta chain,17637,50,0.67 [0.29-1.57],0.3588198304612096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C9,Complement component C9,17611,51,1.54 [0.91-2.58],0.105843397138222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C9orf40,Uncharacterized protein C9orf40,17522,52,0.69 [0.49-0.97],0.0329806310268512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA1,Carbonic anhydrase 1,19784,82,0.69 [0.50-0.95],0.0228567423848171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA11,Carbonic anhydrase-related protein 11,19761,80,0.96 [0.52-1.78],0.9070935047996376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA12,Carbonic anhydrase 12,20108,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA13,Carbonic anhydrase 13,20001,79,1.09 [0.89-1.33],0.3894799312800854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA14,Carbonic anhydrase 14,20371,81,4.86 [3.08-7.65],9.466702589023315e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA2,Carbonic anhydrase 2,20142,80,0.74 [0.55-0.98],0.0389407506942693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA3,Carbonic anhydrase 3,20423,83,2.25 [1.72-2.95],2.858426140593023e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA4,Carbonic anhydrase 4,20456,83,9.36 [4.32-20.24],1.3570004462325e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",19823,80,1.53 [1.28-1.83],2.929816484639198e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA6,Carbonic anhydrase 6,20166,79,0.83 [0.61-1.12],0.2206718967772294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA7,Carbonic anhydrase 7,17281,52,1.18 [0.58-2.41],0.650148663496262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA8,Carbonic anhydrase-related protein,17083,52,1.20 [0.50-2.90],0.6808362976888348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA9,Carbonic anhydrase 9,20371,81,2.50 [1.86-3.37],1.3827694729356167e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CABP2,Calcium-binding protein 2,17117,51,0.99 [0.64-1.54],0.973284020415145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,17030,52,0.66 [0.26-1.71],0.3963510555172626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,17001,51,1.26 [0.92-1.73],0.1530006963026401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,17030,52,1.00 [0.64-1.58],0.988972583615764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,17572,52,1.40 [1.02-1.92],0.0364570269077259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CACYBP,Calcyclin-binding protein,17200,49,1.23 [0.93-1.63],0.1413172125659792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CADPS,Calcium-dependent secretion activator 1,17117,51,1.22 [0.73-2.05],0.4536538706077007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB1,Calbindin,20108,81,3.17 [2.28-4.42],8.205563131144564e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB2,Calretinin,19753,77,1.64 [1.26-2.15],0.0002516900140874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCA,Calcitonin,19988,80,1.83 [1.52-2.21],3.3769717977346127e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,17573,52,2.34 [1.71-3.20],1.2754569107214824e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,20301,80,1.13 [0.93-1.38],0.2036831415297507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,17158,52,1.51 [1.07-2.12],0.0184807435548813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,17001,51,1.20 [0.64-2.25],0.5727689006984643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,19761,80,1.66 [1.12-2.48],0.0125835032822153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,17117,51,1.16 [0.72-1.85],0.5473037334774494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,17572,52,1.15 [0.90-1.48],0.2630824076925656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,20136,82,6.87 [2.74-17.20],3.856325061749725e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAPG,Macrophage-capping protein,20026,79,1.61 [1.19-2.19],0.0021970032011917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAPN3,Calpain-3,17526,51,1.37 [0.77-2.43],0.2799732249984727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAPS,Calcyphosin,17573,52,1.23 [1.02-1.49],0.0282843631640954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,19753,77,0.70 [0.46-1.05],0.0821492084001851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASC3,Protein CASC3,17117,51,1.50 [0.82-2.75],0.1844934988573292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP1,Caspase-1,19753,77,1.01 [0.76-1.36],0.924432180439995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP10,Caspase-10,19753,77,1.16 [0.87-1.55],0.3048269585007063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP2,Caspase-2,20157,80,1.25 [0.94-1.67],0.1312162079293243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP3,Caspase-3,20456,83,1.16 [0.93-1.46],0.1970734493929873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP4,Caspase-4,17281,52,1.05 [0.90-1.22],0.5611453156302297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP7,Caspase-7,17573,52,1.21 [0.88-1.67],0.2405774162899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP8,Caspase-8,20301,81,1.01 [0.73-1.39],0.97311977248544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASP9,Caspase-9,17083,52,1.14 [0.76-1.71],0.5376588436498839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CASQ2,Calsequestrin-2,17001,51,1.07 [0.64-1.80],0.7855861944063195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAT,Catalase,17361,51,0.66 [0.39-1.09],0.1038541790171363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,20167,82,1.43 [1.13-1.82],0.0033349680319017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBLN1,Cerebellin-1,17030,52,0.90 [0.64-1.25],0.5175702243552172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBLN4,Cerebellin-4,20371,81,1.14 [0.66-1.95],0.6423547377786666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBS,Cystathionine beta-synthase,17158,52,0.97 [0.57-1.65],0.9160335465828906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBX2,Chromobox protein homolog 2,17001,51,1.29 [0.79-2.08],0.3050484331213666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,20021,81,1.30 [1.01-1.69],0.0449595354326196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,17573,52,1.01 [0.62-1.66],0.9609175830123546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,17526,51,1.44 [0.90-2.28],0.124726613309063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,17117,51,0.84 [0.33-2.10],0.7042492291827858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,17572,52,1.11 [0.81-1.53],0.508279284241967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,20208,82,4.63 [3.23-6.62],5.807874877064496e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,17158,52,2.21 [1.59-3.08],2.8249833163230733e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL11,Eotaxin,20408,82,4.42 [2.64-7.38],1.4157224203795872e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL13,C-C motif chemokine 13,20376,82,1.18 [0.89-1.56],0.2609575487365136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL14,C-C motif chemokine 14,20192,82,2.52 [1.83-3.48],1.6893309027508894e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL15,C-C motif chemokine 15,20456,83,5.61 [4.02-7.82],2.8193340495628955e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL16,C-C motif chemokine 16,20456,83,2.10 [1.45-3.04],9.407819671389318e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL17,C-C motif chemokine 17,20167,79,1.16 [0.94-1.45],0.1679895582204218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL18,C-C motif chemokine 18,19950,81,1.14 [0.88-1.49],0.3216952078362844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL19,C-C motif chemokine 19,20368,81,1.14 [1.01-1.28],0.0367963059260562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL2,C-C motif chemokine 2,19986,81,1.25 [0.88-1.78],0.2159577067924419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL20,C-C motif chemokine 20,20408,82,1.32 [1.11-1.57],0.0020095680648399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL21,C-C motif chemokine 21,20290,80,2.16 [1.72-2.71],3.940251525816327e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL22,C-C motif chemokine 22,20026,78,1.31 [0.92-1.88],0.1359014109696504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL23,C-C motif chemokine 23,20290,80,1.63 [1.04-2.57],0.0334546669572564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL24,C-C motif chemokine 24,20254,80,1.11 [0.87-1.41],0.3890136367995848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL25,C-C motif chemokine 25,20408,82,4.74 [3.32-6.76],1.005183177474788e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL26,C-C motif chemokine 26,20157,80,0.98 [0.79-1.21],0.8180715667364648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL27,C-C motif chemokine 27,20208,82,1.23 [0.89-1.71],0.2142248697748545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL28,C-C motif chemokine 28,20084,79,1.48 [1.10-2.00],0.0103500389754852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL3,C-C motif chemokine 3,20157,80,1.30 [1.07-1.57],0.0070446340653602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL4,C-C motif chemokine 4,20232,80,0.93 [0.69-1.26],0.6443164807530608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL5,C-C motif chemokine 5,20332,82,1.13 [0.93-1.38],0.2080726924239267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL7,C-C motif chemokine 7,20157,80,1.51 [1.16-1.96],0.0019396438791504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL8,C-C motif chemokine 8,20335,81,1.21 [0.87-1.68],0.2573272945444254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN1,CCN family member 1,20066,81,1.12 [0.85-1.47],0.4070650909835243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN2,CCN family member 2,20173,80,1.47 [1.03-2.10],0.0350743140165936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN3,CCN family member 3,20424,83,8.02 [5.66-11.36],1.2408453528872201e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN4,CCN family member 4,20371,81,5.40 [3.76-7.76],6.944446563066151e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN5,CCN family member 5,20222,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCND2,G1/S-specific cyclin-D2,17281,52,0.68 [0.34-1.33],0.2594872512949177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCNE1,G1/S-specific cyclin-E1,17083,52,1.14 [0.87-1.49],0.3555854180586049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,20021,81,0.55 [0.36-0.85],0.0076797009070971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,19761,80,0.94 [0.59-1.50],0.7852248416395494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD101,Immunoglobulin superfamily member 2,17522,52,1.28 [0.68-2.42],0.4468317686074112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD109,CD109 antigen,20222,80,5.49 [3.05-9.90],1.4528305439898712e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,19846,82,3.77 [2.53-5.62],6.977136876232011e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD160,CD160 antigen,20408,82,4.52 [3.39-6.03],8.98642340459313e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,20332,82,3.35 [2.30-4.87],2.6442922044533427e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD164,Sialomucin core protein 24,20222,80,2.23 [1.66-2.99],9.646666527702604e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,17117,51,1.81 [1.02-3.22],0.0412536675052629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD177,CD177 antigen,20192,80,1.10 [0.93-1.29],0.2608282335565095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,20289,81,0.30 [0.15-0.61],0.0007779086981414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD2,T-cell surface antigen CD2,17001,51,1.50 [0.95-2.37],0.0803627339701386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200,OX-2 membrane glycoprotein,20157,80,3.47 [2.09-5.78],1.6720567341304818e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,20096,79,1.86 [1.10-3.16],0.0211211381906037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD207,C-type lectin domain family 4 member K,19748,79,6.24 [4.17-9.33],5.28031523580689e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD209,CD209 antigen,20265,81,1.09 [0.67-1.79],0.7215548668049803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD22,B-cell receptor CD22,20408,82,1.30 [0.86-1.97],0.2193194759661096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD226,CD226 antigen,17083,52,1.40 [0.76-2.58],0.2779707587465596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD244,Natural killer cell receptor 2B4,20408,82,3.70 [1.98-6.92],4.2547503836513205e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD248,Endosialin,17614,50,1.42 [0.73-2.78],0.2998629835779129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD27,CD27 antigen,20289,81,6.76 [5.04-9.07],2.936278544407444e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,20021,81,4.11 [2.94-5.74],1.1132937675610845e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD276,CD276 antigen,20198,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,19761,80,2.48 [1.84-3.34],1.980489268235085e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD2AP,CD2-associated protein,20208,82,1.18 [0.88-1.59],0.2681766321847033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300A,CMRF35-like molecule 8,17227,49,9.10 [4.78-17.33],1.7901364596934404e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300C,CMRF35-like molecule 6,20368,81,7.19 [4.69-11.04],1.8778317399654121e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300E,CMRF35-like molecule 2,20304,81,5.02 [3.66-6.87],1.1447218980146822e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LF,CMRF35-like molecule 1,20371,81,2.49 [1.77-3.51],1.7851090421475589e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LG,CMRF35-like molecule 9,20222,80,3.55 [2.23-5.64],8.929222402530194e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD302,CD302 antigen,20108,81,9.04 [6.13-13.32],9.0111166697768e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD33,Myeloid cell surface antigen CD33,20289,81,1.30 [1.00-1.70],0.0512068961371935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,20309,80,1.48 [0.66-3.30],0.3384824467368311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD36,Platelet glycoprotein 4,17083,52,1.64 [0.96-2.78],0.0688616679797672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,20108,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,17030,52,0.85 [0.35-2.07],0.7225787329421354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,17281,52,1.25 [0.71-2.20],0.4431310208393989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,17083,52,1.03 [0.77-1.37],0.8638450176884803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,20124,79,2.69 [1.95-3.71],1.835900566798649e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,20196,80,2.92 [2.11-4.05],1.363277639807371e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD40LG,CD40 ligand,20408,82,1.04 [0.80-1.34],0.7818921374107783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD46,Membrane cofactor protein,20129,82,7.72 [5.14-11.58],5.736083463471955e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD48,CD48 antigen,20254,80,7.14 [4.44-11.47],4.427265192033483e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,20335,81,2.59 [1.92-3.49],3.8634324416570317e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD55,Complement decay-accelerating factor,19538,80,7.67 [5.04-11.69],2.2550833969156602e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,20173,79,5.18 [1.69-15.83],0.0039296391655689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD59,CD59 glycoprotein,19533,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD5L,CD5 antigen-like,17537,50,1.79 [1.02-3.14],0.0424098423318846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD6,T-cell differentiation antigen CD6,20379,82,0.72 [0.50-1.03],0.0695228268687312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD63,CD63 antigen,19986,81,1.20 [0.81-1.78],0.3627156078401677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD69,Early activation antigen CD69,20128,82,1.18 [0.94-1.48],0.1540871150035342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD7,T-cell antigen CD7,17043,51,2.75 [1.92-3.94],3.0917632685651354e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD70,CD70 antigen,20157,80,2.02 [1.34-3.06],0.0008213327121543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD72,B-cell differentiation antigen CD72,17227,49,2.68 [1.72-4.18],1.3061576595276596e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,20368,81,8.27 [5.62-12.16],8.679842500153706e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,20408,82,4.06 [3.22-5.11],1.384261085338373e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,17610,52,4.42 [2.72-7.19],2.163451721692654e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD82,CD82 antigen,17281,52,0.61 [0.27-1.40],0.2471530094221091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD83,CD83 antigen,20157,80,5.21 [3.43-7.91],9.052238477931372e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD84,SLAM family member 5,20157,80,1.44 [0.76-2.73],0.2576742401153404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD86,T-lymphocyte activation antigen CD86,17522,52,0.57 [0.24-1.35],0.199332363524214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,20368,81,1.39 [0.96-2.00],0.0805843698349899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD93,Complement component C1q receptor,19469,79,8.86 [5.46-14.39],1.1167827663788771e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD99,CD99 antigen,20222,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,20222,80,6.68 [3.39-13.18],4.178894061187142e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDA,Cytidine deaminase,17569,52,1.62 [0.99-2.65],0.0541251397908182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDAN1,Codanin-1,17573,52,1.07 [0.39-2.96],0.8976701362140588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDC123,Cell division cycle protein 123 homolog,16965,52,1.06 [0.70-1.60],0.7908907866370676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDC25A,M-phase inducer phosphatase 1,16965,52,1.05 [0.55-2.00],0.8916934323719673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,17484,52,1.36 [0.93-1.97],0.1102476190098499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDC27,Cell division cycle protein 27 homolog,19761,80,1.44 [1.06-1.95],0.019100471723588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,20289,81,1.09 [0.86-1.39],0.4567238356224898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,17522,52,1.20 [0.94-1.54],0.1487381692523573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDCP1,CUB domain-containing protein 1,20021,81,1.58 [1.14-2.19],0.0056682464564698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH1,Cadherin-1,19584,81,3.89 [3.09-4.91],1.4288461432768051e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH15,Cadherin-15,20335,80,2.27 [1.88-2.75],2.390805611418118e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH17,Cadherin-17,20208,82,2.10 [1.65-2.67],1.6731920749272252e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH2,Cadherin-2,20208,82,3.23 [1.90-5.51],1.6218900079070554e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH22,Cadherin-22,17281,52,1.11 [0.43-2.86],0.8218952433228651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH23,Cadherin-23,17573,52,0.80 [0.28-2.29],0.6763939489353339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH3,Cadherin-3,20368,81,5.37 [3.74-7.70],6.207230625372693e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH4,Cadherin-4,17030,52,0.85 [0.47-1.55],0.6042966471252724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH5,Cadherin-5,20456,83,2.14 [1.19-3.86],0.011331386598181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH6,Cadherin-6,20208,82,4.10 [2.71-6.23],3.123662636086948e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDHR1,Cadherin-related family member 1,19753,77,1.19 [0.77-1.82],0.4379507895327362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDHR2,Cadherin-related family member 2,20108,81,0.91 [0.71-1.18],0.4935134992141998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDHR5,Cadherin-related family member 5,20208,82,0.54 [0.34-0.85],0.00733757964642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDK1,Cyclin-dependent kinase 1,16965,52,1.50 [0.71-3.15],0.2849381244888468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,17572,52,1.34 [0.89-2.02],0.1650815543274036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,17030,52,1.00 [0.61-1.65],0.9980608407844336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,20108,81,1.32 [1.09-1.59],0.0039601718490842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,20108,81,1.20 [0.96-1.50],0.112231664362206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,20108,81,3.85 [2.58-5.76],4.209047948112911e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,20225,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDSN,Corneodesmosin,20350,81,3.39 [2.28-5.03],1.685317306770472e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,20258,80,1.33 [0.60-2.95],0.4900409662740569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,17522,52,1.03 [0.74-1.44],0.8476011162637389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,17281,52,0.89 [0.57-1.38],0.5936123874302817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,17522,52,2.36 [1.41-3.97],0.0011031184321559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,17281,52,1.61 [1.09-2.36],0.0158043650424098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,20157,80,1.38 [1.11-1.70],0.0035217594419815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,19761,80,1.12 [0.76-1.65],0.5616708469759575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19518,78,1.35 [1.04-1.76],0.0251336860553085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17614,50,1.62 [1.00-2.64],0.0517126959317912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19823,80,2.15 [1.56-2.97],2.8264666993433604e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,17083,52,1.57 [0.92-2.67],0.0987271260687389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,19823,80,1.21 [0.74-2.00],0.4501304087741092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,17614,50,0.31 [0.22-0.44],1.449330086502116e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,20425,83,0.42 [0.30-0.57],4.0668454253918855e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,17227,49,5.41 [2.97-9.84],3.2235024043322114e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEMIP2,Cell surface hyaluronidase,17083,52,1.15 [0.57-2.30],0.699219911353331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,17030,52,1.27 [0.93-1.74],0.1344621248578889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CENPF,Centromere protein F,17281,52,0.78 [0.47-1.30],0.3400115119848318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CENPJ,Centromere protein J,17281,52,1.02 [0.69-1.52],0.9175416432921776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP112,Centrosomal protein of 112 kDa,17001,51,0.72 [0.32-1.60],0.4176471176999994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP152,Centrosomal protein of 152 kDa,16965,52,1.69 [1.10-2.59],0.0164677724664984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP164,Centrosomal protein of 164 kDa,19834,81,1.06 [0.80-1.39],0.696035323836534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP170,Centrosomal protein of 170 kDa,17158,52,1.23 [0.91-1.67],0.1772129572634871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP20,Centrosomal protein 20,19761,80,1.48 [1.16-1.90],0.001856750637676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP290,Centrosomal protein of 290 kDa,17281,52,0.94 [0.54-1.62],0.8150001622614176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP350,Centrosome-associated protein 350,16965,52,1.14 [0.60-2.20],0.6844194921562956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP43,Centrosomal protein 43,19661,78,1.20 [0.90-1.60],0.213489097117185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP85,Centrosomal protein of 85 kDa,19761,80,1.19 [0.87-1.61],0.2756879587925177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CERT,Ceramide transfer protein,19753,77,1.04 [0.75-1.46],0.802956196770972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CES1,Liver carboxylesterase 1,20272,82,0.68 [0.53-0.87],0.0021983249419523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CES2,Cocaine esterase,20108,81,1.53 [1.10-2.11],0.0108516281806035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CES3,Carboxylesterase 3,20108,81,0.77 [0.56-1.07],0.1189070182825522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CETN2,Centrin-2,19753,77,1.32 [1.00-1.75],0.0533674232396956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CETN3,Centrin-3,17522,52,1.20 [0.85-1.69],0.3067321910946287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFB,Complement factor B,17327,49,0.90 [0.39-2.10],0.807538087502889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFC1,Cryptic protein,19761,80,1.25 [0.82-1.91],0.3032725184840238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFD,Complement factor D,17637,50,5.25 [2.39-11.50],3.497914334506094e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFH,Complement factor H,16605,45,1.88 [0.52-6.76],0.3336775968762623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFHR2,Complement factor H-related protein 2,17506,49,2.29 [1.26-4.17],0.0065160582504623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFHR4,Complement factor H-related protein 4,17604,50,1.21 [0.82-1.79],0.3416209949186002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFHR5,Complement factor H-related protein 5,17376,51,1.38 [0.72-2.68],0.3349064204518744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFI,Complement factor I,17637,50,0.28 [0.07-1.05],0.0585831984433332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFP,Properdin,17637,50,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,20222,80,0.96 [0.79-1.17],0.7178590136600538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,17611,51,0.81 [0.43-1.56],0.533818335268933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGN,Cingulin,17117,51,0.68 [0.32-1.46],0.3207099443454364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,20208,82,8.03 [5.46-11.82],4.5561753298570856e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,19761,80,1.01 [0.73-1.40],0.9436992281900636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHAD,Chondroadherin,17227,49,0.57 [0.34-0.93],0.0243816007272161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17573,52,4.09 [2.97-5.62],4.5941544381144826e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,17526,51,2.46 [1.49-4.06],0.0004162497664246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,19823,80,0.59 [0.31-1.10],0.0979013055172204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGA,Chromogranin-A,17614,50,1.67 [1.38-2.02],1.364190173323759e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGB,Secretogranin-1,20306,80,4.36 [3.13-6.08],3.910795453192599e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,19817,80,1.57 [1.29-1.91],6.725989739985806e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHIT1,Chitotriosidase-1,20303,83,1.09 [0.94-1.27],0.2319720211313172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,20301,80,1.79 [0.98-3.28],0.0603220845971862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,17117,51,0.96 [0.62-1.49],0.8543534380637337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,20021,81,1.11 [0.86-1.44],0.4139964617001596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHMP6,Charged multivesicular body protein 6,17610,52,1.19 [0.74-1.92],0.4686360140747372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHP1,Calcineurin B homologous protein 1,17030,52,0.95 [0.64-1.41],0.7926299946920792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHRDL1,Chordin-like protein 1,20254,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHRDL2,Chordin-like protein 2,20208,82,1.32 [0.89-1.96],0.1661675411029879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,17117,51,0.60 [0.25-1.44],0.2530311602276733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CIAPIN1,Anamorsin,20289,81,1.42 [1.03-1.94],0.0316377630625512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,17614,50,7.12 [4.45-11.38],2.5275236112530933e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,17281,52,0.98 [0.53-1.81],0.9474261792461108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,17522,52,1.25 [0.94-1.67],0.1232093539228576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CIT,Citron Rho-interacting kinase,17117,51,1.10 [0.61-1.96],0.7560836273525505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,20321,82,9.76 [6.64-14.33],3.336541165140066e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKB,Creatine kinase B-type,17614,50,3.90 [2.59-5.87],7.621512249986345e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",20144,80,1.20 [0.88-1.64],0.2398348487362301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLASP1,CLIP-associating protein 1,16965,52,1.40 [1.06-1.86],0.019372686395454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLC,Galectin-10,20172,82,1.84 [1.47-2.31],1.5488940822912985e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,20021,81,2.45 [1.44-4.15],0.0008892544295408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,20189,79,1.69 [1.13-2.52],0.0104549677377349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,17083,52,3.48 [1.57-7.70],0.0020987042830918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,20222,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,19823,80,6.51 [4.23-9.99],1.2421916301991636e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,20368,81,1.16 [0.94-1.42],0.1623630984444978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,17117,51,0.92 [0.50-1.68],0.7761687819143404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC3B,Tetranectin,17224,48,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,20157,80,0.77 [0.45-1.32],0.3456994194678252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,20157,80,1.11 [0.74-1.67],0.6214481585252809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,20157,80,2.30 [1.73-3.04],6.998950070086322e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,20157,80,2.13 [1.17-3.86],0.0131150626852888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,17581,50,0.61 [0.35-1.07],0.0840045418707341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,20151,82,4.70 [2.87-7.69],7.15045509984765e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,19761,80,2.05 [1.45-2.91],5.449595694213062e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,20408,82,4.82 [3.30-7.05],4.987797589181396e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLGN,Calmegin,17117,51,1.52 [0.95-2.42],0.0796568566000511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,17117,51,1.59 [0.84-3.01],0.1562102197159813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLINT1,Clathrin interactor 1,16965,52,0.84 [0.43-1.62],0.601389907270955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,20157,80,1.23 [1.02-1.47],0.0284890745968649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLMP,CXADR-like membrane protein,20371,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLNS1A,Methylosome subunit pICln,17117,51,0.98 [0.44-2.17],0.9558779885661046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",19988,80,1.31 [1.07-1.60],0.0096507274251368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLPS,Colipase,20183,80,0.73 [0.55-0.96],0.0230863616804114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLSPN,Claspin,19720,76,0.86 [0.43-1.70],0.6590251162403977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLSTN1,Calsyntenin-1,19753,77,1.19 [0.84-1.70],0.3334949461604353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLSTN2,Calsyntenin-2,20408,82,2.62 [1.80-3.80],4.0355591769600523e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLSTN3,Calsyntenin-3,17573,52,2.11 [0.97-4.59],0.0598387587079548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLTA,Clathrin light chain A,19823,80,1.38 [0.94-2.01],0.0969158707576424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLU,Clusterin,17637,50,0.78 [0.22-2.71],0.6916840753319202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLUL1,Clusterin-like protein 1,20177,82,0.93 [0.61-1.41],0.7221026036190075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,17610,52,1.21 [0.91-1.62],0.1905751619670475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CMIP,C-Maf-inducing protein,17526,51,1.36 [0.99-1.87],0.0557367850513164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,20332,82,0.66 [0.45-0.94],0.0231234334098201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,17030,52,1.00 [0.62-1.62],0.9988946162849792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",17129,52,1.26 [0.89-1.78],0.185242406825636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNPY2,Protein canopy homolog 2,19823,80,1.09 [0.80-1.48],0.5926869148012286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNPY4,Protein canopy homolog 4,20108,81,1.35 [1.03-1.76],0.0296724834373931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNST,Consortin,20208,82,1.13 [0.94-1.35],0.186909128105649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTF,Ciliary neurotrophic factor,17030,52,1.88 [0.96-3.71],0.0669540130804471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN1,Contactin-1,20456,83,4.54 [2.35-8.77],6.5759796578388544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN2,Contactin-2,20371,81,2.28 [1.51-3.45],8.803161148326842e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN3,Contactin-3,20222,80,2.46 [1.31-4.60],0.0050636974505503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN4,Contactin-4,20222,80,6.45 [3.04-13.66],1.1446826136589766e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN5,Contactin-5,20243,80,0.73 [0.44-1.21],0.2260081130895856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,20157,80,2.46 [1.69-3.57],2.4002113301206435e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,17117,51,0.98 [0.75-1.29],0.8990825578290511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COCH,Cochlin,17610,52,1.66 [1.01-2.71],0.0451347704966212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,17614,50,4.50 [2.26-8.95],1.788007868679111e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,20321,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,20456,83,2.16 [1.00-4.65],0.0489074558480151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,17522,52,0.90 [0.59-1.38],0.639033847243531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,17117,51,1.16 [0.83-1.62],0.4001296839674519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,17158,52,1.63 [1.20-2.22],0.0017816373135908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL3A1,Collagen alpha-1(III) chain,17614,50,3.96 [1.48-10.65],0.0063226593605014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,20208,82,5.80 [4.03-8.36],3.881025482128029e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,17253,52,1.10 [0.65-1.87],0.7219128755662825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,17227,49,1.91 [1.08-3.38],0.0268657585465526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,20456,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,20157,80,0.97 [0.65-1.43],0.8644060201428733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,17281,52,1.23 [0.75-2.03],0.4134908060446195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COLEC12,Collectin-12,20198,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COMMD1,COMM domain-containing protein 1,17158,52,1.39 [0.90-2.14],0.1377812672146152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COMMD9,COMM domain-containing protein 9,17526,51,1.34 [0.79-2.27],0.2711377099112164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COMP,Cartilage oligomeric matrix protein,20028,81,1.71 [0.97-3.04],0.0654625283273764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COMT,Catechol O-methyltransferase,19609,77,1.07 [0.83-1.37],0.6066795506842788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COPB2,Coatomer subunit beta',17001,51,0.89 [0.47-1.69],0.719044788351447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COPE,Coatomer subunit epsilon,19753,77,0.75 [0.45-1.26],0.2845014512522447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",17158,52,0.72 [0.35-1.47],0.3631691382280492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CORO1A,Coronin-1A,19793,81,1.16 [0.94-1.42],0.163167454621449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CORO6,Coronin-6,17030,52,2.20 [1.43-3.39],0.0003693417533937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",20108,81,1.57 [1.23-1.99],0.0002494524651123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,17610,52,2.13 [1.04-4.37],0.0388863587660665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA1,Carboxypeptidase A1,20456,83,0.51 [0.38-0.70],1.9584049089705083e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA2,Carboxypeptidase A2,20306,80,2.07 [1.58-2.71],1.3532015482438877e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA4,Carboxypeptidase A4,16897,48,2.03 [1.07-3.87],0.0310686399914166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPB1,Carboxypeptidase B,20456,83,0.59 [0.42-0.83],0.0022040408703483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPB2,Carboxypeptidase B2,17607,50,0.37 [0.12-1.16],0.0877674812295595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPE,Carboxypeptidase E,20203,81,0.87 [0.53-1.43],0.5821506248185709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPLX2,Complexin-2,16965,52,0.93 [0.40-2.15],0.8694040718015579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPM,Carboxypeptidase M,20259,81,4.19 [2.63-6.68],1.7411040691599551e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",17083,52,0.59 [0.21-1.62],0.3028741658546998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,20368,81,1.06 [0.78-1.43],0.7090341451868294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPQ,Carboxypeptidase Q,17575,50,1.09 [0.54-2.22],0.8021559990015211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,17001,51,1.73 [1.08-2.79],0.0238497669012433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,20342,81,2.96 [1.77-4.96],3.505201868281104e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPXM1,Probable carboxypeptidase X1,20289,81,1.35 [1.03-1.77],0.0287121005079761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,17610,52,5.90 [3.23-10.75],7.059369604750543e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CR1,Complement receptor type 1,17543,51,3.95 [2.03-7.69],5.510339659286988e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CR2,Complement receptor type 2,20332,82,2.68 [1.81-3.96],8.035293012405173e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,19761,80,1.18 [0.94-1.47],0.1511088545028826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRADD,Death domain-containing protein CRADD,19988,80,1.16 [0.88-1.52],0.2840424262485269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,16965,52,0.84 [0.49-1.43],0.5109303372502896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,16965,52,0.77 [0.26-2.28],0.6333921339973447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CREG1,Protein CREG1,19961,78,0.41 [0.23-0.73],0.0023016856939343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,17227,49,4.67 [2.39-9.12],6.435414588561529e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,20254,80,2.30 [1.63-3.24],2.2320730815267624e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRH,Corticoliberin,19726,80,0.59 [0.46-0.75],3.1386322971125925e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,20198,79,8.55 [4.24-17.24],2.0363047014931416e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,19823,80,0.84 [0.58-1.22],0.3575307020187096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,20290,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIP2,Cysteine-rich protein 2,20021,81,2.86 [2.17-3.76],5.93661596474423e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,20371,81,1.10 [0.83-1.48],0.4990687584395357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,17456,51,0.44 [0.18-1.06],0.0664817161953316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRKL,Crk-like protein,20229,80,1.16 [0.95-1.41],0.1361720144015004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,20290,80,5.58 [2.82-11.03],7.693759059677846e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRNN,Cornulin,19652,77,1.20 [0.91-1.58],0.1913091061338467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,20456,83,0.33 [0.19-0.59],0.0001919751854499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,20021,81,2.22 [1.56-3.17],9.120682921773052e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAP,Cartilage-associated protein,17117,51,0.69 [0.34-1.41],0.3036809773888527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRX,Cone-rod homeobox protein,19823,80,0.91 [0.74-1.11],0.349563482724091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYBB1,Beta-crystallin B1,17610,52,1.65 [1.11-2.46],0.0142015266122297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYBB2,Beta-crystallin B2,17573,52,1.65 [1.44-1.90],2.2546833155882866e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYGD,Gamma-crystallin D,17573,52,0.98 [0.75-1.29],0.8999431823480329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYM,Ketimine reductase mu-crystallin,17030,52,1.05 [0.74-1.49],0.7863841231638612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,17158,52,1.17 [0.87-1.59],0.2958901367862813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSDE1,Cold shock domain-containing protein E1,17001,51,1.06 [0.84-1.34],0.5966990966065668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,20290,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,17611,51,3.05 [1.85-5.01],1.1523859373398643e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,17001,51,1.22 [0.61-2.44],0.5798859959109299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,20021,81,1.54 [1.17-2.01],0.0018639341515482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,17083,52,1.14 [0.61-2.13],0.6872453501618943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF3,Granulocyte colony-stimulating factor,19834,81,0.80 [0.52-1.22],0.2934317963050347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,17083,52,1.32 [0.59-2.97],0.5038813240006054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,17611,51,0.67 [0.26-1.74],0.4143067296752611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSNK1D,Casein kinase I isoform delta,17083,52,1.18 [0.79-1.78],0.4169706771897775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,17572,52,2.29 [1.31-4.01],0.003547930006848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,17614,50,6.00 [2.87-12.57],1.9988048718563217e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,17030,52,1.16 [0.72-1.87],0.5448122378476875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,17001,51,1.38 [1.14-1.68],0.0011290327596183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST1,Cystatin-SN,15308,40,1.29 [0.99-1.68],0.0629990714009851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST3,Cystatin-C,20303,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST5,Cystatin-D,19802,81,2.02 [1.46-2.81],2.416720109267063e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST6,Cystatin-M,19667,81,2.91 [2.07-4.09],7.137840032676168e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST7,Cystatin-F,20232,80,1.29 [1.11-1.51],0.0012494459268591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSTB,Cystatin-B,19934,80,3.31 [2.33-4.71],2.2247156486639095e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,17253,52,0.58 [0.32-1.05],0.0706794627492852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTBS,Di-N-acetylchitobiase,17337,51,2.12 [0.78-5.79],0.1417178996761635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTF1,Cardiotrophin-1,19823,80,1.22 [0.98-1.52],0.0812395594077358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,17614,50,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,17614,50,0.95 [0.37-2.41],0.9099098460454194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTNNA1,Catenin alpha-1,17030,52,0.91 [0.41-2.03],0.8134752560251751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRB1,Chymotrypsinogen B,20222,80,0.46 [0.32-0.65],1.2088730577293805e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRC,Chymotrypsin-C,20193,79,0.36 [0.27-0.47],1.4924508001660278e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,17573,52,0.34 [0.24-0.48],4.1027170534818944e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSB,Cathepsin B,20262,83,1.23 [0.87-1.73],0.2445287552374494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSC,Dipeptidyl peptidase 1,20158,80,1.25 [0.81-1.94],0.3174132672590949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSD,Cathepsin D,18945,80,2.10 [1.52-2.91],8.621546773090386e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSE,Cathepsin E,17227,49,2.90 [1.78-4.71],1.727110087552613e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSF,Cathepsin F,20289,81,1.06 [0.64-1.74],0.8310799623782552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSH,Pro-cathepsin H,19744,80,1.43 [1.11-1.85],0.0065041216515653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSL,Cathepsin L1,20208,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSO,Cathepsin O,20408,82,7.05 [4.57-10.86],8.21745539641204e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSS,Cathepsin S,15786,71,9.93 [4.63-21.32],3.875410079708902e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSV,Cathepsin L2,20305,81,0.41 [0.25-0.67],0.0003825060815053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSZ,Cathepsin Z,20280,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,17117,51,0.85 [0.39-1.87],0.6933139823319039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,17410,52,1.48 [1.07-2.04],0.0170150753555042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CX3CL1,Fractalkine,20021,81,4.98 [3.16-7.84],3.971773045029545e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,20157,80,2.52 [1.91-3.34],8.462811294862313e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL1,Growth-regulated alpha protein,20166,80,1.20 [1.00-1.44],0.044800551486863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL10,C-X-C motif chemokine 10,20290,80,1.19 [0.91-1.55],0.210390528465226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL11,C-X-C motif chemokine 11,20368,81,1.03 [0.81-1.30],0.8125483201079684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL12,Stromal cell-derived factor 1,19834,81,0.86 [0.52-1.42],0.5563570417399006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,20368,81,1.25 [1.01-1.55],0.0407391966793594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,19834,81,1.47 [1.21-1.78],7.850990019828166e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,20429,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL17,C-X-C motif chemokine 17,20408,82,1.40 [0.92-2.14],0.1159156310900116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL3,C-X-C motif chemokine 3,20196,80,1.08 [0.87-1.34],0.4976645008870473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL5,C-X-C motif chemokine 5,20148,82,0.99 [0.84-1.16],0.873283550867973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL6,C-X-C motif chemokine 6,20408,82,1.33 [1.04-1.69],0.0235542526478217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL8,Interleukin-8,20066,79,1.13 [0.88-1.46],0.3370907181525026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,20290,80,1.74 [1.39-2.18],1.4083168200637438e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CYB5A,Cytochrome b5,16965,52,1.05 [0.74-1.50],0.7745176924312192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,17337,52,1.67 [1.12-2.47],0.0115161641233464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",17001,51,0.98 [0.71-1.34],0.8873893928306594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CYTH3,Cytohesin-3,16965,52,0.95 [0.64-1.41],0.7952604122610305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CYTL1,Cytokine-like protein 1,17614,50,2.07 [0.76-5.66],0.15463835129945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,17227,49,1.23 [0.88-1.70],0.2205225177182833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAB2,Disabled homolog 2,20371,81,1.14 [0.95-1.37],0.1629340774812585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAG1,Dystroglycan,20290,80,2.69 [1.77-4.10],3.973060740253999e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAND5,DAN domain family member 5,17083,52,1.35 [0.98-1.88],0.0689523845850442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAPK2,Death-associated protein kinase 2,17083,52,1.70 [1.24-2.34],0.0010166313999126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,20157,80,1.14 [0.95-1.36],0.1545493647386133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",19988,80,1.02 [0.77-1.35],0.88481719593276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DBH,Dopamine beta-hydroxylase,17570,51,0.82 [0.67-1.00],0.05182771356135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DBI,Acyl-CoA-binding protein,20137,80,1.76 [1.37-2.27],1.1912857636469852e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DBN1,Drebrin,17083,52,1.73 [1.07-2.79],0.0249523688938928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DBNL,Drebrin-like protein,20290,80,1.17 [0.94-1.46],0.1574431163353371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",20289,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCC,Netrin receptor DCC,17117,51,0.16 [0.04-0.71],0.0155370106107462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,16965,52,0.93 [0.60-1.45],0.7580048956798034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCLRE1C,Protein artemis,16965,52,1.61 [0.75-3.44],0.2220565886378295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCN,Decorin,19823,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCTD,Deoxycytidylate deaminase,17227,49,1.15 [0.86-1.55],0.3474186410640572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCTN1,Dynactin subunit 1,20371,81,1.34 [0.99-1.82],0.0568558218778264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCTN2,Dynactin subunit 2,20108,81,0.89 [0.72-1.11],0.3088062080296626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCTN6,Dynactin subunit 6,19753,77,1.17 [0.91-1.51],0.2079137637704359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,20208,82,1.66 [0.92-2.98],0.0902481082791846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCUN1D1,DCN1-like protein 1,17030,52,1.13 [0.81-1.56],0.4793985708597438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCUN1D2,DCN1-like protein 2,16965,52,0.91 [0.63-1.31],0.6143529357742733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCXR,L-xylulose reductase,20289,81,0.94 [0.65-1.34],0.720683846724655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,17001,51,0.94 [0.47-1.86],0.850769348711361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",20108,81,2.65 [1.92-3.67],3.956775308535818e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,20167,82,0.92 [0.62-1.39],0.7062889963816513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDHD2,Phospholipase DDHD2,17572,52,1.27 [0.85-1.91],0.2435093618972007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDI2,Protein DDI1 homolog 2,17227,49,0.68 [0.48-0.97],0.0348058396073597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,20368,81,5.40 [3.00-9.72],1.9611418971726785e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDT,D-dopachrome decarboxylase,17614,50,1.19 [0.64-2.22],0.5755888248015177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,17522,52,1.36 [0.90-2.05],0.1429185180672912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,17117,51,1.00 [0.49-2.03],0.9961977957007728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,17083,52,0.40 [0.10-1.56],0.1874123384589304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,17083,52,0.72 [0.39-1.33],0.2934070971171835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,17117,51,0.59 [0.26-1.32],0.1978365058818917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,19761,80,1.31 [0.98-1.75],0.072243450470298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",20157,80,1.19 [0.97-1.47],0.0963714514481338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,19836,82,2.10 [1.68-2.63],6.313997961338618e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,16938,51,1.70 [1.20-2.42],0.0029264380797471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,17030,52,1.48 [1.03-2.14],0.0351055219546835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB116,Beta-defensin 116,17030,52,1.03 [0.73-1.45],0.8620510834414163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB118,Beta-defensin 118,17030,52,1.41 [1.04-1.92],0.0293913278989328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,19930,81,1.29 [1.14-1.47],9.058653714861612e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DENND2B,DENN domain-containing protein 2B,17001,51,0.86 [0.46-1.57],0.6161481812658179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DENR,Density-regulated protein,17083,52,1.26 [0.80-1.97],0.3224944935052005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,20408,82,1.16 [0.87-1.56],0.3079438433341732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DGCR6,Protein DGCR6,17030,52,1.22 [0.73-2.02],0.446898604038466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DGKA,Diacylglycerol kinase alpha,17083,52,1.27 [0.78-2.06],0.3310210094248228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DGKZ,Diacylglycerol kinase zeta,19834,81,0.65 [0.35-1.19],0.1600139542779453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DHODH,Dihydroorotate dehydrogenase,17001,51,1.09 [0.64-1.87],0.7547776082680284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DHPS,Deoxyhypusine synthase,17526,51,0.95 [0.51-1.79],0.8779771828775261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,17573,52,1.40 [0.87-2.26],0.1617427119323541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",20151,82,0.99 [0.83-1.18],0.9005663538751807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,17117,51,0.57 [0.26-1.26],0.1647898709300875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,17227,49,2.26 [0.99-5.14],0.0531617488580695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK1,Dickkopf-related protein 1,20368,81,1.26 [0.91-1.76],0.1605433718303844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK3,Dickkopf-related protein 3,20456,83,3.90 [2.15-7.09],7.88509548211283e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK4,Dickkopf-related protein 4,19992,81,4.12 [3.26-5.20],1.5761000516528288e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKKL1,Dickkopf-like protein 1,20108,81,1.01 [0.81-1.26],0.920261648801654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLG4,Disks large homolog 4,17573,52,1.14 [0.79-1.66],0.4842957728633558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLGAP5,Disks large-associated protein 5,17572,52,1.20 [0.79-1.80],0.3941347035537265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLK1,Protein delta homolog 1,20456,83,2.57 [1.85-3.58],2.06988588049936e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLL1,Delta-like protein 1,20289,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLL4,Delta-like protein 4,17158,52,1.18 [0.98-1.42],0.075331685069171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMD,Dystrophin,17158,52,1.90 [1.45-2.49],3.2357861035023504e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,17158,52,0.41 [0.31-0.53],1.340526733120938e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,16965,52,1.19 [0.72-1.96],0.4891028062098483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,20350,82,1.28 [1.00-1.63],0.0481550923262877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,17573,52,0.87 [0.60-1.27],0.4715337420421105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,20108,81,1.06 [0.84-1.33],0.6326257041512339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,17522,52,1.46 [1.00-2.14],0.0497704085454229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,17227,49,0.91 [0.54-1.53],0.7238580833145819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,17063,49,1.33 [0.96-1.85],0.0837577252613755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,19823,80,1.11 [0.80-1.53],0.5411582543247412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,17573,52,0.60 [0.28-1.31],0.2002350855014923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,17158,52,1.34 [0.98-1.83],0.0660461298448546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,17522,52,1.08 [0.76-1.53],0.6709129171770605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,20153,79,1.21 [0.56-2.64],0.6255210033308567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNLZ,DNL-type zinc finger protein,17030,52,0.64 [0.41-1.01],0.0552858971051255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNM1,Dynamin-1,17522,52,1.22 [0.96-1.56],0.1073753298971535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNM3,Dynamin-3,17572,52,1.77 [1.25-2.50],0.0012850658578982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNMBP,Dynamin-binding protein,20021,81,1.78 [1.36-2.33],2.204994343996793e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNPEP,Aspartyl aminopeptidase,17573,52,0.82 [0.54-1.23],0.3284553059068188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,20265,80,0.74 [0.50-1.09],0.1312833439042386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,17117,51,0.93 [0.43-2.00],0.8523650449040541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,17030,52,0.77 [0.56-1.06],0.1037881568192655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DOK1,Docking protein 1,17573,52,1.13 [0.92-1.39],0.2366471375353049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DOK2,Docking protein 2,20208,82,1.17 [1.00-1.38],0.0562449731911924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPEP1,Dipeptidase 1,19988,80,1.72 [1.14-2.60],0.0093041102955048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPEP2,Dipeptidase 2,20108,81,0.85 [0.44-1.63],0.627039042826355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,20157,80,1.17 [0.69-1.99],0.5533639979403138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,19876,81,0.68 [0.34-1.35],0.2645212504300863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,20108,81,7.97 [4.72-13.45],8.525389731958366e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP7,Dipeptidyl peptidase 2,20052,81,1.24 [0.90-1.70],0.1826475505253361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPT,Dermatopontin,20456,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPY30,Protein dpy-30 homolog,20296,81,2.11 [1.71-2.60],2.6706645009152624e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DRAXIN,Draxin,20021,81,2.91 [2.04-4.15],4.214398206222495e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,20108,81,1.17 [0.83-1.66],0.3766951537290285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSC2,Desmocollin-2,20016,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,17572,52,3.55 [1.78-7.08],0.0003231269331625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSG2,Desmoglein-2,20222,80,4.57 [2.37-8.80],5.539125370938422e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSG3,Desmoglein-3,20294,80,3.90 [2.53-6.02],7.989247434043309e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSG4,Desmoglein-4,20047,80,0.82 [0.56-1.20],0.309445018853677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,17227,49,1.08 [0.78-1.47],0.6528603610892803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTNB,Dystrobrevin beta,17488,51,3.95 [2.84-5.47],2.0536780445894187e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,17117,51,0.49 [0.27-0.89],0.0180202217067678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,20108,81,7.23 [4.76-10.96],1.3386222712442104e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTYMK,Thymidylate kinase,17610,52,1.07 [0.73-1.59],0.7198521939985945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DUOX2,Dual oxidase 2,19823,80,0.82 [0.60-1.14],0.2419580227531141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,17526,51,1.24 [0.68-2.26],0.491592093697443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DUSP29,Dual specificity phosphatase 29,17117,51,1.44 [1.08-1.91],0.0133225936862471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,19753,77,0.88 [0.67-1.15],0.3351968922377469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",17522,52,1.63 [1.27-2.09],0.0001232328030879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DXO,Decapping and exoribonuclease protein,17573,52,1.16 [0.64-2.10],0.6203523286359607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,17526,51,1.14 [0.68-1.89],0.6255995692834762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,17117,51,1.33 [0.99-1.79],0.0563009651445111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,17526,51,1.26 [0.71-2.24],0.4263015344099266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,20021,81,1.13 [0.91-1.39],0.2685438061442279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EBI3_IL27,Interleukin-27,20337,81,4.47 [2.53-7.88],2.383254802851457e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ECE1,Endothelin-converting enzyme 1,19753,77,0.82 [0.46-1.46],0.4957058164871332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",17610,52,0.90 [0.62-1.33],0.6084045366498743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",17158,52,1.28 [0.98-1.68],0.0693756358121962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,17001,51,1.48 [1.02-2.17],0.0406188806814565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ECM1,Extracellular matrix protein 1,17180,49,0.82 [0.40-1.68],0.5855185513231058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,17030,52,0.92 [0.52-1.62],0.7683247770280206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,20371,81,8.44 [6.27-11.35],3.6775326931647296e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,20157,80,1.17 [0.94-1.45],0.168772829019799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,17526,51,1.22 [0.89-1.67],0.2085751563490359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,17001,51,1.01 [0.48-2.11],0.9750886226616884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDF1,Endothelial differentiation-related factor 1,17572,52,1.18 [0.84-1.67],0.3375409183375246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19823,80,2.90 [1.89-4.44],1.0363426618949225e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDN1,Endothelin-1,17158,52,7.18 [3.45-14.95],1.4160277660288108e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDNRB,Endothelin receptor type B,17083,52,1.76 [1.29-2.41],0.0004189070744721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EEF1D,Elongation factor 1-delta,17610,52,1.38 [1.05-1.82],0.0226348425759165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,17522,52,3.83 [2.51-5.86],5.232145772588429e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,17281,52,2.24 [1.22-4.11],0.0095818548041961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,20305,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,17572,52,2.62 [1.75-3.91],2.5097757843732624e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNA1,Ephrin-A1,20191,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNA4,Ephrin-A4,19986,81,8.79 [6.34-12.21],1.317401092013547e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNB2,Ephrin-B2,17117,51,1.85 [1.46-2.33],2.241951103766893e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGF,Pro-epidermal growth factor,20162,79,1.03 [0.85-1.25],0.761400172452666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,19761,80,2.29 [1.62-3.25],2.943866906050008e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFLAM,Pikachurin,17522,52,2.77 [1.61-4.79],0.000255620981598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFR,Epidermal growth factor receptor,20456,83,0.18 [0.06-0.57],0.0034215519841393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGLN1,Egl nine homolog 1,20157,80,1.38 [1.08-1.77],0.011062252215111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EHBP1,EH domain-binding protein 1,17610,52,1.28 [0.90-1.81],0.1692311284826112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EHD3,EH domain-containing protein 3,17158,52,1.12 [0.89-1.41],0.3391485937898887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",17573,52,0.91 [0.54-1.55],0.732119731141978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",17449,51,1.21 [0.95-1.54],0.131052005401683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,17001,51,0.74 [0.46-1.18],0.2047015052503141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,17158,52,0.82 [0.41-1.66],0.5780294418895122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,20021,81,0.93 [0.66-1.31],0.6715581670810636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,17083,52,1.20 [0.89-1.63],0.2267592821134287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,20208,82,1.27 [0.95-1.69],0.1072388350134415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,20408,82,1.29 [1.05-1.59],0.0146888690578958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,17572,52,1.03 [0.68-1.55],0.9054412109701836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,17001,51,0.90 [0.48-1.68],0.7379338853780937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,19834,81,0.87 [0.43-1.77],0.7039501392333105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,17572,52,1.32 [0.96-1.83],0.0899942655209831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELAVL4,ELAV-like protein 4,17030,52,1.19 [0.88-1.60],0.2505118544295232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELN,Elastin,17610,52,6.78 [3.82-12.06],6.959994748134397e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELOA,Elongin-A,20108,81,0.74 [0.48-1.14],0.176703823102417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELOB,Elongin-B,17001,51,1.95 [1.42-2.68],3.6527888691527314e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENAH,Protein enabled homolog,19834,81,2.07 [1.49-2.89],1.8117357155994347e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,16230,49,2.19 [1.53-3.15],2.045953346267034e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENG,Endoglin,20456,83,2.17 [0.76-6.26],0.1501362311943699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENO1,Alpha-enolase,20181,81,1.22 [0.94-1.57],0.1326346951051983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENO2,Gamma-enolase,20368,81,1.14 [0.84-1.54],0.4038124873522745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENO3,Beta-enolase,17158,52,0.92 [0.58-1.46],0.7184964807412232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENOPH1,Enolase-phosphatase E1,17526,51,0.58 [0.34-0.98],0.0419907419665521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,17001,51,1.04 [0.38-2.82],0.936658233436484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENPEP,Glutamyl aminopeptidase,17001,51,1.20 [0.74-1.94],0.4632218125513644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,20456,83,0.65 [0.36-1.16],0.1449020400299471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,20290,80,1.54 [0.91-2.60],0.1097929856390197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,17158,52,1.30 [0.64-2.62],0.4707285112771645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,19542,77,1.16 [0.92-1.47],0.2163714659285815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENSA,Alpha-endosulfine,17526,51,1.07 [0.65-1.76],0.791136945549133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,19761,80,1.25 [0.83-1.89],0.2802161734492241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,19823,80,0.34 [0.15-0.77],0.0097479780530723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,19823,80,2.91 [1.25-6.78],0.0133062595605768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,17158,52,1.15 [0.75-1.75],0.5179189694234946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EP300,Histone acetyltransferase p300,17083,52,1.31 [0.63-2.74],0.4651469904327329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPB41L5,Band 4.1-like protein 5,17117,51,1.18 [0.82-1.69],0.3710378987556667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPCAM,Epithelial cell adhesion molecule,20187,78,0.97 [0.79-1.19],0.7738148599995269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPGN,Epigen,17526,51,1.05 [0.59-1.89],0.8641112588914972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,20265,80,8.93 [4.91-16.24],6.848433979740164e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA10,Ephrin type-A receptor 10,19753,77,0.95 [0.69-1.31],0.7580214917161177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,19475,77,8.94 [6.09-13.12],4.3916187511776537e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,17227,49,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,20456,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,19988,80,7.68 [4.77-12.36],4.7688044980785517e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,19823,80,0.90 [0.63-1.28],0.559679364520894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPN1,Epsin-1,17281,52,1.08 [0.60-1.94],0.7986824692822745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPO,Erythropoietin,20157,80,1.59 [1.34-1.89],1.388338143948845e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPPK1,Epiplakin,17158,52,1.64 [1.22-2.22],0.0012392870273171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,20330,81,5.99 [3.91-9.19],2.3245899547544683e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,20289,81,0.71 [0.31-1.61],0.4076103580800557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,20142,79,0.27 [0.10-0.73],0.0099210370125139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,20289,81,3.11 [1.45-6.67],0.003560969856288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERBIN,Erbin,20108,81,1.13 [0.93-1.38],0.207865648255763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERC2,ERC protein 2,17117,51,1.17 [0.86-1.58],0.3243967650396173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,16965,52,1.14 [0.53-2.45],0.7448193011947994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EREG,Proepiregulin,19988,80,0.97 [0.75-1.25],0.8176985067417424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERI1,3'-5' exoribonuclease 1,17281,52,0.67 [0.29-1.57],0.3598408233625493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,17083,52,3.64 [2.25-5.91],1.610528764375953e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,17526,51,0.80 [0.39-1.65],0.5462725987829322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,17227,49,1.14 [0.90-1.44],0.2837692205823133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,20066,81,0.63 [0.29-1.37],0.2401770374775044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,17001,51,0.84 [0.43-1.65],0.6093489371336358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,20456,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESM1,Endothelial cell-specific molecule 1,20198,79,0.95 [0.54-1.69],0.8621471023740772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESPL1,Separin,16965,52,0.87 [0.51-1.48],0.6068575686437659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESR1,Estrogen receptor,17083,52,1.02 [0.62-1.66],0.9398584752902136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESYT2,Extended synaptotagmin-2,17573,52,1.69 [1.25-2.28],0.0007330983560678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EVI2B,Protein EVI2B,16965,52,1.09 [0.58-2.04],0.7913899657860242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,17083,52,1.24 [0.92-1.68],0.1555348105735594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EVPL,Envoplakin,17281,52,0.97 [0.43-2.18],0.9398353113323464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EXOSC10,Exosome component 10,17001,51,1.35 [0.93-1.95],0.1123130631756758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EXTL1,Exostosin-like 1,17001,51,1.30 [0.83-2.04],0.2580719703363709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EZR,Ezrin,20368,81,1.05 [0.47-2.33],0.91027416285911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F10,Coagulation factor X,17611,51,0.31 [0.15-0.63],0.0011529867894487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F11,Coagulation factor XI,17384,49,1.31 [0.58-3.00],0.5172189792924979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F11R,Junctional adhesion molecule A,20222,80,1.80 [1.30-2.50],0.0004513645404336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F12,Coagulation factor XII,17637,50,0.62 [0.35-1.12],0.1133664178106133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F13B,Coagulation factor XIII B chain,17537,50,0.69 [0.24-1.92],0.4727596719940047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F2,Prothrombin,17637,50,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F2R,Proteinase-activated receptor 1,20254,80,3.02 [2.13-4.28],5.069763375142836e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F3,Tissue factor,20249,81,4.66 [2.48-8.75],1.645275732307467e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F7,Coagulation factor VII,20301,82,0.60 [0.34-1.05],0.0756607651347448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F9,Coagulation factor IX,20287,82,1.51 [0.50-4.62],0.4660348281707546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",20198,79,2.38 [2.02-2.81],6.69566373823611e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",20208,82,1.91 [1.56-2.35],7.302455292972236e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",17610,52,4.41 [3.28-5.95],1.547494605512128e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",20456,83,3.16 [2.41-4.12],3.993259343899934e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP5,Fatty acid-binding protein 5,20290,81,1.71 [1.33-2.21],3.104262973716213e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP6,Gastrotropin,19785,80,1.66 [1.27-2.17],0.0002122957297188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP9,Fatty acid-binding protein 9,20157,80,1.80 [1.33-2.43],0.0001208685991194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FADD,FAS-associated death domain protein,20208,82,1.08 [0.83-1.40],0.5818991153618034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM13A,Protein FAM13A,17522,52,1.13 [0.76-1.69],0.5439680597786577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM171A2,Protein FAM171A2,17572,52,1.07 [0.92-1.25],0.380595075890808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM171B,Protein FAM171B,17526,51,2.23 [1.33-3.73],0.0022589699970544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,17158,52,1.25 [0.81-1.94],0.3169934671809119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM20A,Pseudokinase FAM20A,17610,52,1.51 [0.60-3.76],0.3812663607446152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3B,Protein FAM3B,20108,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3C,Protein FAM3C,20167,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3D,Protein FAM3D,17522,52,3.38 [2.40-4.75],3.0398722226978135e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAP,Prolyl endopeptidase FAP,20456,83,8.37 [4.20-16.69],1.6110662460092152e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,17117,51,1.07 [0.74-1.56],0.7159281513279426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,20398,83,2.29 [1.78-2.95],1.5833532330473666e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,20408,82,0.83 [0.50-1.38],0.4735928603802826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBLN2,Fibulin-2,17614,50,7.21 [4.17-12.49],1.7192805300330392e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBN2,Fibrillin-2,17117,51,1.48 [0.95-2.29],0.0799196999749835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",20208,82,1.19 [0.92-1.54],0.1807490811433606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,17610,52,1.84 [1.32-2.56],0.000312630392965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,20157,80,2.22 [1.49-3.29],7.99144643889479e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,17572,52,3.88 [1.86-8.09],0.0003071289024048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,20222,80,2.05 [1.68-2.50],1.2201995533843886e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,20155,82,2.18 [1.40-3.38],0.0005285651110572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,19761,80,1.16 [0.83-1.62],0.3846704753807812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,20264,82,0.83 [0.57-1.21],0.3368013141601118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCN1,Ficolin-1,17570,51,1.30 [0.78-2.18],0.3139610285626849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCN2,Ficolin-2,20160,82,0.51 [0.36-0.74],0.0003483867311269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL1,Fc receptor-like protein 1,20208,82,1.53 [1.05-2.23],0.0259651659630936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL2,Fc receptor-like protein 2,20298,82,1.83 [1.39-2.41],1.7001377255629546e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL3,Fc receptor-like protein 3,19834,81,0.93 [0.65-1.33],0.6837158183590059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL5,Fc receptor-like protein 5,20222,80,2.19 [1.66-2.88],2.366970652375574e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL6,Fc receptor-like protein 6,20157,80,1.71 [1.29-2.28],0.0002365613861333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRLB,Fc receptor-like B,19761,80,1.51 [1.25-1.81],1.2293779482064116e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",17001,51,1.54 [1.16-2.05],0.0028349881975711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",17001,51,1.36 [0.93-1.98],0.1131164692017541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FEN1,Flap endonuclease 1,19761,80,1.00 [0.74-1.35],0.9971422886162774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,19761,80,1.02 [0.66-1.57],0.9421333233945464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FETUB,Fetuin-B,20287,82,1.22 [0.64-2.30],0.5477952921685638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGA,Fibrinogen alpha chain,17232,48,1.69 [0.70-4.07],0.2433804029886127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",17572,52,1.19 [0.85-1.66],0.3200470141901327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF12,Fibroblast growth factor 12,17083,52,1.17 [0.74-1.83],0.4994359323492526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF16,Fibroblast growth factor 16,17083,52,0.92 [0.50-1.66],0.7746035915643438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF19,Fibroblast growth factor 19,20290,80,0.86 [0.67-1.11],0.2598406057817481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF2,Fibroblast growth factor 2,20157,80,1.37 [1.04-1.81],0.0253403573175741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF20,Fibroblast growth factor 20,17083,52,1.24 [0.75-2.05],0.4088216173901722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF21,Fibroblast growth factor 21,20337,81,1.08 [0.91-1.27],0.380606385603414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF23,Fibroblast growth factor 23,20345,81,2.06 [1.69-2.52],1.0966444039339553e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF3,Fibroblast growth factor 3,17083,52,1.38 [0.70-2.70],0.3507176392157656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF5,Fibroblast growth factor 5,19834,81,5.08 [3.41-7.56],1.3032913896361906e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF6,Fibroblast growth factor 6,17083,52,1.18 [0.73-1.91],0.5078472547909829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF7,Fibroblast growth factor 7,16965,52,1.10 [0.82-1.47],0.5242138764344261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF9,Fibroblast growth factor 9,16939,52,0.82 [0.43-1.55],0.5425925806445959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,20289,81,0.10 [0.06-0.17],4.505014383890986e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,17614,50,0.20 [0.11-0.37],1.1453188485651653e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,17573,52,0.70 [0.34-1.46],0.3422878649338194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,20289,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,17227,49,0.87 [0.52-1.46],0.5954295645586914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGL1,Fibrinogen-like protein 1,17611,51,2.05 [1.41-2.98],0.0001724423619113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGR,Tyrosine-protein kinase Fgr,19753,77,1.16 [0.87-1.55],0.319280344725079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FH,"Fumarate hydratase, mitochondrial",17030,52,0.59 [0.36-0.97],0.0388947577614803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,17001,51,0.87 [0.47-1.61],0.6666979824699364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,19753,77,1.01 [0.76-1.33],0.9661867300236692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FIS1,Mitochondrial fission 1 protein,20207,80,1.13 [0.87-1.46],0.3537816524234944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,17572,52,1.21 [0.93-1.59],0.1620528209325117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,20246,81,1.12 [0.94-1.33],0.2220442923192566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,20021,81,1.35 [0.85-2.15],0.2018447499822067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,20021,81,1.22 [0.98-1.52],0.0753673866481167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,19720,76,1.18 [0.80-1.74],0.3912804880264241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FKBPL,FK506-binding protein-like,17522,52,1.01 [0.64-1.60],0.949710388224722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,19761,80,1.14 [0.96-1.37],0.136649613197682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,20021,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,20073,81,3.24 [1.76-5.96],0.000160863602946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,19761,80,0.71 [0.37-1.39],0.3231894523206731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,20408,82,2.22 [1.29-3.82],0.0038065777138425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,20289,81,0.94 [0.52-1.70],0.8418915535593271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FMNL1,Formin-like protein 1,19753,77,1.28 [1.02-1.59],0.0313393846933176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FMR1,Synaptic functional regulator FMR1,19761,80,1.26 [0.72-2.19],0.4130380134477428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FN1,Fibronectin,17637,50,0.16 [0.07-0.40],7.561785332898804e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,17573,52,5.10 [2.99-8.70],2.138251076810952e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,17526,51,1.36 [0.68-2.69],0.3829464896237935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,17083,52,1.10 [0.86-1.41],0.4548863395970769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR1,Folate receptor alpha,20204,81,5.55 [3.49-8.83],4.491507138112397e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR2,Folate receptor beta,20368,81,6.03 [3.54-10.26],3.628013532350213e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR3,Folate receptor gamma,20228,80,1.01 [0.91-1.12],0.8961213489616328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOS,Proto-oncogene c-Fos,16939,52,2.22 [1.20-4.09],0.0108193335452697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOSB,Protein fosB,19753,77,1.12 [0.68-1.83],0.6531575807448535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOXJ3,Forkhead box protein J3,17083,52,1.49 [0.88-2.51],0.1350155552247166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOXO1,Forkhead box protein O1,20157,80,1.16 [0.92-1.47],0.213805575255395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOXO3,Forkhead box protein O3,19761,80,1.19 [0.97-1.46],0.0875265861838765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FRMD4B,FERM domain-containing protein 4B,17001,51,0.90 [0.60-1.36],0.6296631860384962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FRMD7,FERM domain-containing protein 7,17117,51,0.55 [0.26-1.20],0.1332923649426098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FRZB,Secreted frizzled-related protein 3,19953,81,1.15 [0.53-2.51],0.728617263174349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSHB,Follitropin subunit beta,17158,52,0.78 [0.59-1.04],0.086618825080303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FST,Follistatin,20254,80,0.77 [0.51-1.17],0.2273619192568882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL1,Follistatin-related protein 1,17158,52,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL3,Follistatin-related protein 3,20158,79,9.95 [6.79-14.60],6.65899345070275e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,17535,52,0.92 [0.67-1.25],0.5811360653631674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,20341,83,0.89 [0.71-1.12],0.3208961466676793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUOM,Fucose mutarotase,17227,49,0.88 [0.58-1.33],0.5352474642123918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FURIN,Furin,20289,81,0.34 [0.18-0.63],0.0006612296354988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUS,RNA-binding protein FUS,19736,80,1.39 [0.89-2.16],0.144764466814306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",17244,51,1.01 [0.65-1.59],0.9493085979836532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,20368,81,2.17 [1.49-3.17],5.996739214933775e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",20021,81,0.83 [0.59-1.17],0.2932642671921585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FXN,"Frataxin, mitochondrial",20371,81,1.26 [0.97-1.64],0.081481722383708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,19834,81,1.23 [0.92-1.66],0.1618993563453374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FYB1,FYN-binding protein 1,20183,80,1.15 [0.93-1.43],0.2050619720922964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FZD10,Frizzled-10,17117,51,0.90 [0.54-1.50],0.67858924116708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FZD8,Frizzled-8,17030,52,1.28 [0.77-2.13],0.3471748292765324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,17526,51,1.58 [1.09-2.29],0.0154436128410158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,17281,52,1.00 [0.65-1.53],0.997234761871782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,17030,52,1.17 [0.82-1.65],0.3838190771406895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAD1,Glutamate decarboxylase 1,16965,52,0.75 [0.27-2.10],0.5803103106404127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAD2,Glutamate decarboxylase 2,17083,52,1.09 [0.65-1.82],0.750224022289293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,17281,52,0.71 [0.34-1.48],0.3616581093772949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,17158,52,1.79 [1.15-2.77],0.0096031780385639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAGE2A,G antigen 2A,16965,52,1.11 [0.77-1.61],0.5631775305394628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAL,Galanin peptides,20290,80,0.94 [0.70-1.26],0.6684447636148272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,20108,81,2.70 [1.37-5.32],0.0041561576084428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,20371,81,1.18 [0.57-2.46],0.6496241476180359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,19834,81,1.83 [1.22-2.75],0.0034935212199367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,17610,52,3.28 [1.82-5.91],7.938260284373917e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,20108,81,3.18 [1.28-7.91],0.0128738518632225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,17001,51,1.19 [0.61-2.32],0.601834789492903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,16848,48,2.19 [0.80-6.02],0.1271218690732639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,17572,52,0.51 [0.16-1.66],0.2626286326498716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAS2,Growth arrest-specific protein 2,17281,52,0.82 [0.47-1.44],0.4927519165440438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAS6,Growth arrest-specific protein 6,20344,83,7.11 [3.49-14.47],6.225563019988222e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GASK1A,Golgi-associated kinase 1A,17001,51,0.54 [0.29-1.01],0.0547836058780965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAST,Gastrin,17573,52,1.27 [1.09-1.48],0.0019058648525032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,16965,52,0.87 [0.32-2.34],0.7786775891947785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",17158,52,1.41 [1.02-1.95],0.0401853089002754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GBA,Lysosomal acid glucosylceramidase,17117,51,1.22 [0.75-1.98],0.4141647714036909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GBP1,Guanylate-binding protein 1,17540,52,1.21 [0.81-1.80],0.3494312166300053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GBP2,Guanylate-binding protein 2,19834,81,1.03 [0.74-1.45],0.8455334408244837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GBP4,Guanylate-binding protein 4,19753,77,1.21 [0.81-1.82],0.3495453272126785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GBP6,Guanylate-binding protein 6,17001,51,0.52 [0.23-1.17],0.1153228556965526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GC,Vitamin D-binding protein,17637,50,0.22 [0.07-0.69],0.0094280479775129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,17573,52,1.25 [0.97-1.62],0.0832824989170135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCG,Pro-glucagon,19761,80,1.56 [1.33-1.83],4.246190091506472e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16814,48,2.19 [1.64-2.94],1.3440165641244317e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,17001,51,0.97 [0.54-1.72],0.9084950541726148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",20108,81,4.00 [2.48-6.45],1.2909197996798376e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF15,Growth/differentiation factor 15,20456,83,8.86 [6.78-11.57],9.347832629003581e-58
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF2,Growth/differentiation factor 2,20208,82,0.88 [0.51-1.49],0.6239796556039783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,19753,77,3.17 [2.33-4.33],3.0306375636681066e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GET3,ATPase GET3,17610,52,1.13 [0.71-1.78],0.6080969377011041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFAP,Glial fibrillary acidic protein,19726,80,1.22 [0.82-1.80],0.329252836357946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,19761,80,1.46 [1.08-1.96],0.0138646096806165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,19761,80,0.98 [0.83-1.16],0.7922956022311485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,20337,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,20108,81,4.11 [2.07-8.19],5.61706291160906e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,19966,81,4.97 [2.98-8.27],7.038798435795752e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRAL,GDNF family receptor alpha-like,17039,51,0.83 [0.53-1.28],0.3989519663274923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,19753,77,0.66 [0.44-1.00],0.0514475836047141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,17610,52,1.28 [0.88-1.85],0.1940605814354438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,17571,52,1.47 [0.85-2.54],0.1672751345976464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGH,Gamma-glutamyl hydrolase,19923,82,1.25 [0.72-2.17],0.4175460559773858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,20191,80,1.05 [0.72-1.54],0.7851291773836531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,20021,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GH1,Somatotropin,20167,82,1.17 [1.05-1.31],0.004708169502667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GH2,Growth hormone variant,19761,80,0.92 [0.80-1.06],0.2476341758582562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GHR,Growth hormone receptor,17227,49,0.16 [0.06-0.42],0.0001968674923158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,19753,77,1.02 [0.71-1.45],0.9316292326826312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GHRL,Appetite-regulating hormone,20208,82,0.90 [0.72-1.12],0.3542125064799475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,17572,52,0.72 [0.28-1.89],0.509520543066101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,17572,52,1.53 [1.10-2.13],0.0124658752387801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIMAP7,GTPase IMAP family member 7,17227,49,0.89 [0.37-2.13],0.7926079891851687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIMAP8,GTPase IMAP family member 8,16965,52,1.19 [0.75-1.89],0.4613656967863723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIP,Gastric inhibitory polypeptide,17158,52,2.20 [1.53-3.17],2.036319050922178e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,17573,52,6.33 [3.70-10.84],1.7694058745530767e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,17522,52,1.17 [0.88-1.55],0.2877598370547806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,17083,52,1.22 [0.77-1.95],0.3981837440753183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,17083,52,1.23 [0.93-1.63],0.1458155967624028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GJA8,Gap junction alpha-8 protein,16965,52,1.04 [0.68-1.58],0.8510660602805954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GKN1,Gastrokine-1,19367,71,2.05 [1.05-4.02],0.0365202972067187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLA,Alpha-galactosidase A,17200,49,1.77 [0.89-3.50],0.1016330200295552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLB1,Beta-galactosidase,20021,81,1.16 [0.73-1.86],0.5239682755662833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLI2,Zinc finger protein GLI2,17083,52,0.87 [0.34-2.20],0.763850858486152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLO1,Lactoylglutathione lyase,19823,80,1.04 [0.74-1.45],0.8241701712216556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,20171,80,1.29 [0.73-2.30],0.3817422622646743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,17030,52,1.10 [0.56-2.15],0.774835127996778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLRX,Glutaredoxin-1,20066,81,0.92 [0.64-1.31],0.6306600256510853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",17227,49,1.26 [0.94-1.70],0.1240060637948616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,19753,77,0.50 [0.27-0.92],0.025257765675981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,17526,51,1.13 [0.74-1.74],0.5682817584345419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GM2A,Ganglioside GM2 activator,17161,48,2.39 [1.85-3.10],3.927102842403157e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GMFG,Glia maturation factor gamma,17610,52,1.36 [0.93-1.99],0.1090684181865761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GMPR,GMP reductase 1,20408,82,0.69 [0.48-0.98],0.0408179585222843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GMPR2,GMP reductase 2,17227,49,1.09 [0.72-1.64],0.6915328585611646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GNAS,Neuroendocrine secretory protein 55,17572,52,1.19 [0.91-1.55],0.2131285302459374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,19761,80,1.18 [0.88-1.60],0.274593978685458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,17117,51,0.92 [0.53-1.59],0.7645016741931085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GNLY,Granulysin,20222,80,1.10 [0.76-1.61],0.6157893004517487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,17158,52,0.87 [0.37-2.07],0.75693693376649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,17227,49,0.94 [0.45-1.98],0.8696757932104792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GOLGA3,Golgin subfamily A member 3,17572,52,1.33 [0.96-1.83],0.0825005298853054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GOLM2,Protein GOLM2,20368,81,3.83 [1.95-7.53],9.670432660490966e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,20157,80,1.12 [0.92-1.37],0.2659488110944628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,17522,52,1.32 [0.77-2.28],0.3151779029997571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",17614,50,0.80 [0.41-1.54],0.5027067291118439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,20151,82,1.16 [0.64-2.10],0.6210005762058326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,17001,51,1.33 [0.89-1.99],0.1649230940923938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,19567,79,1.16 [0.93-1.44],0.1877543453936929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GP5,Platelet glycoprotein V,17227,49,1.77 [0.78-4.00],0.1701195909807039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GP6,Platelet glycoprotein VI,20183,80,1.20 [0.95-1.52],0.1174087798811295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPA33,Cell surface A33 antigen,20108,81,0.80 [0.69-0.93],0.0027514505712208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPC1,Glypican-1,20371,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPC5,Glypican-5,20021,81,0.63 [0.44-0.90],0.0103763841260277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,17526,51,1.38 [0.87-2.20],0.1763295977435695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,17522,52,1.66 [1.16-2.39],0.0056809118834062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPI,Glucose-6-phosphate isomerase,17611,51,1.46 [0.85-2.51],0.1717252793156434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,17522,52,1.26 [0.84-1.88],0.2585503317724187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,19753,77,1.65 [1.07-2.54],0.0230416863422248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,19648,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR101,Probable G-protein coupled receptor 101,17030,52,1.19 [0.83-1.71],0.3444055908650811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR158,Probable G-protein coupled receptor 158,17572,52,1.57 [0.91-2.70],0.1019140804067411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR15L,Protein GPR15L,17522,52,1.40 [0.95-2.07],0.0880382138556287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR37,Prosaposin receptor GPR37,19823,80,3.45 [2.67-4.46],3.621597163239241e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,17526,51,1.36 [0.91-2.03],0.1364090924358645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRAP2,GRB2-related adapter protein 2,20208,82,1.11 [0.95-1.30],0.1857773714436565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,17610,52,1.25 [0.82-1.91],0.3033313725683233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",17572,52,1.46 [0.91-2.33],0.1184022138227256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",17030,52,1.28 [0.89-1.84],0.1797509514154999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRK5,G protein-coupled receptor kinase 5,19823,80,0.77 [0.49-1.20],0.2416496734798614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRN,Progranulin,20125,80,4.57 [2.55-8.19],3.125855145212682e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRP,Gastrin-releasing peptide,17158,52,0.85 [0.53-1.37],0.506926682117331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",20108,81,1.69 [1.30-2.20],8.071813871364824e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRSF1,G-rich sequence factor 1,16881,52,1.42 [1.06-1.90],0.0196896381182565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSAP,Gamma-secretase-activating protein,19761,80,0.90 [0.69-1.19],0.4690871506894909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSN,Gelsolin,17550,51,0.46 [0.20-1.05],0.0666807008977754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSR,"Glutathione reductase, mitochondrial",17503,51,0.76 [0.23-2.48],0.6527766962629034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSTA1,Glutathione S-transferase A1,20172,82,0.94 [0.74-1.19],0.5980171128987954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSTA3,Glutathione S-transferase A3,19761,80,1.10 [0.86-1.42],0.4335049848284135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,17001,51,1.05 [0.75-1.47],0.7878682346139958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSTP1,Glutathione S-transferase P,19630,77,0.84 [0.60-1.15],0.274862341395558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,17573,52,0.97 [0.87-1.09],0.6448689134279665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,17281,52,1.01 [0.70-1.45],0.971132034434966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GTPBP2,GTP-binding protein 2,17117,51,1.08 [0.77-1.52],0.6680399303910203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUCA2A,Guanylin,20113,80,7.48 [5.16-10.82],1.6758897134207834e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,17281,52,1.01 [0.72-1.40],0.9660345675015862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUK1,Guanylate kinase,17001,51,1.46 [0.87-2.45],0.1525349845445937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUSB,Beta-glucuronidase,20316,83,1.19 [0.89-1.60],0.2342277473625765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",19823,80,0.98 [0.79-1.22],0.8472903380256223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GZMA,Granzyme A,20408,82,1.28 [0.74-2.19],0.3795185936472623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GZMB,Granzyme B,20157,80,0.66 [0.47-0.94],0.0211007429264763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GZMH,Granzyme H,19823,80,1.03 [0.80-1.33],0.8249813894015222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",H2AP,Huntingtin-interacting protein M,16965,52,0.82 [0.43-1.55],0.5413012340273073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",17001,51,1.20 [0.88-1.64],0.2457135618250215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",20301,81,0.69 [0.53-0.92],0.0098683056959429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAO1,Hydroxyacid oxidase 1,20371,81,1.08 [0.93-1.26],0.3186141393848277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",20222,80,1.17 [0.90-1.52],0.2435328213142974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,20335,81,3.66 [3.01-4.44],2.4960288677022208e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,20222,80,6.42 [4.36-9.45],4.277705358088048e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,20301,81,1.03 [0.79-1.35],0.8101699454871738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HBQ1,Hemoglobin subunit theta-1,20371,81,0.71 [0.51-1.00],0.0470062533093174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HBZ,Hemoglobin subunit zeta,17610,52,0.68 [0.51-0.89],0.0061289617752816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HCG22,Protein PBMUCL2,17001,51,0.93 [0.53-1.63],0.7986440293344922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,20408,82,1.18 [0.82-1.70],0.3784513918051615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HDAC8,Histone deacetylase 8,17083,52,0.75 [0.41-1.38],0.3556978083527907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HDAC9,Histone deacetylase 9,17030,52,0.65 [0.37-1.17],0.150622387256979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,17522,52,1.14 [0.63-2.06],0.6719778202075903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HDGF,Hepatoma-derived growth factor,20333,81,1.23 [1.00-1.52],0.0539862861942218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,17573,52,1.64 [1.15-2.36],0.0070081412179512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HEBP1,Heme-binding protein 1,19823,80,0.76 [0.51-1.15],0.1936046976869123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HEG1,Protein HEG homolog 1,17227,49,4.04 [1.59-10.27],0.0034079847172796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HEPACAM2,HEPACAM family member 2,17573,52,0.75 [0.40-1.41],0.3756835052651399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HEPH,Hephaestin,17610,52,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HEXIM1,Protein HEXIM1,20157,80,1.30 [1.02-1.66],0.0357266336862559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HGF,Hepatocyte growth factor,20408,82,2.73 [1.76-4.26],8.319093915495367e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HGFAC,Hepatocyte growth factor activator,17443,51,1.03 [0.40-2.64],0.9443696768322448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,19761,80,1.33 [1.03-1.70],0.0257945591536646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,17573,52,1.51 [1.07-2.13],0.0193648690447921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,17083,52,1.20 [0.85-1.69],0.3095810175867921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HIP1,Huntingtin-interacting protein 1,17001,51,1.34 [0.69-2.62],0.3907095772907046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,17533,52,2.28 [1.78-2.92],9.276897949770415e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HJV,Hemojuvelin,17572,52,1.54 [1.04-2.27],0.0313538596222544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HK2,Hexokinase-2,19823,80,0.84 [0.40-1.76],0.6502034316463516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",17572,52,5.00 [2.16-11.55],0.0001671077913604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",20099,78,1.69 [1.01-2.85],0.0478408895669335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",20157,80,7.58 [4.99-11.52],2.2690711768868617e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMBS,Porphobilinogen deaminase,20371,81,0.43 [0.28-0.66],0.0001009753918437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMCN2,Hemicentin-2,17199,49,5.41 [3.28-8.92],3.6696450537360106e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",17158,52,1.21 [0.71-2.04],0.4873425967381697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",17001,51,0.80 [0.42-1.53],0.5074463825522088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMMR,Hyaluronan mediated motility receptor,16928,52,0.83 [0.44-1.54],0.5478148098952739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMOX1,Heme oxygenase 1,19972,81,0.29 [0.19-0.46],1.3191556900348194e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMOX2,Heme oxygenase 2,19753,77,1.51 [1.08-2.12],0.0157452345162036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,17117,51,0.73 [0.45-1.20],0.2161921052846266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNMT,Histamine N-methyltransferase,19919,80,2.97 [2.13-4.15],1.730002992644294e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,19766,80,1.20 [0.93-1.54],0.1613841867339861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,17572,52,1.74 [1.18-2.56],0.0048824254472416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HPCAL1,Hippocalcin-like protein 1,20408,82,1.37 [1.03-1.83],0.0321061313609672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,19761,80,0.35 [0.20-0.60],0.0001342550366988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HPSE,Heparanase,17373,50,1.22 [0.90-1.65],0.1971867693488606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HRAS,GTPase Hras,17242,52,1.09 [0.87-1.37],0.4704516139771288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17158,52,2.65 [1.86-3.78],6.405138460900668e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HRG,Histidine-rich glycoprotein,17537,50,1.20 [0.50-2.87],0.6766025995352549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS1BP3,HCLS1-binding protein 3,17158,52,1.35 [1.00-1.84],0.0532175558101134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,20108,81,2.90 [1.80-4.67],1.229126160568511e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,20371,81,0.77 [0.43-1.38],0.3885136675601172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17083,52,6.98 [4.46-10.92],1.9066511079292202e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSBP1,Heat shock factor-binding protein 1,17158,52,1.73 [1.30-2.29],0.0001529585435257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,20157,80,0.36 [0.23-0.57],1.2130916334410002e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,17573,52,1.32 [0.88-2.00],0.1837952313856871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,17001,51,1.25 [0.76-2.04],0.3780400912680526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,17158,52,1.55 [0.93-2.60],0.0933701210318187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSP90B1,Endoplasmin,19651,77,0.96 [0.70-1.32],0.8127974477488118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,20265,80,1.21 [0.92-1.58],0.1655757101566368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,17526,51,3.07 [2.13-4.41],1.4955136950505463e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB1,Heat shock protein beta-1,19907,81,1.25 [0.91-1.72],0.1645646745561416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB6,Heat shock protein beta-6,20371,81,8.85 [6.37-12.29],1.238913712772817e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,20094,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,17030,52,1.04 [0.74-1.46],0.815753540623973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,17030,52,0.76 [0.37-1.57],0.4630007373836264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",20289,81,1.11 [0.81-1.53],0.5244876983654296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HYAL1,Hyaluronidase-1,20139,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,20456,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICA1,Islet cell autoantigen 1,19834,81,1.19 [0.93-1.53],0.1730070163548611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,20153,82,1.92 [1.03-3.59],0.0405744464670772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,20456,83,3.45 [1.84-6.47],0.0001122747055177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,20456,83,1.83 [0.92-3.62],0.0849572847937314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM4,Intercellular adhesion molecule 4,20157,80,0.72 [0.49-1.06],0.0984393520372579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM5,Intercellular adhesion molecule 5,20208,82,1.11 [0.74-1.69],0.6096513652831836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICOSLG,ICOS ligand,20108,81,9.62 [3.65-25.35],4.66899583232909e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,17281,52,0.69 [0.31-1.52],0.3555843101602798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,19753,77,2.34 [1.82-3.00],3.480649561498996e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",17158,52,1.20 [0.81-1.80],0.3637591449271571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDS,Iduronate 2-sulfatase,20408,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDUA,Alpha-L-iduronidase,20371,81,2.46 [1.56-3.89],0.0001122700179453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17079,50,3.38 [2.11-5.41],3.921322428147921e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,17281,52,0.59 [0.35-1.02],0.0590659344503191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,17281,52,1.23 [0.63-2.39],0.5511892906025844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,17522,52,0.96 [0.33-2.80],0.937191277173078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNG,Interferon gamma,19834,81,1.14 [0.96-1.37],0.1384642872766493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,20290,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNGR2,Interferon gamma receptor 2,20021,81,1.40 [0.98-2.00],0.0657180887223661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNL1,Interferon lambda-1,19753,77,1.75 [1.21-2.53],0.0027908966073465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNL2,Interferon lambda-2,17030,52,1.20 [0.86-1.67],0.2887507138333629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNLR1,Interferon lambda receptor 1,20157,80,1.56 [1.02-2.38],0.0411770672448381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNW1,Interferon omega-1,17001,51,0.46 [0.17-1.29],0.1396306716776253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,17117,51,1.23 [0.67-2.25],0.4977080396572628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,17572,52,1.07 [0.69-1.65],0.7643002098540496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,17030,52,0.86 [0.47-1.56],0.6173885876111512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,17614,50,9.40 [4.70-18.79],2.2501420282272856e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,20108,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,17001,51,0.85 [0.43-1.69],0.6480329061670367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,20222,80,4.83 [2.11-11.06],0.0001957184086562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,20423,83,1.19 [1.01-1.39],0.0324284116963819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,20433,83,4.60 [3.32-6.37],5.677116708764256e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,20332,82,0.17 [0.11-0.26],7.419496450499933e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,19953,77,5.07 [3.99-6.46],7.670380022139625e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,20145,82,8.54 [6.13-11.91],1.2439332651461115e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,20456,83,4.34 [3.07-6.12],6.412050724068875e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,20208,82,5.43 [3.55-8.30],5.671123908371741e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFL4,Insulin growth factor-like family member 4,17083,52,1.00 [0.70-1.44],0.9988041967826744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,17001,51,0.83 [0.48-1.45],0.5152334658207489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,17604,50,2.37 [1.57-3.56],3.6260052343288864e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGLON5,IgLON family member 5,16965,52,1.04 [0.81-1.35],0.7461952156495786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,17158,52,0.67 [0.31-1.44],0.3047209889270055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,20108,81,2.47 [1.84-3.32],2.1382160798992147e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,20208,82,5.78 [3.71-9.00],8.768546356497904e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF9,Protein turtle homolog A,17610,52,0.79 [0.57-1.10],0.166947441436803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IKBKG,NF-kappa-B essential modulator,20157,80,1.20 [0.96-1.50],0.1040330212788088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IKZF2,Zinc finger protein Helios,19761,80,1.08 [0.87-1.35],0.4923713852518102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10,Interleukin-10,19834,81,1.20 [0.98-1.47],0.0738908548012421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,19834,81,1.26 [0.97-1.64],0.083405395630791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,20290,80,8.15 [4.82-13.76],4.341082615187702e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL11,Interleukin-11,19834,81,0.89 [0.63-1.25],0.4863133580020686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12A_IL12B,Interleukin-12,20108,81,1.94 [1.60-2.35],1.189345638352123e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12B,Interleukin-12 subunit beta,20408,82,3.03 [2.22-4.13],3.3382774542293857e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,19834,81,3.42 [2.31-5.05],6.80732231344355e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,17083,52,1.12 [0.58-2.16],0.7345511938649972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL13,Interleukin-13,19834,81,1.21 [0.86-1.70],0.2754433646683487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,19979,79,0.45 [0.18-1.12],0.0860853577160817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,17030,52,0.77 [0.31-1.93],0.5778498997002549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15,Interleukin-15,20157,80,2.92 [1.77-4.82],2.708697708614651e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,19834,81,6.41 [3.92-10.49],1.4709220784269625e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL16,Pro-interleukin-16,20408,82,2.38 [1.76-3.23],1.9902352829030825e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17A,Interleukin-17A,19806,81,1.30 [0.88-1.92],0.1829145039821502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17C,Interleukin-17C,19834,81,1.86 [1.57-2.20],4.5378281547199544e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17D,Interleukin-17D,19834,81,1.77 [1.26-2.49],0.0010562396313673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17F,Interleukin-17F,19834,81,1.17 [0.94-1.45],0.1625491260182863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17RA,Interleukin-17 receptor A,20222,80,1.74 [1.12-2.71],0.0133682726554854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17RB,Interleukin-17 receptor B,19908,80,2.23 [1.55-3.21],1.4973361644009609e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18,Interleukin-18,20136,79,1.79 [1.24-2.57],0.0018051058752266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18BP,Interleukin-18-binding protein,20332,82,9.49 [6.27-14.37],2.102884842722924e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,20408,82,8.06 [4.85-13.40],8.776223767140955e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,19891,80,1.09 [0.97-1.21],0.1407375880562492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL19,Interleukin-19,19686,82,1.97 [1.62-2.40],1.8077814210149528e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1A,Interleukin-1 alpha,19834,81,1.11 [0.84-1.48],0.4625575079591044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1B,Interleukin-1 beta,19751,81,0.87 [0.60-1.26],0.4593482200045307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,20191,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1R2,Interleukin-1 receptor type 2,20167,79,1.39 [0.51-3.76],0.5190592160414591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,20222,80,1.31 [0.85-2.02],0.2135326719029787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,20398,83,3.85 [2.63-5.62],3.206765532043209e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,19834,81,0.59 [0.37-0.96],0.0325319381608405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,20167,80,1.68 [1.27-2.21],0.0002290363614992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2,Interleukin-2,19834,81,0.97 [0.52-1.84],0.9347862819000868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL20,Interleukin-20,19834,81,1.25 [0.91-1.72],0.1757266046356551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,19834,81,1.26 [0.89-1.80],0.1980521796024935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,17083,52,1.03 [0.57-1.89],0.9121553946149183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL21R,Interleukin-21 receptor,17083,52,0.88 [0.53-1.47],0.6248888483536696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL22,Interleukin-22,17526,51,1.86 [1.44-2.42],2.9913498654424515e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,19834,81,1.27 [0.89-1.81],0.1849308344420791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL24,Interleukin-24,19834,81,0.88 [0.57-1.36],0.5635644719640049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL25,Interleukin-25,16906,52,1.64 [0.86-3.13],0.1360850379634165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,20050,81,3.71 [2.65-5.19],2.0355754732751124e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,19834,81,1.41 [0.95-2.10],0.0904822017839938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,17526,51,1.26 [0.72-2.21],0.4130067617221833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL3,Interleukin-3,16965,52,0.91 [0.59-1.41],0.6809957660540156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL31,Interleukin-31,17083,52,0.95 [0.57-1.58],0.8327793831821062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,17012,51,1.09 [0.54-2.20],0.8045412776165086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL32,Interleukin-32,20157,80,1.32 [0.88-1.99],0.176431152140241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL33,Interleukin-33,19834,81,2.15 [1.29-3.57],0.0030951322110063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL34,Interleukin-34,19724,77,1.34 [0.75-2.40],0.3243048348914249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL36A,Interleukin-36 alpha,17083,52,0.94 [0.58-1.55],0.8173534150768442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL36G,Interleukin-36 gamma,17001,52,1.45 [1.11-1.90],0.0058636162895888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,19834,81,2.14 [1.27-3.59],0.0041399688791298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4,Interleukin-4,19834,81,0.82 [0.69-0.96],0.0172898386965109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,20157,80,4.25 [3.17-5.71],6.061487693251918e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL5,Interleukin-5,19834,81,1.03 [0.90-1.18],0.6643915889337803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,20157,80,1.95 [1.48-2.58],2.4346153463985145e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6,Interleukin-6,20108,81,1.38 [1.14-1.66],0.0008610512471976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,20128,82,2.94 [1.66-5.20],0.0002212613787234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,20208,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL7,Interleukin-7,20157,80,1.15 [0.84-1.56],0.3815861093462254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,20222,80,0.89 [0.61-1.29],0.536410056288139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL9,Interleukin-9,17281,52,0.90 [0.53-1.52],0.6854717643619691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,19720,77,1.19 [0.84-1.67],0.3320895110835148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IMMT,MICOS complex subunit MIC60,17526,51,2.35 [1.68-3.29],5.937095399444124e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IMPA1,Inositol monophosphatase 1,20021,81,1.01 [0.72-1.40],0.9751733655301528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IMPACT,Protein IMPACT,17573,52,1.09 [0.67-1.76],0.7350424183112994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,17030,52,0.56 [0.20-1.56],0.2670140198750761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ING1,Inhibitor of growth protein 1,19720,76,1.08 [0.71-1.63],0.7185191843176673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBB,Inhibin beta B chain,17227,49,3.62 [2.51-5.23],6.719687443075536e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBC,Inhibin beta C chain,20222,80,1.11 [0.66-1.86],0.6877773309509148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,20108,81,1.34 [0.94-1.92],0.1106032919775804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",17158,52,1.19 [0.75-1.89],0.4604201303193084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",17572,52,1.32 [0.80-2.20],0.2775477272282518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",20108,81,1.26 [1.02-1.54],0.0282626684304462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INSL3,Insulin-like 3,17573,52,1.13 [0.93-1.37],0.2200279358770744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INSL4,Early placenta insulin-like peptide,17526,51,1.73 [1.28-2.34],0.0003669419818636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INSL5,Insulin-like peptide INSL5,17522,52,1.22 [0.95-1.56],0.1184472514126866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INSR,Insulin receptor,17083,52,2.40 [0.59-9.85],0.223236482336411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,19986,81,1.26 [1.01-1.59],0.0447528418117028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,20108,81,1.46 [1.03-2.05],0.0311956652136519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",19823,80,1.17 [0.94-1.45],0.152222892216975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,19834,81,1.25 [0.94-1.67],0.130719095363596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,20157,80,1.27 [1.04-1.56],0.0201131340684817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,19487,73,0.96 [0.55-1.67],0.8804341679129857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ISM1,Isthmin-1,20157,80,1.49 [0.89-2.50],0.1274039532948987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ISM2,Isthmin-2,17614,50,0.58 [0.29-1.16],0.1251060819271059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IST1,IST1 homolog,17394,51,1.22 [0.92-1.62],0.1633221376661471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGA11,Integrin alpha-11,20157,80,0.65 [0.37-1.14],0.1301915497735277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGA2,Integrin alpha-2,17227,49,0.93 [0.44-1.97],0.8444629838282227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGA5,Integrin alpha-5,20222,80,3.28 [1.57-6.87],0.0015834721144144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGA6,Integrin alpha-6,20157,80,0.90 [0.60-1.35],0.6243415922353555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGAL,Integrin alpha-L,17083,52,1.47 [0.78-2.79],0.2339128500908766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGAM,Integrin alpha-M,20222,80,1.83 [1.01-3.32],0.0463333124598664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGAV,Integrin alpha-V,20371,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGAX,Integrin alpha-X,17281,52,0.65 [0.35-1.18],0.1578016782403005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB1,Integrin beta-1,20233,82,2.01 [0.85-4.77],0.1122408711232553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,19761,80,1.39 [0.86-2.23],0.1779825680857721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,19823,80,1.16 [0.96-1.39],0.1155229610383944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB2,Integrin beta-2,20092,82,3.25 [1.74-6.07],0.0002073917801922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB5,Integrin beta-5,20289,81,1.59 [0.99-2.54],0.0547297224969493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB6,Integrin beta-6,19834,81,5.39 [3.04-9.56],8.040694548249514e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB7,Integrin beta-7,20371,81,1.81 [1.24-2.63],0.0018665653385976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,17614,50,3.24 [2.05-5.13],4.942025794622798e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,17637,50,0.54 [0.12-2.42],0.4219181422615247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,20332,82,5.51 [3.29-9.21],7.976673490742254e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,17637,50,0.73 [0.25-2.09],0.5521405907983101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,17526,51,0.64 [0.32-1.29],0.2131874508354954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITM2A,Integral membrane protein 2A,20157,80,1.75 [1.29-2.39],0.0003939771219379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,17001,51,0.93 [0.62-1.40],0.7340503692484719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",17158,52,1.38 [1.02-1.87],0.0356176890369155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",17030,52,0.76 [0.37-1.56],0.4585233715382283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",19753,77,1.22 [0.83-1.78],0.3116659026153858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,16965,52,1.34 [0.84-2.13],0.2168381918379039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JAM2,Junctional adhesion molecule B,20368,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JAM3,Junctional adhesion molecule C,17227,49,2.89 [1.92-4.35],3.561524737384882e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JCHAIN,Immunoglobulin J chain,19834,81,1.73 [1.28-2.34],0.000364841021434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,16965,52,1.19 [0.79-1.80],0.3999580504814616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,17522,52,1.24 [0.91-1.69],0.1807494368349735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JUN,Transcription factor AP-1,19834,81,1.80 [1.42-2.27],8.020203881737511e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,20108,81,3.61 [2.27-5.73],5.731908389196045e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KAZN,Kazrin,17522,52,1.12 [0.87-1.45],0.3922080163682363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,17030,52,0.99 [0.62-1.59],0.969320970495576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,17117,51,0.87 [0.57-1.33],0.530274140637352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KCNIP4,Kv channel-interacting protein 4,19753,77,0.57 [0.33-0.97],0.0400720586426656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,17256,51,1.18 [0.66-2.10],0.5715417852825888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KDM3A,Lysine-specific demethylase 3A,17083,52,1.07 [0.80-1.44],0.6566069311767094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,20289,81,0.80 [0.36-1.77],0.5765914314454681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KEL,Kell blood group glycoprotein,19753,77,1.14 [0.67-1.95],0.6278622017432091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KHDC3L,KH domain-containing protein 3,16965,52,0.98 [0.66-1.47],0.9280359247925902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KHK,Ketohexokinase,17158,52,1.14 [0.75-1.75],0.5362524044866783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,17573,52,2.60 [1.62-4.18],7.487439298207259e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,17281,52,1.66 [1.24-2.22],0.0005761034018894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,17281,52,0.77 [0.29-2.02],0.5960303819484825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,17526,51,0.92 [0.54-1.56],0.7567854327384053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,17001,51,2.19 [1.55-3.09],7.321952049540122e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIF20B,Kinesin-like protein KIF20B,17030,52,1.22 [0.90-1.64],0.2039799844745289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIF22,Kinesin-like protein KIF22,17001,51,1.33 [1.05-1.69],0.0187219403145484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIFBP,KIF-binding protein,20108,81,1.20 [0.93-1.53],0.1573667990373815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,17526,51,1.05 [0.78-1.41],0.7303417400299894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,19761,80,1.33 [1.05-1.69],0.0200899671319309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,17522,52,0.99 [0.85-1.16],0.926234318490897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,19761,80,0.93 [0.79-1.09],0.3587274918487688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,16965,52,1.18 [0.91-1.53],0.2227533916145601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,17030,52,0.95 [0.58-1.55],0.8326588161744444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,19753,77,1.06 [0.65-1.72],0.821300170488078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,20287,82,1.22 [0.64-2.32],0.5414590245475766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KITLG,Kit ligand,20208,82,2.45 [1.44-4.20],0.0010372036199711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLB,Beta-klotho,19753,77,1.43 [1.12-1.84],0.0045104632560358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLF4,Krueppel-like factor 4,17030,52,1.56 [0.88-2.75],0.1277936470120412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLHL41,Kelch-like protein 41,17572,52,1.56 [1.01-2.41],0.044864685771573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK1,Kallikrein-1,20023,81,0.87 [0.74-1.02],0.0941577417456276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK10,Kallikrein-10,20228,81,1.75 [1.19-2.55],0.0040516176313972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK11,Kallikrein-11,20105,80,3.58 [2.72-4.72],8.560263284959912e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK12,Kallikrein-12,19761,80,1.04 [0.90-1.20],0.6320888747813355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK13,Kallikrein-13,19770,79,1.24 [0.82-1.88],0.3067149521791456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK14,Kallikrein-14,20371,81,1.24 [0.84-1.85],0.2818153670758205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK15,Kallikrein-15,17490,51,1.44 [0.91-2.27],0.1221820703946969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK3,Prostate-specific antigen,17614,50,1.08 [0.92-1.26],0.3443283898450054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK4,Kallikrein-4,20371,81,3.82 [3.17-4.61],5.935659819431e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK6,Kallikrein-6,20249,81,7.76 [4.49-13.39],1.9464046127686254e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK7,Kallikrein-7,16793,48,0.57 [0.28-1.16],0.1187685862472055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK8,Kallikrein-8,19540,76,3.73 [2.58-5.41],3.454927641976795e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLKB1,Plasma kallikrein,17257,49,0.25 [0.09-0.66],0.0049283993446285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,20408,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,17030,52,0.78 [0.46-1.35],0.3778068156568901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,20408,82,2.84 [1.91-4.22],2.193671320052645e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,17083,52,1.49 [1.03-2.15],0.0325261155547134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,17573,52,2.18 [1.46-3.26],0.0001497298977474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",19127,72,0.94 [0.44-2.01],0.8755118046751925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",17001,51,1.07 [0.53-2.15],0.8506866188838287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",20108,81,1.64 [1.36-1.98],2.0975992300270328e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",20117,80,2.37 [1.94-2.89],2.5178009252757964e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",19753,77,1.21 [0.83-1.76],0.3282347624161702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",17001,51,0.76 [0.34-1.71],0.5027486300968151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",17030,52,1.43 [1.20-1.71],7.712857058217566e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,20181,82,0.91 [0.64-1.30],0.6200647517152207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KYNU,Kynureninase,20408,82,0.62 [0.40-0.97],0.0362360744147909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",L1CAM,Neural cell adhesion molecule L1,20289,81,1.44 [0.74-2.80],0.2829835899213843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,17610,52,1.25 [0.94-1.67],0.1295775313643494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LACRT,Extracellular glycoprotein lacritin,17495,51,0.52 [0.24-1.12],0.0940665805485254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LACTB2,Endoribonuclease LACTB2,20208,82,1.22 [0.91-1.64],0.1847602532086369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,20108,81,3.31 [2.45-4.48],7.168766521905167e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,20198,79,4.67 [3.48-6.27],7.999181997339304e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,20021,81,1.39 [1.13-1.70],0.0016225745152204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMA1,Laminin subunit alpha-1,17001,51,0.71 [0.36-1.40],0.3247997593044781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMA4,Laminin subunit alpha-4,20290,80,4.66 [2.74-7.93],1.4618631381740976e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMB1,Laminin subunit beta-1,17158,52,2.60 [1.06-6.36],0.0370457713385986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,17103,48,1.36 [0.74-2.53],0.3227821302422707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,19575,78,0.38 [0.15-0.94],0.0357716163624637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,20379,82,1.77 [1.26-2.49],0.0009537890564812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,17526,51,0.81 [0.40-1.67],0.575105368777022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAP3,Cytosol aminopeptidase,19834,81,1.02 [0.67-1.54],0.9438634738297402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LARP1,La-related protein 1,17526,51,1.20 [0.81-1.79],0.3583772588872139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAT,Linker for activation of T-cells family member 1,20408,82,1.26 [0.96-1.65],0.1020000551917946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAT2,Linker for activation of T-cells family member 2,20108,81,1.18 [1.00-1.38],0.046171899414811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,17083,52,1.25 [0.91-1.72],0.162007727202052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAYN,Layilin,19988,80,9.63 [6.95-13.33],2.885363507165793e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,20332,82,2.19 [1.62-2.96],4.0288571396246426e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,20368,81,1.47 [1.19-1.81],0.0003694079024667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,17611,51,0.37 [0.19-0.72],0.0031882726753291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN15,Lipocalin-15,17572,52,1.81 [1.44-2.28],3.356487701338223e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,19660,82,4.68 [3.50-6.27],2.652368263183163e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCP1,Plastin-2,17614,50,0.30 [0.15-0.59],0.000617662592856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LDLR,Low-density lipoprotein receptor,20257,82,0.59 [0.40-0.87],0.0072494367400006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,17572,52,1.25 [0.95-1.64],0.1116415593528632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,17610,52,1.78 [1.24-2.56],0.001929427364968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEFTY2,Left-right determination factor 2,20337,81,1.54 [1.05-2.28],0.0282339066813075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEG1,Protein LEG1 homolog,16668,48,1.02 [0.70-1.50],0.907254750985101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,17030,52,0.74 [0.48-1.13],0.1643882395262063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,17572,52,1.55 [0.89-2.71],0.1202818314362221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEP,Leptin,20208,82,1.12 [0.88-1.41],0.3627751246462679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEPR,Leptin receptor,20208,82,1.72 [0.98-3.00],0.0567223429808664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,17572,52,2.50 [1.85-3.40],3.8089899048489175e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS1,Galectin-1,20208,82,5.40 [3.66-7.97],2.1288088564207426e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3,Galectin-3,20269,83,3.87 [2.29-6.55],4.184128854040292e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3BP,Galectin-3-binding protein,17637,50,1.41 [0.73-2.69],0.3045017030082058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS4,Galectin-4,20198,79,6.15 [4.69-8.06],2.2036435445770528e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,20128,81,2.30 [1.74-3.05],5.315848940705911e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS8,Galectin-8,20368,81,1.24 [0.91-1.71],0.174255961669791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS9,Galectin-9,20196,80,7.28 [4.63-11.46],9.623329388056697e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGMN,Legumain,20290,80,3.21 [1.93-5.34],6.929060939736938e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LHB,Lutropin subunit beta,19761,80,0.75 [0.57-0.97],0.0292596664960091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,20225,80,0.70 [0.51-0.97],0.0310943357134043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LIF,Leukemia inhibitory factor,19753,77,1.29 [0.93-1.79],0.1216169169952152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,20157,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,20222,80,1.30 [0.77-2.20],0.3221866060899125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,17614,50,1.00 [0.82-1.22],0.9816553149685928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,17001,51,0.99 [0.57-1.73],0.978563933092794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,20167,82,5.23 [3.02-9.04],3.2160430017844434e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,17610,52,2.13 [1.44-3.16],0.0001648528652522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,20456,83,1.54 [0.76-3.13],0.231922483126573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,20375,83,2.77 [1.53-5.04],0.0008269440326926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19834,81,3.32 [2.30-4.81],1.8286125104526227e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,20456,83,0.91 [0.69-1.19],0.4835176786409935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LIPF,Gastric triacylglycerol lipase,17158,52,0.67 [0.43-1.02],0.0639460594938266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMNB1,Lamin-B1,17493,52,1.27 [0.88-1.83],0.1938922186291289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMNB2,Lamin-B2,17573,52,5.00 [3.05-8.21],1.8498845437019863e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMOD1,Leiomodin-1,17572,52,3.73 [2.76-5.05],1.2622313198948732e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMOD2,Leiomodin-2,17030,52,0.97 [0.61-1.55],0.9085119511021408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",17158,52,1.51 [1.13-2.03],0.0058842107861114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPA,Apolipoprotein(a),17237,48,1.13 [0.96-1.32],0.141545533145264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,20108,81,1.39 [1.03-1.88],0.032067373481121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPL,Lipoprotein lipase,20208,82,0.63 [0.46-0.88],0.0062970481256513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPO,Lactoperoxidase,19505,81,2.17 [1.65-2.85],2.420967941177388e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPP,Lipoma-preferred partner,17001,51,1.26 [0.83-1.91],0.2690083003818891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,17001,51,1.36 [0.93-1.97],0.1086147885502221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,17117,51,0.67 [0.33-1.38],0.2769590968562939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,17637,50,2.84 [1.12-7.20],0.0282393430862945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,20301,81,3.58 [2.16-5.94],7.819689434144332e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17023,52,2.50 [1.37-4.55],0.0027432167778202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,20108,81,1.88 [0.95-3.72],0.0706779260471262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,20208,82,7.64 [4.99-11.70],8.628348825324626e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,17117,51,0.69 [0.31-1.54],0.3624200227494725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP2BP,LRP2-binding protein,17117,51,0.94 [0.67-1.33],0.7393623182610662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,20368,81,1.14 [0.83-1.55],0.4149754712326515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,20108,81,1.85 [1.17-2.92],0.0087778867679216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,17522,52,1.14 [0.61-2.13],0.6724296719151548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,17117,51,1.72 [1.14-2.60],0.0096162182884201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,17610,52,1.32 [0.79-2.19],0.2854452034797035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,17526,51,1.45 [0.87-2.43],0.154898165207235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,19834,81,1.40 [0.83-2.33],0.2040294479184865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,17117,51,1.15 [0.61-2.16],0.663858840128785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,17572,52,1.58 [0.71-3.54],0.2622903927024528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,19761,80,1.10 [0.79-1.52],0.5701879322632616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,17281,52,1.03 [0.77-1.38],0.8527212135906485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,20157,80,2.00 [1.29-3.12],0.0020114669147603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTA,Lymphotoxin-alpha,20157,80,0.99 [0.60-1.61],0.9544194100847404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,20371,81,0.69 [0.48-0.99],0.0413451111553669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTB,Lymphotoxin-beta,17526,51,0.67 [0.28-1.60],0.3695584248572373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,20456,83,5.61 [3.64-8.65],5.181050687470217e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,19761,80,1.85 [1.45-2.36],8.628214240025837e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,20115,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTO1,Protein LTO1 homolog,19834,81,1.01 [0.64-1.59],0.9674077063130512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LUZP2,Leucine zipper protein 2,17526,51,2.07 [1.53-2.81],2.705249150851123e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LXN,Latexin,19942,81,0.57 [0.41-0.81],0.001374386842548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY6D,Lymphocyte antigen 6D,20105,79,3.52 [2.63-4.72],3.734067634503544e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY75,Lymphocyte antigen 75,20157,80,1.73 [1.01-2.96],0.0467665612109692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,19944,82,4.87 [2.93-8.09],9.307367309336351e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY96,Lymphocyte antigen 96,20021,81,3.25 [2.23-4.75],9.710301204412982e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,19761,80,0.38 [0.23-0.64],0.0002761744749895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYN,Tyrosine-protein kinase Lyn,20108,81,1.21 [0.95-1.53],0.1283880234046664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,19753,77,0.76 [0.49-1.18],0.2273340246267674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,20122,80,2.15 [1.31-3.53],0.0024839246890964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,19761,80,1.38 [0.99-1.92],0.0581394040252425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,17030,52,1.00 [0.79-1.28],0.9694466700568316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,17117,51,0.95 [0.72-1.24],0.703123478804933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,17637,50,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYZL2,Lysozyme-like protein 2,16965,52,2.01 [1.19-3.40],0.0091627819255647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,17227,49,1.18 [0.80-1.73],0.40869893274036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,17158,52,1.29 [0.71-2.33],0.4009910901492802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,19952,80,1.80 [1.46-2.21],2.664957844895374e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,19761,80,0.86 [0.50-1.49],0.6012370420029649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAG,Myelin-associated glycoprotein,17117,51,0.67 [0.39-1.14],0.139046932893628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAGEA3,Melanoma-associated antigen 3,17281,52,0.95 [0.70-1.30],0.7664044856590859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAGED1,Melanoma-associated antigen D1,19761,80,1.24 [0.84-1.82],0.2757028303662817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,17610,52,7.19 [4.49-11.52],2.49867341145969e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC4,Apical endosomal glycoprotein,17526,51,0.47 [0.28-0.79],0.0044602029625728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",17158,52,0.95 [0.34-2.68],0.9297244059886488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,17610,52,1.16 [0.75-1.81],0.5013496908037252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",16965,52,0.72 [0.42-1.24],0.243005620498772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,20290,80,1.12 [0.94-1.34],0.1940312917085994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,20289,81,6.24 [3.59-10.83],7.999056829391502e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MANSC4,MANSC domain-containing protein 4,17001,51,1.05 [0.71-1.55],0.7942897245366751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,17030,52,1.28 [0.55-2.99],0.5697104861998267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,17001,51,1.04 [0.71-1.53],0.831302711975858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP2,Microtubule-associated protein 2,17573,52,1.96 [1.31-2.92],0.0009553148193635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,17522,52,1.39 [0.93-2.10],0.1123717311104101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,20157,80,1.15 [0.94-1.41],0.1733686208594915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,19761,80,1.10 [0.89-1.35],0.3715655792928313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,19988,80,1.14 [0.95-1.36],0.1714324475103505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,16965,52,1.87 [1.30-2.69],0.000785395905775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,20157,80,1.80 [1.12-2.88],0.0147018766819816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,17281,52,1.35 [0.96-1.89],0.0833328624359025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,16965,52,1.02 [0.84-1.23],0.8594540484442854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPT,Microtubule-associated protein tau,19753,77,1.61 [1.09-2.40],0.0178934360678964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MARCO,Macrophage receptor MARCO,20208,82,3.39 [1.64-6.98],0.0009442877777929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",17200,49,1.27 [0.92-1.76],0.146106517071022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,19988,80,1.06 [0.46-2.48],0.8843073560227722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MATN2,Matrilin-2,20225,79,3.68 [1.99-6.79],3.0904695113934824e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MATN3,Matrilin-3,19986,81,0.41 [0.22-0.74],0.0032098917361996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,19761,80,1.20 [0.96-1.48],0.1021390341027561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAX,Protein max,19753,77,1.09 [0.90-1.33],0.3850160305710273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MB,Myoglobin,20456,83,3.53 [2.81-4.44],4.456863026030025e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MBL2,Mannose-binding protein C,17393,49,1.10 [0.85-1.41],0.4626589168284559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,20332,82,3.85 [2.31-6.44],2.519607395230113e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",17572,52,0.62 [0.29-1.30],0.2060002888168527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,17083,52,1.34 [1.02-1.77],0.0384412717158873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,20105,82,2.91 [1.90-4.45],9.387864485044184e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,17522,52,0.70 [0.23-2.09],0.5192463567589942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,20021,81,1.52 [1.15-2.02],0.0034606660200913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",17513,51,1.23 [0.64-2.38],0.531800983599917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDK,Midkine,20233,81,2.23 [1.84-2.71],6.075892969813496e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDM1,Nuclear protein MDM1,17117,51,0.77 [0.31-1.88],0.5610692764125629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",17158,52,1.57 [1.19-2.08],0.001496252871841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,19761,80,1.20 [0.92-1.57],0.1826610694364753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,17001,51,1.16 [0.69-1.94],0.5773256996851035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,20198,79,1.90 [1.14-3.16],0.0138227238699418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,17001,51,0.60 [0.23-1.60],0.3099991903048424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,20398,83,0.92 [0.34-2.49],0.8759750639450942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MELTF,Melanotransferrin,17610,52,1.51 [0.67-3.39],0.3153952923196114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MENT,Protein MENT,17227,49,0.22 [0.08-0.59],0.002694738199506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MEP1A,Meprin A subunit alpha,17522,52,1.20 [0.85-1.71],0.2959259718963198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MEP1B,Meprin A subunit beta,20208,82,0.83 [0.71-0.97],0.0184580593224505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,20198,79,2.58 [1.16-5.71],0.0196513356217572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,20408,82,8.58 [4.79-15.37],5.0682891793835e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MESD,LRP chaperone MESD,20222,80,1.12 [0.95-1.32],0.1921718852979663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MET,Hepatocyte growth factor receptor,20251,80,1.14 [0.43-3.00],0.7953614464774288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",METAP1,Methionine aminopeptidase 1,19753,77,0.70 [0.33-1.47],0.3480394942630453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",20157,80,1.19 [0.94-1.51],0.1461522747278522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",METAP2,Methionine aminopeptidase 2,20337,81,1.31 [0.91-1.89],0.14066364258198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,19823,80,0.90 [0.58-1.40],0.6492676032416029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,17117,51,1.16 [0.82-1.64],0.4086356983490664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,17227,49,8.00 [3.70-17.31],1.298895748708751e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,20456,83,4.96 [3.21-7.68],6.516695171500015e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFGE8,Lactadherin,20222,80,3.20 [2.12-4.82],2.6062866312797694e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MGLL,Monoglyceride lipase,20254,80,1.13 [0.89-1.43],0.3084960512963122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,20157,80,1.15 [0.97-1.37],0.1071196022320763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,20289,81,1.85 [1.17-2.93],0.0086723130760095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MICALL2,MICAL-like protein 2,17117,51,1.07 [0.72-1.59],0.7481454103545422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,20157,80,1.20 [1.02-1.42],0.0326960964984486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MIF,Macrophage migration inhibitory factor,20191,80,0.98 [0.73-1.33],0.9161044982371416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MILR1,Allergin-1,19834,81,2.36 [1.70-3.29],3.00697829030187e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,17526,51,1.13 [0.88-1.46],0.3319805284161704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MINK1,Misshapen-like kinase 1,17573,52,1.15 [0.86-1.55],0.3377539970535808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MITD1,MIT domain-containing protein 1,20021,81,1.22 [0.99-1.51],0.064457949243468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MKI67,Proliferation marker protein Ki-67,17083,52,1.24 [0.67-2.32],0.4944623494102108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MLLT1,Protein ENL,16965,52,1.23 [0.88-1.70],0.2252120408109249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MLN,Promotilin,20157,80,1.81 [1.43-2.30],8.040656216297392e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MME,Neprilysin,20108,81,1.37 [1.09-1.71],0.006385001327662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP1,Interstitial collagenase,19460,80,1.47 [1.16-1.87],0.001445349103181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP10,Stromelysin-2,20144,79,2.42 [1.90-3.09],1.1332387829448618e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP12,Macrophage metalloelastase,20201,80,2.96 [2.24-3.91],3.18048587833919e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP13,Collagenase 3,19753,77,2.40 [1.34-4.32],0.003384493672294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP15,Matrix metalloproteinase-15,17610,52,1.21 [0.78-1.86],0.391581598195049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP3,Stromelysin-1,20222,80,2.06 [1.55-2.75],7.150956754884742e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP7,Matrilysin,19792,80,5.46 [3.80-7.84],3.468290129659675e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP8,Neutrophil collagenase,20329,81,1.22 [0.94-1.59],0.1279541181914177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP9,Matrix metalloproteinase-9,20181,80,1.17 [0.84-1.62],0.3536099537994911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",17001,51,1.33 [0.81-2.18],0.2604724191871517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MN1,Transcriptional activator MN1,17117,51,1.26 [0.86-1.85],0.2389997049254189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,17281,52,1.08 [0.58-1.99],0.815778627597025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,20172,82,0.94 [0.77-1.15],0.5633170366156577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,17227,49,1.54 [1.04-2.27],0.02934801369756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,20371,81,5.39 [3.27-8.87],3.9114481762036336e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,17573,52,1.09 [0.41-2.91],0.8606641233867248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,17281,52,0.64 [0.28-1.45],0.282475895484831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,16965,52,1.13 [0.57-2.24],0.7309689146221579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MORN4,MORN repeat-containing protein 4,16965,52,0.90 [0.60-1.34],0.5957716054664237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,19823,80,1.23 [0.95-1.59],0.110351834212185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MPI,Mannose-6-phosphate isomerase,20108,81,1.33 [1.06-1.67],0.0142312704417064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,20254,80,1.16 [0.88-1.54],0.2871152777662152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MPO,Myeloperoxidase,20222,80,1.38 [0.94-2.03],0.0982329421596742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,17489,50,0.70 [0.37-1.35],0.2905658784233358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRC1,Macrophage mannose receptor 1,17611,51,5.10 [2.35-11.04],3.5832452326052704e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,17117,51,1.11 [0.74-1.68],0.6079159038539343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",17001,51,1.32 [0.75-2.31],0.3347767038472515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",17572,52,0.89 [0.39-2.00],0.7743093576525192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",19753,77,1.36 [0.71-2.61],0.3480354576063816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",16928,52,0.69 [0.23-2.08],0.5140421923635055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",17572,52,1.44 [1.10-1.89],0.0081805209104938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",17083,52,1.04 [0.39-2.73],0.9417737230362822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSLN,Mesothelin,20074,80,1.31 [0.97-1.77],0.0789688952508002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSLNL,Mesothelin-like protein,17117,51,1.09 [0.56-2.15],0.7929143966504957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSMB,Beta-microseminoprotein,20166,82,1.80 [1.40-2.30],3.5831041299248025e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,20368,81,3.44 [2.38-4.96],4.0818193000284936e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,20289,81,1.19 [0.91-1.57],0.2099037307145469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MST1,Hepatocyte growth factor-like protein,17334,51,1.14 [0.69-1.88],0.6104934653956949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSTN,Growth/differentiation factor 8,19823,80,2.34 [1.71-3.21],1.3399837144588034e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTDH,Protein LYRIC,17083,52,1.61 [1.23-2.12],0.0006308084600004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",17573,52,1.65 [0.83-3.28],0.1531668742612177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,17281,52,1.11 [0.88-1.41],0.3706272737184711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",17522,52,1.52 [1.14-2.03],0.0044994453257737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTPN,Myotrophin,19823,80,0.50 [0.24-1.05],0.0669460897866145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTR,Methionine synthase,17001,51,0.78 [0.47-1.29],0.3352452831878985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTSS1,Protein MTSS 1,17522,52,1.12 [0.88-1.42],0.3616072620217453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTSS2,Protein MTSS 2,17526,51,1.22 [0.93-1.59],0.1563795407249315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,17281,52,1.21 [0.78-1.88],0.3905909513590772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC13,Mucin-13,19753,77,4.55 [3.42-6.06],2.440663868157481e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC16,Mucin-16,20108,81,0.99 [0.90-1.10],0.8979610199000408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC2,Mucin-2,17614,50,1.11 [0.83-1.47],0.4920326200300401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUCL3,Mucin-like protein 3,16965,52,0.84 [0.44-1.62],0.602791491868846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MVK,Mevalonate kinase,19834,81,1.49 [1.19-1.86],0.0004587100953718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,17227,49,1.37 [0.59-3.19],0.4696911807845264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",17610,52,2.36 [1.86-3.00],2.5084825479576738e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",17158,52,1.75 [1.51-2.04],3.745662441890102e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,17572,52,0.99 [0.67-1.46],0.9571725296533142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYDGF,Myeloid-derived growth factor,17610,52,1.40 [1.07-1.83],0.015551190654499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYH4,Myosin-4,17001,51,0.94 [0.53-1.67],0.8396567758891501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYH7B,Myosin-7B,16965,52,1.30 [0.79-2.13],0.2977280473018002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYH9,Myosin-9,17614,50,1.05 [0.82-1.33],0.709406328076353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17001,51,2.09 [1.60-2.73],5.257274751593775e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL3,Myosin light chain 3,17158,52,2.09 [1.54-2.83],2.5526685680299414e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL4,Myosin light chain 4,17158,52,1.36 [0.91-2.02],0.1327691735032233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL6B,Myosin light chain 6B,17117,51,0.98 [0.73-1.32],0.9066020478649476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",17117,51,2.24 [1.76-2.85],4.739788070444849e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYO6,Unconventional myosin-VI,17572,52,1.37 [0.75-2.52],0.3078651931837615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYO9B,Unconventional myosin-IXb,19834,81,1.14 [0.86-1.51],0.3758506180136941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOC,Myocilin,20222,80,1.48 [0.95-2.31],0.0838373702844458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM1,Myomesin-1,17030,52,1.07 [0.64-1.78],0.806475901568563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM2,Myomesin-2,17001,51,2.19 [1.61-2.98],6.631407149655123e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM3,Myomesin-3,17227,49,1.85 [1.42-2.40],4.409679693661436e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,20261,79,2.50 [1.84-3.39],4.103348945944999e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,19761,80,1.06 [0.72-1.58],0.7601346488883857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAA10,N-alpha-acetyltransferase 10,17001,51,1.41 [0.84-2.36],0.199579888150116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAA80,N-alpha-acetyltransferase 80,17117,51,1.20 [0.96-1.51],0.115339120817675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,19935,81,0.93 [0.66-1.31],0.6732332165782594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,17526,51,1.38 [0.90-2.09],0.1371584574979819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NADK,NAD kinase,20208,82,1.35 [1.01-1.81],0.0455204635987014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,17043,51,1.39 [0.96-2.01],0.0779522114872901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,17129,52,0.53 [0.32-0.88],0.0144671825005381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,17227,49,1.78 [0.52-6.07],0.354890036920245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,19761,80,1.10 [0.78-1.55],0.5894096267987994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,17484,52,1.05 [0.54-2.03],0.8903205766743202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,17573,52,0.91 [0.40-2.07],0.8132049337957843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",17572,52,1.82 [1.00-3.32],0.048619049054122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,20289,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NBN,Nibrin,19834,81,0.99 [0.68-1.44],0.9695137825311912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,20332,82,2.93 [1.61-5.31],0.000408289983404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAM2,Neural cell adhesion molecule 2,20222,80,1.50 [0.73-3.10],0.2712908668853413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAN,Neurocan core protein,20368,81,0.25 [0.16-0.40],5.562560721380278e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCF2,Neutrophil cytosol factor 2,20128,79,1.04 [0.82-1.31],0.7606129294899603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCK2,Cytoplasmic protein NCK2,20290,80,1.12 [0.93-1.36],0.2304378841505636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCLN,Nicalin,19834,81,1.12 [0.77-1.63],0.546437242174928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,20125,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17522,52,8.12 [5.19-12.70],4.2871861928825605e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCS1,Neuronal calcium sensor 1,20371,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NDRG1,Protein NDRG1,19753,77,1.32 [1.06-1.66],0.0140077962789059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,17526,51,1.06 [0.72-1.56],0.7619095852939278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,17064,52,2.18 [1.09-4.39],0.0284663500669277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,17522,52,1.35 [1.01-1.80],0.0431597658469013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",19761,80,1.26 [1.03-1.54],0.0242475077186064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEB,Nebulin,17001,51,2.21 [1.54-3.17],1.5473590545613372e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,17001,51,1.28 [0.90-1.82],0.1638553340461722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN1,Nectin-1,17083,52,1.09 [0.49-2.44],0.827025804632508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN2,Nectin-2,20167,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN4,Nectin-4,20289,81,5.56 [4.09-7.55],5.3558398588028245e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,17083,52,0.77 [0.45-1.29],0.3193353917275232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEDD9,Enhancer of filamentation 1,17083,52,1.65 [0.91-3.01],0.1008186772972306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEFL,Neurofilament light polypeptide,19692,77,4.34 [3.39-5.57],6.0476122453861575e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,17281,52,0.92 [0.62-1.35],0.6636218620552277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,20289,81,0.18 [0.12-0.27],7.977807130312128e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,20290,80,1.55 [0.80-2.98],0.1935397774723917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NENF,Neudesin,17526,51,0.99 [0.77-1.28],0.9473147383204796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEO1,Neogenin,17572,52,3.20 [1.53-6.67],0.0019172705454051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEXN,Nexilin,17611,51,1.20 [0.82-1.75],0.3445942452161442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFASC,Neurofascin,20408,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,17083,52,0.98 [0.71-1.35],0.8868247358899137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",20157,80,1.13 [0.92-1.39],0.2534884963899451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19834,81,1.33 [0.99-1.78],0.0599768563210985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,17158,52,1.34 [0.94-1.91],0.1048683327224991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFIC,Nuclear factor 1 C-type,17572,52,0.95 [0.50-1.80],0.8685714884843463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,17001,51,1.19 [0.82-1.73],0.3586456351920029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,17281,52,0.98 [0.59-1.63],0.942413597770384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,19761,80,1.43 [0.98-2.08],0.060970733119197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",17522,52,1.49 [1.15-1.94],0.0025380119427386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFX1,Transcriptional repressor NF-X1,17001,51,1.13 [0.76-1.69],0.5345709961300553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,17001,51,1.52 [0.94-2.47],0.0897110923865906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NGF,Beta-nerve growth factor,20021,81,4.93 [1.14-21.33],0.0330029711168934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,17610,52,2.09 [1.23-3.54],0.0061139553815478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NGRN,Neugrin,17573,52,3.43 [1.94-6.09],2.404355307553124e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,16791,48,4.30 [1.88-9.80],0.0005273655896727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NID1,Nidogen-1,20250,82,1.68 [1.04-2.71],0.0334193404059741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NID2,Nidogen-2,20222,80,0.97 [0.75-1.26],0.8337200003322908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NINJ1,Ninjurin-1,19761,80,1.12 [0.78-1.60],0.5412017464423826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NIT1,Deaminated glutathione amidase,17158,52,0.86 [0.49-1.51],0.591430880166214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NIT2,Omega-amidase NIT2,17549,52,1.31 [0.91-1.90],0.1513044588622872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NLGN1,Neuroligin-1,17117,51,0.88 [0.55-1.38],0.5687005636421054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NLGN2,Neuroligin-2,17030,52,0.85 [0.46-1.58],0.6125457822306726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NME1,Nucleoside diphosphate kinase A,17083,52,0.76 [0.21-2.79],0.6831053277666794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NME3,Nucleoside diphosphate kinase 3,20225,79,1.05 [0.46-2.36],0.9136017751015814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NMI,N-myc-interactor,17469,50,1.30 [0.91-1.85],0.1434356809238797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,20021,81,1.06 [0.82-1.36],0.6749919071549846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,16965,52,0.98 [0.49-1.95],0.9450881010673802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,17572,52,1.08 [0.75-1.57],0.6772362782642571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOMO1,Nodal modulator 1,20222,80,0.99 [0.42-2.33],0.9880578670477664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOP56,Nucleolar protein 56,17001,51,1.24 [1.03-1.50],0.0245837843915152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",19753,77,3.58 [2.82-4.55],1.13394534446547e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS2,"Nitric oxide synthase, inducible",17001,51,0.66 [0.31-1.41],0.2822317886494775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",19753,77,1.63 [1.29-2.06],3.566955045056568e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,20456,83,8.22 [2.75-24.51],0.0001584833954253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,17614,50,5.30 [2.20-12.76],0.0001995919172448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,20456,83,2.80 [1.65-4.76],0.0001411444015062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,17305,50,4.67 [3.28-6.63],8.691286014135985e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,20208,82,6.44 [4.65-8.91],3.318679747076548e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPHS1,Nephrin,17083,52,0.33 [0.14-0.77],0.0103060127959834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPHS2,Podocin,17083,52,1.07 [0.84-1.36],0.5894908107101544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPL,N-acetylneuraminate lyase,17610,52,1.10 [0.63-1.92],0.7284162256271868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPPB,Natriuretic peptides B,19823,80,1.32 [1.15-1.53],9.568225801123412e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPPC,C-type natriuretic peptide,20157,80,2.05 [1.58-2.66],6.657650475539343e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,17001,51,0.60 [0.25-1.40],0.2332390707366582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPTN,Neuroplastin,19761,80,1.00 [0.77-1.29],0.9916251871210936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPTX1,Neuronal pentraxin-1,20222,80,1.18 [0.74-1.90],0.4871483556352124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPTX2,Neuronal pentraxin-2,17614,50,2.40 [1.20-4.80],0.0131893650546121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPTXR,Neuronal pentraxin receptor,20208,82,1.31 [0.77-2.22],0.3258289990208959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPY,Pro-neuropeptide Y,20371,81,3.85 [2.74-5.41],6.941577371028816e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,20208,82,7.10 [4.45-11.32],1.768108916086631e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRGN,Neurogranin,17611,51,1.22 [0.91-1.64],0.1909750441519648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRN1,Neuritin,17572,52,0.60 [0.23-1.57],0.3007771112492303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRP1,Neuropilin-1,20359,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRP2,Neuropilin-2,20222,80,2.24 [1.24-4.06],0.0078033506025709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRTN,Neurturin,19834,81,1.08 [0.74-1.58],0.6932988321182723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRXN3,Neurexin-3,17117,51,0.44 [0.16-1.22],0.1132264597927965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NSFL1C,NSFL1 cofactor p47,20368,81,1.01 [0.75-1.36],0.9701672179724536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",17610,52,1.20 [0.83-1.74],0.3419052587676564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,17573,52,2.57 [1.79-3.69],3.5794300386920745e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,20130,80,1.04 [0.82-1.31],0.759937624926365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5E,5'-nucleotidase,20289,81,0.98 [0.69-1.40],0.9117227641278608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTF3,Neurotrophin-3,20157,80,2.17 [1.42-3.31],0.0003485140713649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTF4,Neurotrophin-4,19761,80,1.16 [0.74-1.81],0.5126026764447954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,20208,82,6.63 [3.50-12.56],6.6672094517773274e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTRK3,NT-3 growth factor receptor,20368,81,0.69 [0.28-1.66],0.4042893894466816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,20208,82,1.73 [1.51-1.98],2.1324245184004548e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUB1,NEDD8 ultimate buster 1,20157,80,1.15 [0.91-1.45],0.2478290258734038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,17526,51,1.10 [0.85-1.44],0.4634477113159322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUCB2,Nucleobindin-2,20329,81,4.74 [2.98-7.54],4.5132537758873906e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDC,Nuclear migration protein nudC,20408,82,1.41 [1.02-1.96],0.0383015429489934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,17158,52,0.60 [0.17-2.11],0.422618807259957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,17001,51,1.17 [0.72-1.87],0.5271109986343264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,17485,51,1.57 [1.17-2.10],0.0027229255470397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],20108,81,1.00 [0.70-1.43],0.9839516732438348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,20222,80,1.48 [1.03-2.12],0.033993657962464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUMB,Protein numb homolog,17083,52,1.23 [0.88-1.71],0.2298236713439431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUP50,Nuclear pore complex protein Nup50,17001,51,1.05 [0.48-2.29],0.8956108507947678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NXPE4,NXPE family member 4,17001,51,1.08 [0.50-2.35],0.8385446113581667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NXPH1,Neurexophilin-1,19753,77,1.75 [1.28-2.39],0.0004413016602417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NXPH3,Neurexophilin-3,17083,52,6.24 [2.98-13.09],1.2369976394291842e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OBP2B,Odorant-binding protein 2b,19957,81,1.71 [1.31-2.24],9.39143035565314e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OCLN,Occludin,17572,52,3.19 [2.27-4.48],2.3571576154139977e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,19724,77,0.98 [0.69-1.39],0.8933882814029397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,17281,52,1.33 [0.98-1.80],0.0715612272976642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGA,Protein O-GlcNAcase,17522,52,1.32 [0.90-1.93],0.150133141361657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGFR,Opioid growth factor receptor,20108,81,2.22 [1.27-3.89],0.0053258606383893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGN,Mimecan,20222,80,6.98 [5.12-9.52],8.727765426127595e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,17281,52,0.92 [0.58-1.46],0.7226926969204165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OLFM4,Olfactomedin-4,16582,47,1.79 [1.41-2.28],1.8296174055156088e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,20008,81,1.33 [0.98-1.79],0.0635636269801566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OMD,Osteomodulin,20290,80,0.79 [0.51-1.23],0.3008769118367175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,20108,81,0.66 [0.49-0.88],0.0049287988921796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OMP,Olfactory marker protein,17030,52,1.07 [0.63-1.79],0.8115590409627449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OPHN1,Oligophrenin-1,17573,52,1.21 [0.94-1.55],0.1461730195344403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OPLAH,5-oxoprolinase,17158,52,1.38 [0.93-2.04],0.1062736535840568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OPTC,Opticin,20108,81,1.54 [1.14-2.09],0.0048735302771257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,17569,49,0.58 [0.15-2.28],0.4328910536995215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,17573,52,1.53 [0.99-2.38],0.0555462770881279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,20225,79,3.72 [2.12-6.52],4.411685785296079e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSM,Oncostatin-M,20069,79,1.23 [0.93-1.63],0.1472768090444184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,20359,83,2.15 [0.84-5.52],0.1125269259521213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSTN,Osteocrin,17117,51,1.39 [0.84-2.32],0.200916783488257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OTOA,Otoancorin,17030,52,0.89 [0.51-1.55],0.6818939086988973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,17522,52,1.24 [0.79-1.95],0.3430890705433206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OTUD7B,OTU domain-containing protein 7B,17572,52,1.78 [1.18-2.70],0.0058910929747104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",17158,52,1.61 [1.12-2.31],0.0097501203374065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OXT,Oxytocin-neurophysin 1,20368,81,1.08 [0.94-1.24],0.2634911152000124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",P4HB,Protein disulfide-isomerase,20126,80,2.21 [1.34-3.65],0.0018214695219042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,17001,51,1.59 [1.05-2.41],0.0301051534211277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,19834,81,1.42 [1.13-1.78],0.0025014211640165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PADI4,Protein-arginine deiminase type-4,19724,77,1.10 [0.87-1.40],0.4156197774811969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAEP,Glycodelin,20021,81,1.30 [1.08-1.56],0.0049317441357635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,17572,52,0.96 [0.74-1.24],0.7509726909897008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",17281,52,1.17 [0.69-1.98],0.5634873900774542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,19823,80,1.73 [1.29-2.32],0.0002297346245837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,17158,52,1.29 [0.72-2.30],0.3896416455088189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,16939,52,1.16 [0.69-1.93],0.5727490482754727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,19753,77,1.31 [0.96-1.78],0.0895752119666354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALLD,Palladin,17083,52,1.31 [0.77-2.22],0.3221084370419221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM,Paralemmin-1,17422,52,5.05 [3.23-7.90],1.3978248248581332e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM2,Paralemmin-2,17573,52,4.74 [3.25-6.90],5.387144500565274e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM3,Paralemmin-3,17001,51,0.81 [0.48-1.35],0.4154554606512013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,20359,82,3.29 [1.54-7.00],0.0020365314797894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAMR1,Inactive serine protease PAMR1,20222,80,1.36 [0.64-2.86],0.4215317948633654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAPPA,Pappalysin-1,19834,81,0.81 [0.53-1.23],0.3143662484439093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PARD3,Partitioning defective 3 homolog,17281,52,1.26 [0.94-1.69],0.1185461608447181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PARK7,Parkinson disease protein 7,20222,80,1.15 [0.79-1.69],0.467853828961029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,20157,80,1.03 [0.73-1.45],0.8720066250322736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAXX,Protein PAXX,17227,49,1.58 [0.91-2.75],0.1060328461405898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,16965,52,1.03 [0.44-2.42],0.9529083488660824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,19753,77,0.73 [0.49-1.10],0.1290708601403638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,17522,52,2.75 [1.64-4.61],0.000122508705769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCARE,Photoreceptor cilium actin regulator,17030,52,1.00 [0.72-1.39],0.998120793072903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,17200,49,1.46 [0.86-2.48],0.1593059512838927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCBP2,Poly(rC)-binding protein 2,17572,52,1.27 [0.88-1.85],0.2065294240000789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH1,Protocadherin-1,20346,82,4.05 [2.43-6.74],7.761972984975597e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH12,Protocadherin-12,17572,52,3.35 [1.28-8.75],0.0136594116012632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH17,Protocadherin-17,20208,82,3.17 [2.15-4.67],6.016226604344154e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH7,Protocadherin-7,17522,52,2.48 [1.82-3.36],7.222663716940018e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH9,Protocadherin-9,17522,52,1.94 [0.92-4.11],0.081757058088972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDHB15,Protocadherin beta-15,17526,51,2.55 [1.65-3.95],2.5681470083891247e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCNA,Proliferating cell nuclear antigen,16965,52,0.85 [0.52-1.40],0.5270996503136833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,17526,51,0.71 [0.37-1.38],0.3153352493575874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,20456,83,1.50 [0.93-2.41],0.0987617725057253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,17522,52,1.27 [0.89-1.81],0.1806345381547792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,17610,52,1.34 [1.02-1.77],0.036912296226663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1,Programmed cell death protein 1,20334,81,2.39 [1.78-3.21],7.023981409302264e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,20108,81,9.07 [5.82-14.15],2.149902302430861e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD5,Programmed cell death protein 5,20368,81,1.36 [0.98-1.90],0.0674163883867316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD6,Programmed cell death protein 6,20208,82,1.29 [0.92-1.81],0.1462603790372103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCL2,Phosducin-like protein 2,16965,52,0.62 [0.32-1.20],0.1541533757529884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",16965,52,1.39 [1.00-1.95],0.0533803453336792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",17001,51,0.72 [0.39-1.32],0.2861842413482435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",17227,49,1.15 [0.87-1.52],0.3211096507241796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,20456,83,0.96 [0.73-1.25],0.7453211601805128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,20290,80,0.99 [0.78-1.24],0.9080931205239036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFC,Platelet-derived growth factor C,19761,80,0.77 [0.37-1.60],0.4846760901429678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,20208,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,20456,83,2.25 [1.25-4.06],0.0069600875863584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDIA2,Protein disulfide-isomerase A2,16965,52,1.29 [0.76-2.20],0.3529664420016221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,17227,49,3.81 [2.20-6.60],1.906057662191225e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDIA4,Protein disulfide-isomerase A4,17614,50,1.26 [0.81-1.95],0.3034679223911247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDIA5,Protein disulfide-isomerase A5,16965,52,1.29 [0.93-1.79],0.1240548671876956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,17572,52,1.12 [0.89-1.42],0.3395053727141068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,20290,80,1.20 [1.03-1.41],0.0206931771680556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",19761,80,1.20 [0.84-1.71],0.3245230472450146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,17117,51,1.01 [0.61-1.69],0.95820390213831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,16965,52,0.97 [0.61-1.53],0.8850537528629419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDZD2,PDZ domain-containing protein 2,17001,51,1.49 [1.03-2.17],0.033794133423477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17083,52,2.33 [1.57-3.46],2.565938550781656e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,20456,83,8.10 [3.55-18.48],6.823957400236766e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,20222,80,1.35 [0.96-1.90],0.0807727958672748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,20222,80,1.76 [0.94-3.29],0.0767108797059554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,17158,52,1.49 [0.72-3.12],0.2840727783102273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PENK,Proenkephalin-A,17227,49,4.21 [2.85-6.22],5.32214441312534e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEPD,Xaa-Pro dipeptidase,17611,51,0.25 [0.10-0.63],0.0033709097202958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PER3,Period circadian protein homolog 3,17083,52,0.99 [0.79-1.22],0.8919576590915871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PF4,Platelet factor 4,17504,50,0.95 [0.71-1.26],0.7158035159552087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PFDN2,Prefoldin subunit 2,19753,77,0.97 [0.66-1.44],0.8953233415064044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PFDN4,Prefoldin subunit 4,16965,52,1.00 [0.59-1.70],0.9931734810466288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PFDN6,Prefoldin subunit 6,17117,51,0.92 [0.58-1.45],0.7112915198704342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",20066,81,1.19 [0.93-1.53],0.1620580010939151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGA4,Pepsin A-4,17611,51,1.31 [0.94-1.81],0.1079220409595961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",17610,52,2.01 [1.26-3.21],0.003577501606413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGF,Placenta growth factor,20408,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,20375,83,3.03 [2.25-4.06],1.7101942243943067e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,17419,49,0.47 [0.20-1.12],0.0890516895198807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,17001,51,0.95 [0.59-1.52],0.8281994057476512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGM2,Phosphoglucomutase-2,17117,51,0.51 [0.25-1.04],0.0651733588736333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGR,Progesterone receptor,17083,52,1.20 [0.96-1.50],0.1153680930832647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,17572,52,1.21 [0.96-1.54],0.1091628154538909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,17522,52,2.81 [1.87-4.24],7.765101095928057e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,16965,52,0.83 [0.59-1.17],0.2944189030012932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,20021,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,17227,49,1.12 [0.58-2.19],0.7287250885703984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI16,Peptidase inhibitor 16,17611,51,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI3,Elafin,19959,83,2.63 [2.12-3.27],2.767446956917237e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",17572,52,1.33 [0.95-1.86],0.0939040365805507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,19954,80,8.32 [5.44-12.73],1.5527798325538852e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,20157,80,0.86 [0.62-1.20],0.3795690550058961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,20222,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,17083,52,0.88 [0.51-1.50],0.6341279643938615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,20222,80,8.06 [5.23-12.42],2.8427773584881312e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,20208,82,5.31 [3.58-7.88],1.0720363581332374e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,17227,49,1.05 [0.71-1.57],0.7984588942342977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PITHD1,PITH domain-containing protein 1,16939,52,0.81 [0.53-1.23],0.3137451481236973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PKD1,Polycystin-1,17610,52,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PKD2,Polycystin-2,17001,51,1.83 [1.28-2.61],0.0009054595982584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PKLR,Pyruvate kinase PKLR,20229,80,0.62 [0.45-0.86],0.0037705445780574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PKN3,Serine/threonine-protein kinase N3,17281,52,1.01 [0.71-1.45],0.9412283044939466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,20021,81,2.27 [1.64-3.15],8.880794175665348e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,20289,81,2.92 [1.48-5.78],0.0020579270951984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G1B,Phospholipase A2,20427,83,0.50 [0.33-0.76],0.0010571577327061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",20173,83,0.95 [0.67-1.34],0.7661508329513509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,20290,80,1.20 [0.95-1.51],0.1217092112774721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,20222,80,0.11 [0.07-0.18],9.311445562316191e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLAT,Tissue-type plasminogen activator,20398,83,0.84 [0.58-1.23],0.3749501098253784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLAU,Urokinase-type plasminogen activator,20222,80,0.91 [0.48-1.74],0.7756825912968226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,20069,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",17573,52,0.63 [0.41-0.96],0.0316845412869917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",17083,52,1.62 [1.04-2.52],0.0322146318236586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",17573,52,1.28 [0.97-1.70],0.0836784644333836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,17573,52,1.36 [0.94-1.97],0.1059751611865229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLG,Plasminogen,17208,48,0.43 [0.12-1.52],0.1893723115647154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLIN1,Perilipin-1,19753,77,1.35 [0.83-2.20],0.2267911113166385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLIN3,Perilipin-3,20208,82,3.14 [2.18-4.53],8.660193139098833e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,20208,82,1.07 [0.80-1.43],0.6579928850148737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLSCR3,Phospholipid scramblase 3,17538,51,1.76 [1.12-2.76],0.014911490363478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLTP,Phospholipid transfer protein,20400,82,1.18 [0.69-2.02],0.541407205272596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,19761,80,1.82 [1.21-2.72],0.0037044701558305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,17573,52,2.86 [1.87-4.38],1.2289224200453178e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXNA4,Plexin-A4,20157,80,1.20 [0.94-1.53],0.1393920869698443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXNB2,Plexin-B2,20354,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXNB3,Plexin-B3,20155,82,1.34 [0.89-2.00],0.1579316606526337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,20089,82,1.09 [0.98-1.22],0.1119026351893234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PMCH,Pro-MCH,17001,51,1.05 [0.78-1.42],0.7513908160056811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PMM2,Phosphomannomutase 2,17001,51,1.13 [0.71-1.78],0.6133194818933017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PMS1,PMS1 protein homolog 1,17117,51,1.10 [0.66-1.82],0.7232894069435283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PMVK,Phosphomevalonate kinase,19717,77,1.14 [0.93-1.40],0.2018239581463056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,17611,51,0.39 [0.26-0.58],2.9709409253032542e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,17573,52,0.89 [0.64-1.24],0.4995051088009447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,20198,79,1.00 [0.94-1.07],0.9418717096581226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,17158,52,1.32 [0.83-2.09],0.2374935319585032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,17030,52,0.79 [0.41-1.53],0.4901302455814993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",19834,81,0.86 [0.69-1.06],0.1468894231235966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PODXL,Podocalyxin,20108,81,0.82 [0.23-2.96],0.7622968350120952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,20289,81,2.45 [1.35-4.45],0.0033677370910104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POF1B,Protein POF1B,17083,52,2.62 [1.98-3.48],2.6444155552627983e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,17083,52,0.50 [0.19-1.33],0.1661725568754619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",20108,81,2.22 [1.65-2.98],1.0086175291642185e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POMC,Pro-opiomelanocortin,17158,52,1.28 [0.90-1.84],0.1728900784644709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,17611,51,0.31 [0.17-0.55],6.405307476290055e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,19823,80,0.63 [0.36-1.10],0.1051746670309815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PON3,Serum paraoxonase/lactonase 3,20290,80,0.56 [0.40-0.79],0.0010718059828766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POSTN,Periostin,17614,50,3.13 [1.85-5.28],1.931892874615085e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPBP,Platelet basic protein,17515,50,1.07 [0.77-1.49],0.6847546709399301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,20368,81,0.91 [0.59-1.40],0.6785688405887339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,20254,82,1.23 [0.99-1.53],0.0589496729174575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,17281,52,0.95 [0.61-1.48],0.8294732752055924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",17614,50,0.87 [0.56-1.37],0.5608635790743346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPL,Periplakin,17083,52,2.26 [1.33-3.82],0.0024305397948382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPM1A,Protein phosphatase 1A,19761,80,0.88 [0.45-1.74],0.7102980323558494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPM1B,Protein phosphatase 1B,17083,52,0.98 [0.60-1.60],0.9404231421712348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPM1F,Protein phosphatase 1F,17610,52,1.52 [0.92-2.52],0.1038566210516587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPME1,Protein phosphatase methylesterase 1,20108,81,0.79 [0.58-1.10],0.1615320930162684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,17526,51,0.99 [0.71-1.37],0.946671357136573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,20289,81,1.22 [1.00-1.49],0.0517460172308834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,17281,52,1.24 [0.92-1.68],0.1619863482461321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,17572,52,1.18 [0.87-1.59],0.2806817697734836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17572,52,2.27 [1.52-3.38],5.694000851460119e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,20208,82,1.31 [1.03-1.67],0.0292434899182826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R9B,Neurabin-2,20408,82,1.34 [1.09-1.65],0.005703592744364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,17522,52,1.40 [1.14-1.73],0.0016252427539172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP3R1,Calcineurin subunit B type 1,20021,81,1.94 [1.21-3.10],0.0060502029907253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,17117,51,0.91 [0.60-1.38],0.6605386984529333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPY,Pancreatic prohormone,20207,79,1.59 [1.33-1.90],3.291035936288657e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PQBP1,Polyglutamine-binding protein 1,19761,80,1.16 [0.86-1.57],0.3257087981806238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,16965,52,0.46 [0.16-1.36],0.1599144548405082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,17614,50,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRC1,Protein regulator of cytokinesis 1,17526,51,0.29 [0.09-0.91],0.03451452210505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,20345,83,3.99 [2.71-5.88],2.476963060136723e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRDX1,Peroxiredoxin-1,19616,80,0.87 [0.68-1.11],0.2527328348665808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRDX2,Peroxiredoxin-2,17293,51,0.71 [0.46-1.11],0.1342108085932595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",19834,81,1.46 [1.13-1.89],0.0038723712585284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",20408,82,1.23 [0.90-1.67],0.1967167263789041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRDX6,Peroxiredoxin-6,20371,81,0.65 [0.46-0.91],0.0132344875993058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,19834,81,2.82 [1.88-4.22],4.731972018232824e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRELP,Prolargin,20198,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRG2,Bone marrow proteoglycan,17614,50,4.03 [2.63-6.17],1.4329756022435276e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRG3,Proteoglycan 3,17614,50,1.43 [0.85-2.42],0.1798748600820418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,19834,81,1.68 [1.24-2.28],0.0008099362395342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,17117,51,0.59 [0.22-1.56],0.2885905236776166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,20208,82,1.21 [0.95-1.54],0.1212099506048866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,17541,51,1.40 [0.99-1.98],0.0579448069512685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKCQ,Protein kinase C theta type,19834,81,0.79 [0.47-1.33],0.3684409936958126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,17001,51,0.68 [0.32-1.44],0.3172490476166839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,17227,49,1.11 [0.89-1.38],0.3728292024672602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,19761,80,1.33 [1.00-1.76],0.0465526208429478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRL,Prolactin,20368,81,1.53 [1.23-1.90],0.000158730695363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRND,Prion-like protein doppel,17573,52,2.71 [1.92-3.83],1.4536232654304996e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROC,Vitamin K-dependent protein C,20287,82,0.24 [0.12-0.48],6.820661027714326e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROCR,Endothelial protein C receptor,17001,51,0.82 [0.34-1.96],0.652698799758453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROK1,Prokineticin-1,20157,80,1.81 [1.43-2.29],9.105741427538408e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROS1,Vitamin K-dependent protein S,17637,50,0.15 [0.06-0.35],1.2847588800371075e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRR4,Proline-rich protein 4,17092,48,1.67 [1.19-2.33],0.0029970298658731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRR5,Proline-rich protein 5,17083,52,1.30 [0.81-2.08],0.2795171536028077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,17158,52,4.16 [2.51-6.90],3.4876841847548943e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS2,Trypsin-2,20332,82,1.33 [0.96-1.83],0.0874136472800337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS22,Brain-specific serine protease 4,17083,52,1.65 [1.08-2.52],0.0212644619265004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS27,Serine protease 27,20151,82,3.73 [2.42-5.76],2.6024505213634282e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS53,Serine protease 53,17573,52,0.79 [0.39-1.59],0.5111739760924655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS8,Prostasin,20126,80,6.12 [4.23-8.88],1.0777909182717857e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,19753,77,1.06 [0.88-1.28],0.5223584428399888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTG,Protogenin,20371,81,5.58 [2.74-11.33],2.045750113857162e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTN3,Myeloblastin,19695,82,1.43 [1.02-2.02],0.0393815186414469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRUNE2,Protein prune homolog 2,17281,52,0.63 [0.22-1.79],0.3848008073865457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSAP,Prosaposin,17439,50,4.17 [2.84-6.13],3.0346883123100963e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,17522,52,1.17 [0.71-1.93],0.5314885045069383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSCA,Prostate stem cell antigen,17522,52,1.15 [1.02-1.29],0.022642951510142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,20021,81,2.47 [1.98-3.07],5.675128985798509e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,20157,80,1.28 [0.99-1.64],0.0554010508707989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMA1,Proteasome subunit alpha type-1,19761,80,1.07 [0.69-1.65],0.7765293611606399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,16965,52,0.70 [0.28-1.74],0.4465334465349215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,17572,52,1.61 [1.04-2.49],0.032890267133553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,17117,51,0.99 [0.60-1.63],0.9642137548062364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,20108,81,0.64 [0.43-0.94],0.0232617076856107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSME1,Proteasome activator complex subunit 1,19973,81,0.90 [0.53-1.53],0.7005848487109205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSME2,Proteasome activator complex subunit 2,19918,78,1.21 [0.70-2.08],0.4968399569477918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMG3,Proteasome assembly chaperone 3,20157,80,0.83 [0.56-1.22],0.3379610429220093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMG4,Proteasome assembly chaperone 4,17083,52,0.78 [0.48-1.28],0.3346919826551729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSPN,Persephin,20157,80,1.49 [1.28-1.73],3.157127202155455e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,19761,80,1.25 [0.92-1.71],0.1581529549812491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,16635,44,1.04 [0.79-1.38],0.7637265179592343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",19753,77,0.93 [0.47-1.85],0.8441947786326144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,20086,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGES2,Prostaglandin E synthase 2,16958,51,1.92 [1.24-2.97],0.0034166995475779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGR1,Prostaglandin reductase 1,17610,52,1.18 [0.87-1.60],0.2810207653909021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTH,Parathyroid hormone,17117,51,1.02 [0.75-1.38],0.9202471778877518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,20157,80,2.02 [1.62-2.53],6.374764732123114e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,19753,77,4.90 [3.28-7.32],8.663481804832111e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTN,Pleiotrophin,19823,80,1.53 [1.05-2.23],0.0265873899467388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,17083,52,1.25 [0.80-1.97],0.3291434140805902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,20021,81,1.26 [0.99-1.59],0.0600012415053319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,20254,80,1.20 [0.95-1.53],0.130344205345727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,17054,52,1.14 [0.59-2.20],0.6944267318851842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,17610,52,1.92 [0.79-4.67],0.1499408681695031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,17614,50,2.39 [0.90-6.35],0.0793134283309029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,20456,83,4.44 [2.31-8.54],8.037567718418874e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,17522,52,1.57 [0.93-2.64],0.089476988216675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,17522,52,2.11 [0.94-4.74],0.0687765949410696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,20132,80,1.89 [0.85-4.19],0.1192380719399082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,19959,80,6.84 [4.41-10.59],7.161318606250401e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,17573,52,3.27 [1.95-5.49],7.464297108657688e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,20456,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,17610,52,1.67 [0.79-3.53],0.1789858876208867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,17227,49,1.20 [0.75-1.91],0.4425616164208248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,19657,77,0.99 [0.69-1.42],0.9637531106158008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTTG1,Securin,17281,52,1.05 [0.57-1.94],0.8809930186990911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTX3,Pentraxin-related protein PTX3,20157,80,1.85 [1.13-3.02],0.0144096025517874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PVALB,Parvalbumin alpha,20259,81,1.27 [1.04-1.54],0.0167958659112685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PVR,Poliovirus receptor,20368,81,1.52 [0.92-2.51],0.0994605479391856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PXDNL,Peroxidasin-like protein,17526,51,1.08 [0.69-1.70],0.7266759542556636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PXN,Paxillin,19753,77,1.61 [1.21-2.15],0.0010193930841025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PYDC1,Pyrin domain-containing protein 1,17158,52,1.64 [1.05-2.55],0.0283434193103187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PYY,Peptide YY,17001,51,1.93 [1.54-2.42],1.4816580644269806e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PZP,Pregnancy zone protein,17637,50,0.53 [0.34-0.83],0.0054732969472068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QDPR,Dihydropteridine reductase,20108,81,1.07 [0.67-1.70],0.7800958591678981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,20256,83,9.31 [5.92-14.65],5.2554479687482e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QSOX1,Sulfhydryl oxidase 1,17298,50,1.41 [0.97-2.05],0.0700147145334461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB10,Ras-related protein Rab-10,17610,52,1.33 [0.83-2.14],0.2395333916919456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,17610,52,1.13 [0.88-1.45],0.3400918091721452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB27B,Ras-related protein Rab-27B,17610,52,1.40 [0.98-2.00],0.0661971389982651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB2B,Ras-related protein Rab-2B,17526,51,1.24 [0.80-1.93],0.3284933292407788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB33A,Ras-related protein Rab-33A,17001,51,1.10 [0.74-1.65],0.6283775359646542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB37,Ras-related protein Rab-37,19834,81,0.96 [0.74-1.25],0.7563824533630451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB39B,Ras-related protein Rab-39B,17001,51,1.00 [0.74-1.34],0.9774716085496852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,17030,52,0.67 [0.36-1.23],0.1972229919911355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB44,Ras-related protein Rab-44,17526,51,1.70 [1.23-2.34],0.0012427007061095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,20157,80,0.46 [0.30-0.70],0.0002773656623238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB6B,Ras-related protein Rab-6B,19753,77,0.81 [0.51-1.29],0.3749393708544286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,17227,49,1.14 [0.80-1.62],0.4744409775314788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,19761,80,1.04 [0.73-1.48],0.8237965590615627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,19834,81,1.22 [0.89-1.68],0.2167631922534769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,17117,51,0.74 [0.44-1.26],0.269284291895327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,19761,80,1.33 [0.89-1.99],0.1655760986951132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,17281,52,1.29 [0.90-1.86],0.1619447613660126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RALB,Ras-related protein Ral-B,17083,52,1.46 [0.61-3.54],0.3967101586449866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RALY,RNA-binding protein Raly,17526,51,1.39 [0.91-2.13],0.1321679830373503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,17158,52,0.91 [0.55-1.52],0.7175670716547917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,17030,52,0.96 [0.42-2.21],0.93256809602276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,19761,80,1.06 [0.68-1.64],0.8065799064777579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAP1A,Ras-related protein Rap-1A,17083,52,1.10 [0.81-1.49],0.5621672344687244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,17281,52,1.17 [0.71-1.90],0.5410940456218981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,19761,80,2.02 [1.51-2.70],1.7303718686738026e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,20359,83,2.36 [1.78-3.13],2.390433949030148e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RASA1,Ras GTPase-activating protein 1,19753,77,0.65 [0.33-1.26],0.2021694300561625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,16965,52,1.20 [0.66-2.18],0.5504196783175763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,19761,80,1.45 [1.15-1.82],0.0014258939701955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17572,52,3.66 [2.78-4.82],2.18213188218938e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBKS,Ribokinase,19709,79,0.70 [0.49-0.98],0.0375414594544157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBM17,Splicing factor 45,17572,52,1.25 [0.89-1.75],0.2003207785121535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBM19,Probable RNA-binding protein 19,17001,51,0.80 [0.41-1.60],0.5339236916499788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBM25,RNA-binding protein 25,16965,52,1.32 [0.79-2.21],0.2939567569309538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP1,Retinol-binding protein 1,17117,51,1.24 [0.91-1.68],0.1787202746816951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP2,Retinol-binding protein 2,20108,81,2.52 [2.01-3.16],1.409402714957534e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP5,Retinol-binding protein 5,20108,81,2.04 [1.52-2.73],1.700291969133772e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP7,Retinoid-binding protein 7,17522,52,2.06 [1.54-2.76],1.0722463078282405e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,17083,52,1.03 [0.68-1.57],0.8841604216472336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,17158,52,1.23 [0.95-1.59],0.1201416517400809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RCC1,Regulator of chromosome condensation,17526,51,1.24 [0.79-1.93],0.3480436167370768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RCOR1,REST corepressor 1,19823,80,0.82 [0.47-1.44],0.493414481778423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,17158,52,0.97 [0.28-3.34],0.961862004399371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REEP4,Receptor expression-enhancing protein 4,17572,52,1.18 [0.78-1.79],0.4378133469783343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1A,Lithostathine-1-alpha,20108,82,4.63 [3.75-5.73],1.23632431299124e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1B,Lithostathine-1-beta,20456,83,3.06 [2.49-3.77],5.020122184402264e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,20456,83,2.92 [2.35-3.63],4.94464624719518e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,17526,51,0.88 [0.45-1.74],0.7209210275777174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG4,Regenerating islet-derived protein 4,20225,79,7.46 [5.51-10.10],1.2460861218477908e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RELB,Transcription factor RelB,17083,52,1.15 [0.71-1.84],0.5713146163547465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,20222,80,7.71 [5.27-11.28],6.681520421548496e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REN,Renin,20208,82,3.65 [3.09-4.31],3.009035159288657e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,17083,52,0.63 [0.29-1.35],0.2352213423029675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REST,RE1-silencing transcription factor,16965,52,1.56 [0.95-2.56],0.0812640824689905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,20108,81,4.72 [2.94-7.60],1.5828364893464418e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RETN,Resistin,20164,81,3.72 [2.74-5.05],4.215168664873208e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",17001,51,0.96 [0.55-1.67],0.8864835028526865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RFC4,Replication factor C subunit 4,17526,51,1.88 [0.62-5.73],0.2677338101790045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGCC,Regulator of cell cycle RGCC,17572,52,1.15 [0.81-1.65],0.4377805064397906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,17281,52,1.13 [0.76-1.68],0.5447035813123579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGMA,Repulsive guidance molecule A,20368,81,8.83 [5.01-15.54],4.5477536347787456e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGMB,RGM domain family member B,20368,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGS10,Regulator of G-protein signaling 10,17572,52,1.17 [0.76-1.80],0.4719921032321466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGS8,Regulator of G-protein signaling 8,19834,81,0.93 [0.67-1.29],0.6710198303440863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,19897,81,1.27 [1.06-1.53],0.0104130204687601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,17083,52,0.85 [0.45-1.60],0.6111871399493061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,17227,49,1.88 [1.18-2.99],0.0078191930082422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RILP,Rab-interacting lysosomal protein,20301,81,0.95 [0.68-1.32],0.7617175523390469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RILPL2,RILP-like protein 2,17610,52,1.26 [0.95-1.67],0.1130860853939038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,17001,51,1.09 [0.75-1.57],0.6499256254111827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RLN1,Prorelaxin H1,17572,52,1.18 [0.80-1.74],0.3985470878021525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RLN2,Prorelaxin H2,17194,49,1.83 [1.36-2.46],6.312256539833328e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE1,Ribonuclease pancreatic,17611,51,5.00 [3.18-7.87],3.350943792931407e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,17158,52,2.16 [1.66-2.82],1.2104404925419454e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE3,Eosinophil cationic protein,20115,82,1.20 [1.03-1.39],0.0191642189896132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE4,Ribonuclease 4,17010,50,4.87 [3.05-7.79],3.526770752405737e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE6,Ribonuclease K6,17482,51,2.95 [2.21-3.93],1.3399313548369524e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,17572,52,1.45 [0.93-2.27],0.0988260618151632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASET2,Ribonuclease T2,20369,83,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,17158,52,4.93 [2.89-8.40],4.5514274696274825e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,17083,52,1.10 [0.58-2.11],0.7649343220707474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,17083,52,1.26 [0.63-2.54],0.5100822629382138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,17281,52,0.67 [0.40-1.11],0.1213794641196009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,19761,80,1.17 [0.86-1.57],0.3142957754181001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,17281,52,1.15 [0.80-1.66],0.4379547451444762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,17158,52,1.13 [0.77-1.64],0.54131005432165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO1,Roundabout homolog 1,20225,79,3.90 [2.06-7.37],2.7455359681498e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO2,Roundabout homolog 2,20368,81,2.96 [1.48-5.92],0.0021597023188654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO4,Roundabout homolog 4,17158,52,4.92 [1.20-20.17],0.0270272941093275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,20208,82,9.80 [5.75-16.71],5.102356911790444e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RP2,Protein XRP2,20108,81,1.06 [0.66-1.70],0.8052973391370962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RPA2,Replication protein A 32 kDa subunit,17083,52,1.42 [0.73-2.76],0.3017680875447202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,17281,52,1.06 [0.72-1.56],0.7712162196004135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,17117,51,1.07 [0.58-2.00],0.8226645490709039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RPL14,60S ribosomal protein L14,17158,52,1.60 [0.96-2.66],0.070612640051479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RPS10,40S ribosomal protein S10,17001,51,0.84 [0.42-1.71],0.6363778774170605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RRAS,Ras-related protein R-Ras,17117,51,1.03 [0.83-1.27],0.7834293994511726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,19761,80,0.91 [0.60-1.38],0.6567763888684474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,19761,80,1.23 [0.92-1.66],0.1686321380598053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RRP15,RRP15-like protein,17030,52,1.17 [0.88-1.56],0.2751614780839879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO1,R-spondin-1,20021,81,2.69 [1.74-4.16],9.161667669301422e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO3,R-spondin-3,20371,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTBDN,Retbindin,20108,81,3.03 [2.03-4.52],6.355045733545251e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTKN2,Rhotekin-2,17001,51,1.09 [0.67-1.79],0.7194606868318596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",17572,52,1.51 [1.14-2.01],0.0040339801949893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTN4R,Reticulon-4 receptor,20371,81,5.83 [4.12-8.27],3.2623299646596e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RUVBL1,RuvB-like 1,19761,80,0.87 [0.71-1.08],0.211476228887585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RWDD1,RWD domain-containing protein 1,20368,81,1.19 [0.87-1.63],0.281496995793966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RYR1,Ryanodine receptor 1,17001,51,0.84 [0.35-1.98],0.6837244706574035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A11,Protein S100-A11,20061,82,1.23 [0.86-1.77],0.2596130825296825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A12,Protein S100-A12,19918,79,0.78 [0.59-1.02],0.0738458156145788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A13,Protein S100-A13,17083,52,2.14 [1.31-3.50],0.0023586744902258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A14,Protein S100-A14,17572,52,0.55 [0.31-0.96],0.0350223141495229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A16,Protein S100-A16,19724,77,0.90 [0.64-1.27],0.5572176133141133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A3,Protein S100-A3,17526,51,1.32 [0.89-1.97],0.1656290349369373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A4,Protein S100-A4,20289,81,0.80 [0.56-1.13],0.2072366933724937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100G,Protein S100-G,17572,52,1.10 [0.63-1.92],0.7321575508819933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100P,Protein S100-P,19823,80,1.95 [1.57-2.43],2.328328132021629e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAA4,Serum amyloid A-4 protein,17637,50,0.29 [0.04-1.88],0.1940395511323669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAFB2,Scaffold attachment factor B2,17572,52,1.49 [0.67-3.27],0.3261157404662657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAG,S-arrestin,17030,52,1.24 [0.77-1.98],0.3726658749417656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,20157,80,1.29 [0.99-1.70],0.0631588592413411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,17281,52,0.88 [0.59-1.30],0.5178778435691858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SARG,Specifically androgen-regulated gene protein,17528,52,1.23 [0.96-1.58],0.1060799728036702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,17001,51,1.36 [0.79-2.33],0.2637616293070344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAT1,Diamine acetyltransferase 1,17001,51,0.83 [0.45-1.52],0.5463912316270046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,17281,52,1.46 [1.10-1.94],0.0081029382664409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SATB1,DNA-binding protein SATB1,17572,52,1.46 [0.70-3.03],0.3142729058569994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SBSN,Suprabasin,17583,50,1.94 [0.95-3.97],0.0681313630782431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,20108,81,1.46 [1.16-1.83],0.0010214961772007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,20368,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB1,Scavenger receptor class B member 1,19753,77,1.21 [0.91-1.61],0.1868461605370077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB2,Lysosome membrane protein 2,19651,81,7.57 [5.50-10.41],1.6812828381643288e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,20456,83,3.60 [2.41-5.40],4.720129591036551e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,20368,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCG2,Secretogranin-2,20259,81,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCG3,Secretogranin-3,20225,79,2.83 [1.63-4.92],0.0002265588204997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB1A1,Uteroglobin,20209,80,4.39 [2.96-6.51],1.695720200940648e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB2A2,Mammaglobin-A,17001,51,1.04 [0.43-2.48],0.9357174381323564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,17227,49,2.45 [0.92-6.58],0.0743698033267423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,20254,80,1.11 [0.92-1.33],0.2743055597528767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGN,Secretagogin,19834,81,4.68 [3.43-6.38],1.7520470215016902e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCIN,Adseverin,17030,52,1.00 [0.69-1.44],0.9836479717197067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCLY,Selenocysteine lyase,20301,81,0.93 [0.62-1.40],0.7299786919214444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,17030,52,0.88 [0.49-1.58],0.6637914690964128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN2B,Sodium channel subunit beta-2,17117,51,1.33 [0.59-3.02],0.4908000553249985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,17117,51,0.87 [0.39-1.95],0.730715867925064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN3B,Sodium channel subunit beta-3,17030,52,0.84 [0.44-1.58],0.5822959892627722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,17158,52,5.34 [3.45-8.25],5.0925937343621603e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCP2,Non-specific lipid-transfer protein,19761,80,1.03 [0.78-1.35],0.83732550991277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,17088,52,1.55 [0.92-2.61],0.1018014563709596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,17610,52,4.80 [2.79-8.25],1.4379140102403386e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCRIB,Protein scribble homolog,17158,52,1.12 [0.86-1.47],0.3950374622804272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCRN1,Secernin-1,20157,80,1.15 [0.80-1.64],0.4472266423243882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCT,Secretin,17117,51,2.17 [1.40-3.35],0.0005066339504724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDC1,Syndecan-1,20208,82,2.68 [1.92-3.75],8.453954151778488e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDC4,Syndecan-4,20208,82,0.57 [0.39-0.85],0.005234119377263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,17526,51,1.24 [0.98-1.58],0.0724915449103891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDHB,Succinate dehydrogenase,17522,52,1.04 [0.69-1.55],0.8576859645171794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDK2,Protein sidekick-2,17227,49,1.95 [1.24-3.08],0.0038618318470726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEC31A,Protein transport protein Sec31A,17158,52,1.27 [0.88-1.83],0.19568664614284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,17158,52,3.03 [2.24-4.09],4.859190073784373e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELE,E-selectin,20456,83,2.05 [1.39-3.03],0.0003114639275603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELENOP,Selenoprotein P,17637,50,0.54 [0.16-1.85],0.3245013120486701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELL,L-selectin,17637,50,0.23 [0.09-0.61],0.0033248457233442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELP,P-selectin,20332,82,1.49 [1.07-2.09],0.0194113273456616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,20157,80,0.76 [0.43-1.34],0.3399648586201698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA3F,Semaphorin-3F,20208,82,9.62 [5.05-18.33],6.038226157314793e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA3G,Semaphorin-3G,17227,49,0.94 [0.51-1.76],0.8519686456801404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA4C,Semaphorin-4C,20108,81,1.50 [0.85-2.65],0.1591002989949723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA4D,Semaphorin-4D,20368,81,1.54 [0.79-3.00],0.2082842944448599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA6C,Semaphorin-6C,17083,52,2.16 [1.08-4.34],0.0304513159254006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA7A,Semaphorin-7A,20398,83,3.48 [2.39-5.08],8.746718033848954e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN3,Neuronal-specific septin-3,17572,52,1.33 [0.97-1.81],0.0751528263492431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN7,Septin-7,17281,52,1.34 [0.95-1.89],0.0999666619634198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN8,Septin-8,17547,52,4.29 [2.81-6.56],1.509894107387851e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN9,Septin-9,20108,81,0.57 [0.26-1.22],0.1464405463129678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA1,Alpha-1-antitrypsin,17279,50,1.81 [0.09-35.10],0.6933178973992946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA11,Serpin A11,20456,83,0.82 [0.53-1.26],0.3638493906071967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA12,Serpin A12,19591,80,0.94 [0.78-1.13],0.5031943970413266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,17563,50,1.38 [0.27-7.08],0.702549100428726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA4,Kallistatin,17316,50,0.45 [0.14-1.44],0.1785846495736518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA5,Plasma serine protease inhibitor,17376,50,0.75 [0.29-1.89],0.5381238856561099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA6,Corticosteroid-binding globulin,17637,50,0.77 [0.16-3.60],0.7354261639931274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA7,Thyroxine-binding globulin,17637,50,0.24 [0.06-0.97],0.0456495428680986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA9,Serpin A9,20007,81,1.05 [0.80-1.38],0.7003002062896647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,20150,80,1.24 [1.00-1.53],0.0520082951555567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB5,Serpin B5,19823,80,1.18 [0.77-1.78],0.4472610164831986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB6,Serpin B6,20303,81,1.65 [1.18-2.30],0.0032808451493535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB8,Serpin B8,20408,82,1.50 [1.19-1.88],0.0004783542655945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB9,Serpin B9,20021,81,1.22 [0.66-2.24],0.5259623885232135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINC1,Antithrombin-III,17607,50,1.08 [0.19-6.26],0.9338312842991268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPIND1,Heparin cofactor 2,17607,50,0.62 [0.25-1.58],0.3198759486332391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,20456,83,0.99 [0.74-1.34],0.9709855347115433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINE2,Glia-derived nexin,17610,52,1.12 [0.75-1.69],0.5698688099957709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,17359,50,5.41 [2.56-11.45],9.971348521908192e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINF2,Alpha-2-antiplasmin,17295,49,0.33 [0.05-2.28],0.2627511565239188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPING1,Plasma protease C1 inhibitor,17607,50,0.38 [0.09-1.58],0.1858916660422724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINH1,Serpin H1,17281,52,1.18 [0.96-1.44],0.1150362809335484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINI1,Neuroserpin,17200,49,0.88 [0.35-2.17],0.7745675731844861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINI2,Serpin I2,17522,52,0.41 [0.23-0.70],0.0012634334520558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,19753,77,1.06 [0.77-1.45],0.7212779355372547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,19951,81,0.98 [0.54-1.79],0.9585171828571712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6,Seizure protein 6 homolog,17117,51,1.81 [0.87-3.78],0.1148225786660508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6L,Seizure 6-like protein,20289,81,5.96 [3.41-10.39],3.2561914001242886e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,20108,81,2.26 [1.13-4.50],0.0204099599865551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SF3B4,Splicing factor 3B subunit 4,20108,81,0.93 [0.70-1.22],0.5847555459597682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,19957,81,2.57 [1.99-3.32],4.627416075030784e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,17227,49,9.99 [5.42-18.41],1.672299795850365e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,19761,80,0.80 [0.52-1.21],0.2884993475684819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,19761,80,1.39 [1.01-1.91],0.0422696039751447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,20208,82,1.31 [0.99-1.73],0.0578288827254283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,17285,51,1.26 [0.80-1.98],0.3241677536286553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SH2B3,SH2B adapter protein 3,19761,80,1.32 [1.07-1.63],0.0101011626361344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,20157,80,1.37 [1.05-1.79],0.0201921995862845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,17030,52,1.27 [0.90-1.79],0.1695963156574629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SH3BP1,SH3 domain-binding protein 1,17522,52,1.74 [1.19-2.55],0.0039401525813921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SH3GL3,Endophilin-A3,17200,51,1.13 [0.82-1.55],0.4690450455880671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SH3GLB2,Endophilin-B2,17573,52,0.98 [0.66-1.46],0.935585727570988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHBG,Sex hormone-binding globulin,17611,51,0.51 [0.33-0.79],0.0027270543492063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHC1,SHC-transforming protein 1,16965,52,0.98 [0.77-1.24],0.8429887887607004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHD,SH2 domain-containing adapter protein D,16961,50,1.03 [0.77-1.38],0.8345896748142858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHH,Sonic hedgehog protein,17083,52,0.63 [0.33-1.19],0.1545550792637004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHISA5,Protein shisa-5,17614,50,4.90 [3.30-7.27],2.7815029611890707e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",20254,80,1.07 [0.85-1.36],0.5565313145206705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHPK,Sedoheptulokinase,17281,52,0.60 [0.27-1.35],0.2150406267636265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIAE,Sialate O-acetylesterase,20254,81,2.12 [1.42-3.16],0.0002240275196563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC1,Sialoadhesin,20290,80,4.76 [3.43-6.59],8.091544391169417e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,20157,80,4.58 [3.18-6.60],2.8628404818846125e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,19753,77,1.25 [1.02-1.52],0.0295232340551735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,20222,80,1.36 [1.09-1.69],0.0056504952517314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,20371,81,4.01 [2.81-5.74],2.7849480328481963e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,20208,82,4.02 [2.14-7.54],1.469740964905626e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,17158,52,2.94 [1.73-4.99],6.477713673315019e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,20335,81,1.27 [0.67-2.41],0.4663076637184221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIL1,Nucleotide exchange factor SIL1,17158,52,1.10 [0.49-2.46],0.8182669239783779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,20272,82,2.61 [1.69-4.04],1.585781426208799e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,20173,79,5.30 [3.82-7.35],1.598293172360338e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,17083,52,1.17 [0.88-1.55],0.2752189735520728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,20108,81,1.09 [0.87-1.37],0.4382873013574341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",19753,77,1.10 [0.77-1.58],0.5861246526908539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,19834,81,1.55 [1.10-2.16],0.0113472917254662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,19988,80,0.97 [0.74-1.26],0.8009471714977336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,20290,80,1.14 [0.94-1.38],0.1765324917020196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SKIV2L,Helicase SKI2W,17001,51,0.76 [0.35-1.65],0.4870309145026427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLA2,Src-like-adapter 2,17572,52,1.14 [0.88-1.48],0.314798181800603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,19834,81,2.77 [2.10-3.66],5.279962085056044e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF6,SLAM family member 6,19761,80,1.81 [1.15-2.85],0.009879034598599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF7,SLAM family member 7,20157,80,2.16 [1.64-2.84],4.0967382512967264e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF8,SLAM family member 8,19761,80,2.18 [1.53-3.11],1.503836188995625e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC12A2,Solute carrier family 12 member 2,17001,51,0.77 [0.27-2.18],0.6198699603736888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC13A1,Solute carrier family 13 member 1,17526,51,0.95 [0.60-1.53],0.8457323671076563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC16A1,Monocarboxylate transporter 1,19753,77,1.36 [1.04-1.77],0.0259449219749436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC1A4,Neutral amino acid transporter A,17117,51,1.28 [0.81-2.02],0.297452511693552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,19753,77,1.27 [0.97-1.67],0.0792228599390734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,16965,52,1.24 [0.85-1.81],0.2742971093585812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,16965,52,1.19 [0.75-1.88],0.4650258960764588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,19753,77,2.15 [1.46-3.16],0.0001062957153217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,20157,80,1.50 [1.17-1.92],0.0012859016800934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC44A4,Choline transporter-like protein 4,17117,51,0.71 [0.41-1.21],0.2043919912010818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC4A1,Band 3 anion transport protein,17614,50,0.85 [0.47-1.54],0.590917182198148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC51B,Organic solute transporter subunit beta,17001,51,1.09 [0.77-1.55],0.6265540427300765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,17227,49,1.30 [0.94-1.78],0.1113018811929439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,17522,52,1.57 [1.15-2.13],0.004023483486911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",16965,52,0.88 [0.54-1.46],0.6300853541292415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLIT2,Slit homolog 2 protein,19753,77,0.76 [0.49-1.16],0.2050755964498476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,17083,52,1.61 [0.74-3.46],0.2275554964118574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,20371,81,5.69 [3.68-8.80],5.099554244897345e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,19823,80,3.25 [2.24-4.72],6.508868110007057e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,17281,52,1.06 [0.76-1.49],0.7184952386862039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,17522,52,1.88 [1.42-2.49],9.296673812957686e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,17486,50,1.65 [1.04-2.63],0.0344818087115574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,19761,80,1.18 [0.93-1.49],0.182270705491423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,17526,51,1.09 [0.75-1.60],0.6470489375678719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,17526,51,1.21 [0.73-1.99],0.4631186309529138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,20108,81,0.70 [0.26-1.85],0.4683527177617096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,19753,77,1.35 [1.06-1.70],0.0138444265973462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,16965,52,0.66 [0.36-1.19],0.1681698348876129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,17522,52,1.23 [0.85-1.76],0.2757191355712252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,20371,81,5.95 [3.92-9.03],6.228766820112545e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,20290,80,7.10 [5.16-9.78],2.9420615450813445e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,20262,80,1.52 [1.04-2.24],0.0325697762982962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,17083,52,1.49 [1.07-2.08],0.0172000030728519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,20265,80,0.89 [0.65-1.20],0.4311315356693963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,17526,51,0.87 [0.57-1.32],0.5091993756431595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMS,Spermine synthase,17030,52,1.14 [0.76-1.70],0.5211653195288827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMTN,Smoothelin,17548,52,1.47 [1.15-1.88],0.0019491399793586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNAP23,Synaptosomal-associated protein 23,20208,82,1.21 [0.95-1.54],0.1144401760930181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNAP25,Synaptosomal-associated protein 25,17030,52,1.58 [0.93-2.70],0.0917487637393861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNAP29,Synaptosomal-associated protein 29,20289,81,1.23 [0.99-1.53],0.0629784169555461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,17572,52,0.51 [0.31-0.85],0.009943049805087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNCA,Alpha-synuclein,17227,49,1.00 [0.79-1.27],0.988737572560222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNCG,Gamma-synuclein,20021,81,4.00 [3.06-5.22],2.6032171293008042e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",17158,52,2.48 [1.64-3.73],1.5171813702562637e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',17573,52,1.75 [1.34-2.30],4.529722384283047e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNU13,NHP2-like protein 1,17001,51,0.77 [0.45-1.32],0.3431625244132446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNX15,Sorting nexin-15,17227,49,1.06 [0.64-1.76],0.8189516955868663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNX18,Sorting nexin-18,17522,52,0.86 [0.44-1.67],0.6552878292792295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNX2,Sorting nexin-2,17526,51,1.21 [0.90-1.64],0.2128822432156042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNX5,Sorting nexin-5,17158,52,1.12 [0.45-2.76],0.8136196369442057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNX9,Sorting nexin-9,20208,82,1.48 [1.12-1.94],0.0050244377697701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],19852,81,1.23 [0.82-1.83],0.3205314229862872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",20222,80,0.85 [0.51-1.43],0.5424245081862675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOD3,Extracellular superoxide dismutase,17611,51,1.06 [0.70-1.62],0.7869236291272953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,17572,52,1.94 [1.45-2.61],9.923205188932676e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,19761,80,6.76 [4.54-10.05],4.070555744392321e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORD,Sorbitol dehydrogenase,20275,81,0.79 [0.60-1.04],0.0923823596706931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORT1,Sortilin,20167,82,1.26 [0.74-2.11],0.3934849166871688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOST,Sclerostin,20167,82,5.34 [3.45-8.27],5.5202926917912527e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,17117,51,0.95 [0.53-1.69],0.858688862450651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOX2,Transcription factor SOX-2,17535,52,1.72 [0.65-4.55],0.2763185434990662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOX9,Transcription factor SOX-9,17117,51,4.67 [1.87-11.61],0.0009352455308941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,17572,52,2.64 [1.77-3.96],2.364112184829596e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPAG1,Sperm-associated antigen 1,17572,52,1.33 [0.92-1.93],0.1282609713164123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPARC,SPARC,20289,81,1.02 [0.77-1.36],0.8718247299804055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPARCL1,SPARC-like protein 1,20266,82,2.43 [1.64-3.60],9.46276157213599e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPART,Spartin,17227,49,1.37 [0.96-1.95],0.0828464587404853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPESP1,Sperm equatorial segment protein 1,17610,52,1.92 [0.96-3.86],0.06651169503202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,20222,80,5.09 [3.93-6.59],7.747256863631669e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,17227,49,3.72 [2.24-6.16],3.4225677326272685e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,20157,80,3.62 [2.91-4.50],4.964594320839214e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,20222,80,4.28 [2.66-6.89],2.108580102098063e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,20371,81,1.79 [1.22-2.61],0.0026863563875211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,17001,51,0.95 [0.45-2.04],0.9039092194990108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,20160,80,2.55 [1.49-4.36],0.0005962409312075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,20290,80,6.91 [4.47-10.67],2.9959286237474476e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,17522,52,1.12 [1.02-1.24],0.023404957928206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPOCK1,Testican-1,20021,81,0.22 [0.10-0.47],0.0001353764970902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON1,Spondin-1,20225,79,5.03 [3.47-7.30],1.6956644509822898e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON2,Spondin-2,20109,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPP1,Osteopontin,20433,83,2.91 [2.12-4.01],5.851961447123305e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",17083,52,0.99 [0.51-1.90],0.9702206665033648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPRING1,SREBP regulating gene protein,16965,52,1.24 [0.85-1.81],0.2619971549117517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPRR1B,Cornifin-B,17281,52,1.14 [0.85-1.52],0.3771435460819272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPRR3,Small proline-rich protein 3,17573,52,1.55 [1.13-2.12],0.0066787605212176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPRY2,Protein sprouty homolog 2,19834,81,1.18 [0.96-1.46],0.1144867329084736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",17030,52,1.09 [0.48-2.45],0.8446128914395152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,17573,52,1.78 [1.22-2.59],0.0026348690844948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,20252,81,1.09 [0.93-1.30],0.2927916920413963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,20108,81,1.21 [0.89-1.66],0.2281040682632084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRPK2,SRSF protein kinase 2,20157,80,1.24 [0.99-1.54],0.0594197385514323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,17610,52,3.68 [2.05-6.60],1.2818362948224298e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SSB,Lupus La protein,19753,77,0.92 [0.61-1.37],0.6771732565556334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",17083,52,1.26 [0.62-2.56],0.5282798775895117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,20167,82,1.06 [0.91-1.24],0.4764867998491888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,20332,82,1.51 [0.95-2.39],0.0811341099747582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,16965,52,0.46 [0.16-1.31],0.1453604561617953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,17522,52,1.12 [0.69-1.84],0.6427194119190482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST13,Hsc70-interacting protein,17227,49,0.84 [0.51-1.37],0.4735579651966007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",20108,81,1.73 [1.22-2.45],0.0020638226767877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20456,83,3.48 [2.32-5.22],1.6420330208322314e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",17083,52,1.55 [1.07-2.23],0.019367480831713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STAB2,Stabilin-2,17614,50,1.57 [0.60-4.11],0.359776756427223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STAM,Signal transducing adapter molecule 1,17526,51,1.35 [0.71-2.56],0.3592030785147962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STAMBP,STAM-binding protein,19988,80,1.08 [0.79-1.49],0.6290468511967435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STAT2,Signal transducer and activator of transcription 2,17083,52,1.51 [1.08-2.11],0.016120555715672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,20108,81,1.11 [0.95-1.28],0.178722482804053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,16965,52,0.92 [0.59-1.44],0.7206385907573698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC1,Stanniocalcin-1,20368,81,3.18 [2.36-4.29],4.0743725153660894e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC2,Stanniocalcin-2,20196,78,6.73 [3.63-12.48],1.3836373322217756e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STEAP4,Metalloreductase STEAP4,17030,52,0.96 [0.66-1.39],0.8138868782698527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,20191,80,0.99 [0.72-1.34],0.9257228194770748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STK11,Serine/threonine-protein kinase STK11,19823,80,1.32 [1.01-1.72],0.0400115780412347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STK24,Serine/threonine-protein kinase 24,19753,77,1.28 [0.92-1.78],0.1458700445878433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STK4,Serine/threonine-protein kinase 4,20208,82,1.18 [0.94-1.48],0.1627668561416833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",16965,52,1.02 [0.76-1.37],0.9012257690736004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX16,Syntaxin-16,19761,80,1.54 [1.20-1.99],0.0007983920076539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX1B,Syntaxin-1B,17117,51,1.32 [0.76-2.27],0.3207742773541232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX3,Syntaxin-3,17573,52,0.78 [0.35-1.74],0.5406589167765468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX4,Syntaxin-4,20108,81,1.63 [1.30-2.04],1.7940322338580125e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX5,Syntaxin-5,17083,52,1.18 [0.67-2.08],0.5723993291204621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX6,Syntaxin-6,19761,80,1.27 [0.96-1.69],0.0922243260154113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX7,Syntaxin-7,17083,52,1.85 [1.07-3.18],0.0270948102553967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX8,Syntaxin-8,20157,80,1.82 [1.29-2.57],0.0006580292789102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STXBP1,Syntaxin-binding protein 1,17572,52,1.21 [0.85-1.72],0.2941217384403189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STXBP3,Syntaxin-binding protein 3,19761,80,1.27 [0.83-1.93],0.2708366104870046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,17522,52,1.18 [0.62-2.26],0.6175153047519166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUGT1,Protein SGT1 homolog,19761,80,1.13 [0.88-1.46],0.3373095099569146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SULT1A1,Sulfotransferase 1A1,20368,81,1.22 [1.04-1.44],0.0157194496917927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SULT2A1,Bile salt sulfotransferase,20157,80,1.26 [0.93-1.70],0.1385923433918655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUMF1,Formylglycine-generating enzyme,17083,52,1.07 [0.73-1.58],0.7232324221633495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,20368,81,1.50 [1.01-2.23],0.044598384851424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",17572,52,1.48 [1.03-2.13],0.0329800112497167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD1,Sushi domain-containing protein 1,19823,80,1.05 [0.69-1.58],0.8351195998672393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,20222,80,2.15 [1.27-3.66],0.0044286493360246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,17526,51,1.99 [1.30-3.06],0.0015673142548815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,17124,49,5.50 [2.77-10.93],1.0803073544698278e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,17117,51,1.46 [1.05-2.03],0.0225547944548125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SWAP70,Switch-associated protein 70,17522,52,0.87 [0.39-1.95],0.7357189729490985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SYAP1,Synapse-associated protein 1,17227,49,1.09 [0.68-1.76],0.7077965210418606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,17030,52,1.00 [0.63-1.59],0.9908756430631188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SYT1,Synaptotagmin-1,17573,52,1.69 [1.16-2.46],0.0064574323662443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SYTL4,Synaptotagmin-like protein 4,17610,52,1.16 [0.82-1.64],0.4117198148114321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,17281,52,1.14 [0.88-1.48],0.3183971419738453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,20108,81,1.09 [0.92-1.30],0.3078442125127686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,17845,70,2.28 [1.47-3.56],0.0002546870700594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TADA3,Transcriptional adapter 3,17526,51,1.52 [0.79-2.93],0.2145060580082451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,20108,81,7.33 [5.24-10.25],2.312779907947597e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAGLN3,Transgelin-3,16965,52,0.87 [0.54-1.40],0.5622306637821204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TALDO1,Transaldolase,17534,50,1.80 [1.02-3.18],0.0416553857870746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,19834,81,1.25 [0.94-1.67],0.126002198108405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAP1,Antigen peptide transporter 1,17281,52,1.00 [0.63-1.59],0.9869448712392436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,19753,77,1.34 [1.03-1.73],0.0271095032773413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",17117,51,1.06 [0.77-1.45],0.7219667948111925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",17526,51,1.26 [0.63-2.51],0.5089620996097444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAX1BP1,Tax1-binding protein 1,17573,52,1.44 [0.98-2.11],0.063915433078561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBC1D17,TBC1 domain family member 17,19753,77,1.06 [0.69-1.64],0.7879939816387986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBC1D23,TBC1 domain family member 23,20108,81,1.14 [0.92-1.42],0.231988609400231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBC1D5,TBC1 domain family member 5,20157,80,1.26 [1.01-1.59],0.0449296007328822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBCA,Tubulin-specific chaperone A,17227,49,1.21 [0.88-1.67],0.2407679468739207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBCB,Tubulin-folding cofactor B,20021,81,1.17 [0.95-1.44],0.134974624970371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBCC,Tubulin-specific chaperone C,20021,81,1.20 [0.93-1.54],0.1601750717210152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,19761,80,1.17 [0.92-1.49],0.2058403094034715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBR1,T-box brain protein 1,17117,51,0.77 [0.39-1.55],0.4671220003771901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,20001,81,0.89 [0.74-1.07],0.2269048788103513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,19823,80,1.09 [0.87-1.37],0.4387663864378999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN1,Transcobalamin-1,17255,51,1.19 [0.59-2.39],0.6318503620363956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN2,Transcobalamin-2,20433,83,4.56 [3.23-6.44],6.754339165510517e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCOF1,Treacle protein,17610,52,1.60 [0.86-3.00],0.1410126611501106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCP11,T-complex protein 11 homolog,17281,52,0.87 [0.50-1.50],0.6101146163510704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCTN3,Tectonic-3,17610,52,0.59 [0.25-1.41],0.2392936899209927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,19753,77,1.12 [0.98-1.28],0.0868953682326713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",17117,51,0.30 [0.12-0.77],0.0123926029990466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,17526,51,1.21 [0.87-1.68],0.2664644185481558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TDRKH,Tudor and KH domain-containing protein,19753,77,1.27 [1.01-1.60],0.0379162376423931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TEF,Thyrotroph embryonic factor,17001,51,0.99 [0.52-1.89],0.9797229708083536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TEK,Angiopoietin-1 receptor,20289,81,2.04 [0.84-4.94],0.1155930752947821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TERF1,Telomeric repeat-binding factor 1,17083,52,1.23 [0.52-2.93],0.635146869893159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TET2,Methylcytosine dioxygenase TET2,17242,52,0.99 [0.75-1.30],0.9229138394975438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TEX101,Testis-expressed protein 101,17117,51,2.02 [1.52-2.68],1.0715420740298109e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TEX33,Testis-expressed protein 33,17281,52,1.15 [0.62-2.15],0.6521669305251241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TF,Serotransferrin,17637,50,1.42 [0.41-4.90],0.5836597224550482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,17030,52,1.14 [0.74-1.73],0.553986492163471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF1,Trefoil factor 1,20116,80,2.35 [1.97-2.80],1.629866894862857e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF2,Trefoil factor 2,20254,80,4.09 [3.15-5.33],9.508439917716794e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF3,Trefoil factor 3,20226,83,3.51 [2.82-4.37],2.8405210814753304e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFPI,Tissue factor pathway inhibitor,20192,82,0.49 [0.25-0.97],0.0401457761568391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,20235,81,1.63 [1.23-2.15],0.0006475486874629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFRC,Transferrin receptor protein 1,20322,83,2.01 [1.27-3.19],0.0028715937412711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TG,Thyroglobulin,17526,51,1.15 [0.94-1.41],0.1779971772440739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFA,Protransforming growth factor alpha,20157,80,2.84 [2.08-3.87],5.6847053923088554e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,20379,82,2.82 [1.95-4.07],3.5885097169587776e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,17526,51,1.34 [0.86-2.09],0.1965433213532956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,20128,82,0.43 [0.21-0.90],0.0256167797501359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,17083,52,3.25 [1.75-6.04],0.0001832013900106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,20289,81,6.75 [5.00-9.13],1.9797160438490823e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,20456,83,4.94 [2.88-8.47],6.343711618725871e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,20185,82,0.76 [0.59-0.99],0.0388472617803296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,17611,51,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,16939,52,0.70 [0.45-1.06],0.0939094565424976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBD,Thrombomodulin,20208,82,7.93 [4.95-12.73],9.055639121450077e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS2,Thrombospondin-2,20222,80,2.85 [2.03-4.01],1.6337176016124e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS4,Thrombospondin-4,20250,82,3.43 [2.31-5.08],9.074985370133132e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THOP1,Thimet oligopeptidase,20092,82,0.26 [0.13-0.52],0.0001162550980424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THPO,Thrombopoietin,19823,80,1.00 [0.61-1.66],0.995740119464525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,17001,51,1.06 [0.85-1.33],0.5776404071189222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,16952,51,1.77 [0.86-3.64],0.1240113136882786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THTPA,Thiamine-triphosphatase,17498,50,1.20 [0.87-1.65],0.2617647887792068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,20368,81,9.15 [5.72-14.65],3.009471548661854e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,19592,80,1.15 [0.97-1.35],0.0995375438885498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,20456,83,1.30 [0.77-2.18],0.3306652895258211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",19720,76,1.05 [0.67-1.63],0.8321867710276886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,17281,52,2.27 [1.44-3.57],0.0003993612714876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,20332,82,1.19 [0.78-1.83],0.4204525590425015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,17610,52,1.62 [0.87-3.01],0.1258274206230605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,17573,52,1.04 [0.76-1.43],0.7996421511255862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,20036,82,7.96 [5.00-12.66],1.916736451236976e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,17610,52,2.15 [1.53-3.01],8.698246852702783e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,20290,80,1.11 [0.96-1.28],0.1691809594314781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,20222,80,1.58 [1.04-2.40],0.0338696649824972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,20137,82,5.47 [2.40-12.47],5.409865079037218e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TJAP1,Tight junction-associated protein 1,20289,81,1.21 [0.96-1.54],0.1098174924105736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TJP3,Tight junction protein ZO-3,17030,52,0.85 [0.43-1.69],0.6359609705197506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TK1,"Thymidine kinase, cytosolic",17281,52,1.21 [0.71-2.06],0.4925450995304771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TLR1,Toll-like receptor 1,17083,52,1.70 [0.68-4.27],0.2571465096544058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TLR2,Toll-like receptor 2,17281,52,1.58 [0.51-4.94],0.4319208029060436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TLR3,Toll-like receptor 3,20408,82,1.32 [0.93-1.87],0.1159159704670077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TLR4,Toll-like receptor 4,17083,52,0.57 [0.22-1.53],0.2668860821962541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,17117,51,0.91 [0.54-1.54],0.7237673903485902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,17281,52,1.36 [0.94-1.96],0.1020882336712574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,17001,51,0.74 [0.35-1.56],0.4291741494632598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,17001,51,1.08 [0.73-1.60],0.7021554827870768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMED8,Protein TMED8,17522,52,1.24 [0.95-1.62],0.119970024928097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMEM106A,Transmembrane protein 106A,17526,51,1.39 [1.01-1.92],0.0405382451398461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMEM132A,Transmembrane protein 132A,17158,52,1.03 [0.67-1.59],0.8914080295998371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMEM25,Transmembrane protein 25,17572,52,1.54 [1.07-2.21],0.0186071383648696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMOD4,Tropomodulin-4,16965,52,1.95 [1.19-3.18],0.0076255946577414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,17030,52,1.25 [0.94-1.66],0.1263393867861536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,17547,52,2.16 [1.44-3.23],0.0001879487990282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS15,Enteropeptidase,20108,81,1.70 [1.37-2.11],1.576826906785537e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS5,Transmembrane protease serine 5,19930,80,1.18 [0.70-2.00],0.5338069916092896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMSB10,Thymosin beta-10,20222,80,1.91 [1.47-2.49],1.5331089713222825e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNC,Tenascin,20332,82,1.29 [0.87-1.91],0.2061364912650377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNF,Tumor necrosis factor,19796,79,1.91 [1.45-2.52],3.745417919822156e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17522,52,1.88 [1.25-2.84],0.0024400316958996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,19834,81,0.98 [0.57-1.70],0.9454922506253336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,17227,49,1.18 [0.77-1.81],0.4354829466085386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,20021,81,5.27 [3.67-7.56],2.3137856163400304e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,20021,81,1.93 [1.68-2.22],7.808001462769766e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,20279,82,1.11 [0.74-1.67],0.6173657145311418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20408,82,9.50 [7.01-12.89],1.556157521287342e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,20198,79,7.29 [4.32-12.30],9.664194969934029e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,20289,81,7.51 [5.33-10.59],1.356434774049232e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,20225,79,2.98 [2.32-3.82],8.275380865403421e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,19834,81,2.09 [1.48-2.95],2.5189155298323865e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,20225,79,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,17227,49,3.73 [2.28-6.09],1.426336739718444e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,20371,81,7.57 [5.53-10.35],1.0880469318844658e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,20222,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,20222,80,2.72 [2.23-3.33],9.089587913872044e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,20368,81,7.55 [4.63-12.32],5.828794992183262e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,20379,82,5.53 [4.07-7.52],1.1886586265686194e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,20021,81,2.22 [1.79-2.76],5.405995093660389e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,20368,81,2.32 [1.70-3.16],9.312008546036086e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,20021,81,3.18 [2.56-3.96],3.4143271948530443e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,20408,82,0.62 [0.29-1.31],0.2094586884420738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,20157,80,1.30 [0.95-1.79],0.1009747516005339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,20408,82,0.26 [0.13-0.52],0.0001287901678406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,20290,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,20429,83,1.85 [1.07-3.21],0.0278403548441001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,20021,81,1.16 [0.83-1.63],0.3892851093804921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,17614,50,3.17 [1.89-5.30],1.1362632696161434e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,17573,52,1.26 [0.93-1.69],0.1331683824541028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNN,Tenascin-N,17614,50,1.33 [0.72-2.46],0.362219678250688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",19823,80,1.41 [1.09-1.82],0.008640783446947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNPO1,Transportin-1,17281,52,0.80 [0.36-1.76],0.5772924864565749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNR,Tenascin-R,20021,81,2.34 [1.56-3.49],3.4829204487787016e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNXB,Tenascin-X,20222,80,0.46 [0.24-0.90],0.0222835283790265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,17610,52,1.65 [1.22-2.24],0.0011789712622305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TOP1,DNA topoisomerase 1,17522,52,1.28 [1.02-1.61],0.02968511707656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",16965,52,1.22 [0.76-1.97],0.4159435824274617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TOP2B,DNA topoisomerase 2-beta,17083,52,1.50 [1.10-2.04],0.0094872005252293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,17158,52,1.62 [1.12-2.34],0.0101258382800001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TP53,Cellular tumor antigen p53,19761,80,1.62 [1.04-2.53],0.0324939617825569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TP53BP1,TP53-binding protein 1,17083,52,1.19 [0.87-1.62],0.2830912634428483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,16863,48,1.63 [0.99-2.67],0.0525668728959201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,19823,80,0.77 [0.36-1.65],0.5050637188708182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TP73,Tumor protein p73,17117,51,0.45 [0.21-0.97],0.0413496947956049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPBGL,Trophoblast glycoprotein-like,17117,51,1.18 [0.66-2.10],0.5735707968599286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPD52L2,Tumor protein D54,17227,49,1.13 [0.87-1.47],0.3635734086414379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,17610,52,0.71 [0.27-1.86],0.487720747841928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPM3,Tropomyosin alpha-3 chain,17001,51,1.42 [0.83-2.43],0.2038323319880826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,19761,80,0.79 [0.59-1.07],0.1255040767293821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,20056,79,1.91 [1.37-2.65],0.0001284517069601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,17281,52,0.65 [0.42-0.99],0.0456286303247366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,19753,77,0.79 [0.44-1.40],0.4167907198580476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPR,Nucleoprotein TPR,17001,51,1.57 [1.14-2.16],0.0052225736212637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,16965,52,0.94 [0.60-1.47],0.7855441160028532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,20376,82,2.25 [1.53-3.31],3.973092189465098e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPSD1,Tryptase delta,17572,52,1.50 [0.92-2.45],0.1081553759992882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPSG1,Tryptase gamma,17083,52,0.81 [0.28-2.34],0.6932739475020474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPT1,Translationally-controlled tumor protein,19834,81,0.84 [0.58-1.23],0.3699412523898167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRAF2,TNF receptor-associated factor 2,20157,80,1.01 [0.76-1.35],0.9458442519461964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",17083,52,0.73 [0.32-1.66],0.4578167299988827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,17001,51,1.00 [0.57-1.78],0.9902849897025044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,17281,52,1.01 [0.74-1.38],0.930844625616854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TREH,Trehalase,17614,50,1.50 [1.03-2.21],0.0364654733804761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,20198,79,1.56 [1.10-2.22],0.0121266978324095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TREML1,Trem-like transcript 1 protein,17611,51,1.33 [0.82-2.18],0.2474267953877735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TREML2,Trem-like transcript 2 protein,20222,80,2.91 [1.87-4.52],2.1690038569667567e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,20371,81,1.89 [1.41-2.55],2.544641635414368e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,20157,80,0.97 [0.76-1.24],0.8008983312319984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,17253,52,1.27 [0.87-1.87],0.221227300917734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,17522,52,1.13 [0.88-1.46],0.3298029347386475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIM26,Tripartite motif-containing protein 26,16965,52,1.00 [0.62-1.61],0.9988696208245024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,17117,51,1.14 [0.78-1.67],0.4963454181762081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIM5,Tripartite motif-containing protein 5,20157,80,1.18 [0.93-1.49],0.1712195127120399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,17526,51,1.31 [0.97-1.78],0.0766455785760728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,17001,51,0.78 [0.40-1.50],0.4515922678376596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSC1,Hamartin,17083,52,1.36 [1.03-1.80],0.0328877357288349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSC22D1,TSC22 domain family protein 1,17572,52,1.50 [1.11-2.03],0.0092254296140131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSHB,Thyrotropin subunit beta,20208,82,0.84 [0.66-1.07],0.1465495890923418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSLP,Thymic stromal lymphopoietin,19823,80,0.95 [0.68-1.32],0.753674951624933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSNAX,Translin-associated protein X,17001,51,0.55 [0.26-1.13],0.1044787141820546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSPAN1,Tetraspanin-1,19823,80,1.34 [1.11-1.63],0.0027297685478531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSPAN15,Tetraspanin-15,17001,51,1.35 [0.91-2.00],0.1328862559673883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSPAN7,Tetraspanin-7,17030,52,0.89 [0.64-1.25],0.5089894574725551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSPAN8,Tetraspanin-8,17522,52,1.05 [0.81-1.35],0.7247676608028061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,17083,52,1.82 [1.05-3.18],0.0339015098328429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TST,Thiosulfate sulfurtransferase,19711,77,1.05 [0.80-1.38],0.7137873993620129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TTF2,Transcription termination factor 2,17117,51,1.43 [0.86-2.36],0.167336774455022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TTN,Titin,17001,51,1.59 [1.20-2.12],0.0013794314451711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TTR,Transthyretin,17446,50,0.18 [0.07-0.47],0.0004201546888509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TUBB3,Tubulin beta-3 chain,17030,52,0.93 [0.35-2.46],0.8855093231368931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TWF2,Twinfilin-2,17614,50,1.21 [0.87-1.67],0.2504289302295023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXK,Tyrosine-protein kinase TXK,17281,52,0.66 [0.39-1.11],0.1157027603026035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXLNA,Alpha-taxilin,20021,81,1.28 [1.01-1.61],0.0374282811528892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXN,Thioredoxin,17314,51,1.08 [0.60-1.92],0.8041755788920929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,20289,81,1.96 [0.99-3.91],0.0551265503104319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,20368,81,1.84 [1.40-2.42],1.070003274993031e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,17573,52,1.73 [1.14-2.64],0.0101676703313162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNL1,Thioredoxin-like protein 1,16995,52,1.15 [0.90-1.46],0.2735044118251125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",20222,80,1.13 [0.73-1.75],0.5710067886935943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TYMP,Thymidine phosphorylase,20076,82,1.27 [0.94-1.72],0.1237806992356739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,20208,82,2.07 [1.02-4.17],0.0427588578475348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",17083,52,2.04 [1.31-3.17],0.0015278695145752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,20108,81,0.77 [0.43-1.36],0.3595907077419703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,17526,51,1.21 [0.49-2.96],0.6784603384105306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,17610,52,1.91 [1.27-2.87],0.0018182444372576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,17083,52,1.25 [0.82-1.90],0.2941292666022588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UBQLN3,Ubiquilin-3,17001,51,1.18 [0.78-1.80],0.428516790459173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UBXN1,UBX domain-containing protein 1,17227,49,1.19 [0.80-1.77],0.3861895514721575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,17522,52,1.12 [0.93-1.37],0.2357026016867522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,17001,51,0.89 [0.63-1.26],0.5202554330420692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,17001,51,0.56 [0.22-1.44],0.2322851166380007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ULBP2,UL16-binding protein 2,20021,81,6.04 [4.36-8.37],2.6603637520491398e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UMOD,Uromodulin,20405,81,0.26 [0.20-0.34],3.97174016587737e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UNC5D,Netrin receptor UNC5D,17083,52,3.12 [1.61-6.05],0.0007713028046704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UNC79,Protein unc-79 homolog,16965,52,1.28 [0.83-1.98],0.2675248125537599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UNG,Uracil-DNA glycosylase,17526,51,1.82 [1.07-3.07],0.0263376142897885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UPB1,Beta-ureidopropionase,17610,52,1.14 [0.86-1.51],0.3573943596382811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UPK3A,Uroplakin-3a,17030,52,0.42 [0.23-0.76],0.004127527683635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,17243,52,1.17 [0.79-1.73],0.4250486793305326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UROD,Uroporphyrinogen decarboxylase,17227,49,1.14 [0.76-1.69],0.5342806872398634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UROS,Uroporphyrinogen-III synthase,17117,51,0.95 [0.63-1.43],0.8014814399365082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",USO1,General vesicular transport factor p115,20108,81,1.25 [1.00-1.56],0.0518946546658182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,17526,51,1.32 [0.91-1.92],0.1469700410527296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,17573,52,2.44 [1.76-3.39],8.875243076009213e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,17001,51,1.24 [0.94-1.63],0.1242503484730332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,19823,80,1.15 [0.94-1.42],0.1790540347971263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,19761,80,1.17 [0.82-1.66],0.3965719609821923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,19823,80,1.37 [1.06-1.78],0.0161907635129376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,17083,52,1.23 [0.91-1.66],0.182484773922571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,20157,80,1.18 [0.93-1.49],0.182564338525641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VASN,Vasorin,19923,82,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,17611,51,1.22 [0.85-1.75],0.2755566365162338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,20108,81,0.74 [0.27-2.05],0.5675813831087759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,17030,52,1.20 [0.91-1.58],0.1986134434393087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,20287,82,8.43 [4.99-14.23],1.506509627767694e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAN,Versican core protein,20368,81,1.17 [0.61-2.24],0.6467605220656036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,16965,52,0.96 [0.68-1.35],0.7993368230219686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,20345,82,1.58 [1.16-2.15],0.0040511265239228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,17083,52,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFC,Vascular endothelial growth factor C,20289,81,1.02 [0.72-1.44],0.9241978072257804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,20376,82,5.71 [3.41-9.55],3.284239173084173e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VGF,Neurosecretory protein VGF,17572,52,1.87 [0.84-4.12],0.1231383986124962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VIM,Vimentin,19823,80,1.11 [0.92-1.34],0.2575055627532291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,17158,52,0.88 [0.27-2.87],0.8271732997851213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VIT,Vitrin,17610,52,4.63 [2.85-7.52],6.364044002052759e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,20108,81,2.57 [1.89-3.49],1.6635077402244787e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VNN1,Pantetheinase,17611,51,1.01 [0.70-1.46],0.9626370189722228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,20108,81,1.24 [0.79-1.93],0.3465976273976986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,17281,52,1.20 [0.83-1.74],0.3301701329257477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,20108,81,1.18 [0.92-1.50],0.1897231859425185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,17526,51,1.19 [0.90-1.57],0.220051472497719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,20108,81,1.27 [0.99-1.62],0.0626417466943032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,17526,51,0.85 [0.37-1.93],0.6930775749893369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17001,51,1.74 [0.92-3.28],0.0903597027605726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17526,51,2.69 [2.02-3.56],7.855393537106323e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,20196,78,6.71 [4.95-9.11],2.5545679959600682e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,20172,82,1.54 [1.17-2.03],0.0020656994021001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSNL1,Visinin-like protein 1,17573,52,1.26 [0.66-2.39],0.4874231803204257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,19753,77,1.57 [1.13-2.18],0.0078543185164477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,17281,52,0.34 [0.12-0.93],0.0355786645142643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,19823,80,1.57 [1.27-1.94],3.151343567321573e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,20368,81,1.23 [0.94-1.62],0.1253482257357744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,19761,80,1.40 [0.80-2.46],0.2360263441151573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,17227,49,1.68 [1.10-2.57],0.0173405271378858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,20337,81,1.01 [0.62-1.63],0.9683575539288134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,16965,52,1.07 [0.77-1.47],0.6975091424743461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWC2,Brorin,19953,80,,
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,17572,52,1.17 [0.71-1.92],0.5350762704275452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWF,von Willebrand factor,20456,83,1.22 [0.93-1.60],0.1474660757683531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",20222,80,1.17 [0.70-1.96],0.5527768500023599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,19834,81,0.95 [0.70-1.30],0.7600304933321378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,19823,80,1.22 [0.99-1.51],0.061421657080287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,19753,77,1.14 [0.89-1.45],0.3054360228910945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WASHC3,WASH complex subunit 3,17573,52,1.49 [1.09-2.03],0.0119173920736435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,17083,52,1.23 [0.86-1.76],0.2482510398276917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WDR46,WD repeat-containing protein 46,17526,51,0.54 [0.23-1.28],0.1606387688835637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,17162,48,1.54 [1.22-1.95],0.000327261852803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,20342,81,1.92 [1.50-2.46],2.6589872092761186e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,19211,78,4.41 [3.41-5.71],2.526598246278496e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",19951,81,0.65 [0.41-1.04],0.0701198347492641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",20225,79,2.40 [1.38-4.16],0.0018717408725207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WIF1,Wnt inhibitory factor 1,20371,81,0.34 [0.20-0.60],0.0001595666668536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WNT9A,Protein Wnt-9a,19834,81,9.55 [6.25-14.58],1.5089330167407598e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,20021,81,0.93 [0.64-1.36],0.7231100618668866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XCL1,Lymphotactin,20371,81,1.87 [1.51-2.31],8.436476094121024e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XG,Glycoprotein Xg,20369,83,4.81 [3.41-6.79],3.3341169971565934e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,17083,52,1.75 [1.14-2.69],0.0102067228302702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,20289,81,0.63 [0.53-0.75],3.608114110854028e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XRCC4,DNA repair protein XRCC4,19753,77,1.20 [0.71-2.03],0.4938975048600591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,17573,52,9.07 [5.69-14.44],1.5562888409322148e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",17522,52,1.18 [0.97-1.43],0.0959672672080497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YES1,Tyrosine-protein kinase Yes,20108,81,1.25 [1.05-1.49],0.0125388389779982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YJU2,Splicing factor YJU2,17526,51,1.33 [0.60-2.91],0.4821442255113546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,17001,51,0.58 [0.37-0.90],0.015191515498426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YTHDF3,YTH domain-containing family protein 3,19834,81,1.18 [0.94-1.48],0.1494981117880384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YWHAQ,14-3-3 protein theta,17227,49,1.31 [0.91-1.89],0.1463089866572852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YY1,Transcriptional repressor protein YY1,17083,52,0.73 [0.26-2.00],0.5341342387504007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZBP1,Z-DNA-binding protein 1,17083,52,1.80 [1.14-2.84],0.0109497316101169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,19761,80,1.24 [0.95-1.61],0.1146932715932407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,19823,80,1.84 [1.39-2.44],1.889238874788616e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,17001,51,1.28 [0.91-1.80],0.1524574266379111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,17522,52,1.10 [0.82-1.49],0.5263395994615812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,17573,52,1.71 [1.07-2.74],0.0250164476185955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZNF174,Zinc finger protein 174,17083,52,0.77 [0.33-1.80],0.5471852382784343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZNF75D,Zinc finger protein 75D,17281,52,1.25 [0.87-1.79],0.2351080870818872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZNF830,Zinc finger protein 830,17526,51,0.76 [0.49-1.18],0.2200684591546111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZNRD2,Protein ZNRD2,17522,52,1.47 [1.06-2.05],0.0218296923611902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,17526,51,1.46 [0.95-2.26],0.0854094204100085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,17158,52,0.97 [0.88-1.08],0.6158606189191476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,16965,52,0.88 [0.36-2.13],0.7704865460701086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZPR1,Zinc finger protein ZPR1,17030,52,0.92 [0.67-1.26],0.5994161253416117
